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THESIS SUMMARY 
 
Background. Exercise is a natural medicine that has been prescribed for the 
prevention and management of chronic diseases, to enhance quality of life, improve 
health status and promote longevity. Current efforts to implement exercise as routine 
practice in the conventional renal replacement therapy population have been hampered 
by a lack of randomised controlled data. The aim of this thesis was to investigate the 
effect of exercise as an adjunctive therapy to enhance outcomes pertaining to renal 
transplantation, vascular access, haemodialysis adequacy and muscle wasting in Stages 
four and five Chronic Kidney Disease patients. It was hypothesised that randomised 
controlled trials employing gold standard outcome measures would reveal significant 
beneficial effects of exercise that are strongly associated with quality of life, 
hospitalisation and survival in this patient population. 
Reports. The first report presents a systematic literature review of exercise in the 
kidney transplant population. The largest positive effects were noted on intermediate 
outcomes such as aerobic fitness and muscle strength.  Presumably these adaptations 
contributed to the trends observed for improvement in quality of life. Whether exercise 
impacts on outcomes associated with longevity of life requires further study.   
The rest of the thesis focused on patients receiving the more popular form of renal 
replacement therapy, haemodialysis. The first empirical study of the thesis appertaining 
to vascular access investigated the feasibility of implementing a post-operative forearm 
exercise intervention for arteriovenous fistula maturation. Exercise had no effect on 
primary outcomes measures of arterial diameter (95% CI, -0.24 [-1.12; 0.51] mm) and 
venous diameter (95% CI, 0.16 [-1.84; 1.24] mm). It was concluded that future 
randomized controlled trials should investigate a similar protocol implemented before 
arteriovenous fistula creation to enhance surgery success and maturation. 
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   The second randomised controlled trial explored the effect of intradialytic 
exercise in comparison to the traditional prescription of increased dialysis time to 
enhance dialysis adequacy and solute removal. Increased haemodialysis time, but not 
exercise, increased equilibrated Kt/Vurea compared to control trials (Extra time vs. 
control: 95% CI, 0.15 [0.05; 0.26]; exercise vs. control: 95% CI, 0.03 [-0.05; 0.12]). 
Exercise, but not increased time, increased phosphate reduction ratio (exercise vs. 
control: 95% CI, 8.6 [0.5; 16.7] %; extra time vs. control: 95% CI, 5.0 [-1.0; 11.1] %). 
Thus intradialytic exercise cannot replace the traditional prescription of increased 
haemodialysis time, but may be a useful adjunctive therapy for serum phosphate 
control.  
The third study implemented a randomised controlled trial of intradialytic 
progressive resistance training for muscle wasting. The primary outcome measure of 
thigh muscle volume, as measured by magnetic resonance imaging, significantly 
increased following 12 weeks of training compared to a sham exercise control (95% CI, 
193 [63; 324] cm
3
). Intradialytic resistance exercise elicited an anabolic and strength 
response in haemodialysis patients. However, a surprising lack of a change in functional 
capacity despite increased muscle mass warrants further investigation.   
Conclusion. The findings suggested that exercise had a beneficial effect on 
factors relating to outcomes in Stages 4 and 5 Chronic Kidney Disease patients. 
However, to ensure effectiveness of interventions and to maximize programme 
efficiency, careful consideration of basic exercise and physiological principles is 
required. Nevertheless, the observed benefits of exercising outweighed its risks thus 
supporting the initiative for exercise prescription as an adjunctive therapy for the 
management of this disease state. 
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CHAPTER 1 
General Introduction 
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The kidneys are two bean shaped, anatomically complex organs that lie in the 
retroperitoneal space. They are responsible for several regulatory roles in the body 
including the maintenance of the body composition with regards to fluid regulation; 
excretion of metabolic waste products and toxins and the production and secretion of 
hormones that mediate blood pressure, haematologic and bone health. It is therefore 
unsurprising that injury, disease or failure of these organs leads to a vast quantity of 
physiological complications. 
Chronic Kidney Disease (CKD) is a progressive an irreversible condition 
diagnosed by structural or functional abnormalities of the kidneys with a decrease in the 
filtration function of the nephrons known as the glomerular filtration rate (GFR). The 
disease progresses through five stages (Table 1.1.) with the fifth stage requiring some 
form of renal replacement therapy such as peritoneal dialysis, haemodialysis or a kidney 
transplant. Recent reports indicate that 6 – 8.5% of adults in the UK present with CKD. 
However, Stages 1 and 2 are usually asymptomatic with complications only apparent 
from Stage 3 (Beddhu, 2009) and as a result an estimated 1.8 million people in the UK 
are undiagnosed (Kerr et al., 2012). The prevalence of renal replacement therapy has 
increased by almost 57% over the last decade (Gilg, Castledine & Fogarty, 2012). 
Although these patients comprise only 2% of the CKD population, more than half of the 
£1.45 billion NHS CKD cost in England is spent on renal replacement therapy (Kerr et 
al., 2012).   
During stages 1 – 4 clinical approaches aim to slow the progression of CKD. 
Treatment goals are centred around tight blood pressure control utilizing a multidrug 
approach as well as lifestyle changes, gylcemic control, management of hyperlipidemia 
and occasionally protein restriction (Scheippati, Pisoni & Remuzzi 2009). However, 
when kidney failure occurs in Stage 5, additional therapies are required to address the 
 5 
 
complications of water, electrolyte, acid-base, metabolic and organ system disorders. 
Factors predicting mortality at this stage, such as anaemia, cardiovascular disease, 
nutritional status, metabolic disorders, dialysis related factors and graft function 
(Beddhu, 2009) are targeted with an array of therapeutic strategies.  
 
Table 1.1.  The National Kidney Foundation Kidney Disease Outcome Quality Initiative classification, 
diagnosis and action plan for Stages 1- 5 chronic kidney disease (National Kidney Foundation 2002) 
Stage Description GFR 
(ml/min/1.73m
2
) 
Clinical Action Plan 
1 Kidney damage with 
normal or increased GFR 
>90 Diagnosis  treatment; slowing 
progression; co morbidity  risk 
reduction 
2 Kidney damage with a 
mild decrease in GFR 
 
60 - 89 Estimation of progression 
3 Moderate decrease in 
GFR 
 
30 - 59 Evaluation of treatment complications 
4 Severe decrease in GFR 
 
 
15 - 29 Preparation for renal replacement 
therapy 
5 Kidney failure 
 
 
< 15 Renal replacement therapy (if uremia 
is present) 
 
GFR, glomerular filtration rate. 
 
Despite pharmaceutical (Verbeeck & Musuamba, 2009) and technological 
(Parker, 2000) advancements in renal replacement therapies,  in some age groups 
mortality rates are 30 times higher in Stage 5 CKD patients in comparison to the age 
matched general population (Castledine et al., 2011). Furthermore, quality of life in this 
patient population remains poor with patients substantially burdened by a limited 
physical capacity and dialysis related symptoms (Morsch, Goncalves & Barros, 2006). 
Efforts to enhance life expectancy and quality of life in this population are therefore 
required. 
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Exercise As Medicine in Chronic Kidney Disease. 
‘If we could give every individual the right amount of nourishment and exercise, not too 
little, not too much, we would have found the safest way to health.’  
Hippocrates (460 – 370 BC). 
The principle that physical activity underpins health status predates to ancient 
Greek medicine and is included in the historical writings of Greek philosophers and 
physicians.  This concept has since been reinstated in the 21
st
 Century. With the 
population living longer and urbanisation leading to decreased physical activity levels, 
there has been an increase in chronic diseases. There is irrefutable evidence supporting 
physical activity status as a risk of chronic disease (Morris & Crawford 1958, Blair et 
al., 1989, Wei et al., 1999, Barlow et al., 2006, Peel et al., 2009, O'Donnell et al., 
2010). Furthermore, in the USA, physical inactivity and poor diet is the second leading 
actual cause of death following tobacco use (Mokdad et al., 2004).  Unsurprisingly 
there is a wealth of evidence towards implementing exercise for the prevention and 
management of a wide range of chronic diseases, increasing quality of life and 
enhancing longevity (Warburton, Nicol & Bredin, 2006).  
Physical activity levels in CKD patients are approximately 25% of those recorded 
in age matched sedentary healthy individuals (Johansen et al., 2000) with one third of 
patients being unable to carry out activities of daily living unassisted (Ifudu et al., 
1994). These patients report very low exercise tolerance with peak oxygen uptakes 
(VO2peak) of 17 – 20 mL/kg/min
  
(Koufaki, Naish & Mercer, 2001).  With oxygen levels 
of  approximately 13 mL/kg/min
 
 required to carry out activities of daily living  these 
patients would have to work at 65 -74% of their VO2peak  just to carry out their activities 
of daily living, this clearly having an impact on their functional ability (Ip et al., 2006). 
These reductions in physical activity are highly correlated with mortality risk (Stack et 
al., 2005). 
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Implementing exercise interventions for health benefits in the CKD population, 
however, may differ from other disease states in that maintenance haemodialysis 
patients present with what is referred to as „reverse epidemiology‟. This is a 
phenomenon whereby risk factors of cardiovascular disease in the general population 
such as obesity, hyperlipidemia and hypertension are seen as protective in maintenance 
haemodialysis patients and factors such as a low body mass index, reduced serum 
cholesterol and lower creatinine concentrations are linked with increased morbidity and 
mortality (Kalantar-Zadeh et al., 2003).  
Despite this paradox, over three decades of research has investigated the effects of 
exercise in the CKD population and suggests that exercise has a myriad of health 
benefits.  According to recent meta-analyses the most established benefits of exercise in 
the CKD population relate to physical fitness. Increases in maximal oxygen uptake 
(VO2max) of 17 – 20% have been observed following aerobic and combined aerobic and 
resistance exercise interventions (Johansen 2008, Segura-Orti & Johansen, 2010).The 
mechanisms behind these increases are not yet completely understood. However, they 
could be due peripheral to adaptations such as the increase in muscle capillary density 
observed following aerobic exercise (Sakkas et al., 2003b) or central adaptations such 
as increased ejection fractions and stroke volumes observed at rest and during exercise 
following aerobic exercise in this patient cohort (Deligiannis et al., 1999). Yet despite 
these increases, cardiorespiratory fitness levels of trained haemodialysis patients still lie 
below the normative values of the age matched general population (Segura-Orti & 
Johansen, 2010) suggesting there are limitations to exercise capacity. As the criteria for 
VO2max is rarely achieved in this patient population, often due to lower limb fatigue, 
these limitations are thought to be at the peripheral rather than the central level (Kouidi, 
2001). With regards to oxygen carrying capacity, it could be thought that anaemia 
associated with chronic kidney disease (Wish, 2009) could be such a limiting factor. 
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However, although increases in cardiorespiratory fitness have been observed with 
complete correction of anaemia through erythropoietin therapy (Macdougall et al., 
1990), fitness levels still remain 38% below age matched healthy controls (Barany et 
al., 1993) as well as below population normative values (Macdougall et al., 1990, 
Barany et al., 1993). Therefore, limitations may lie elsewhere in the oxidative transport 
chain, possibly in the form of blunted aerobic enzyme activity (Sakkas et al., 2003b) for 
example. Furthermore, limitations could potentially lie at the skeletal muscle (Diesel et 
al., 1990) with myopathies commonly observed in this disease state (Diesel et al., 1993, 
Moore et al., 1993).   
In addition, exercise has been shown to increase strength and physical function in 
this patient population (Segura-Orti & Johansen, 2010; Johansen, 2007; Heiwe & 
Jacobson, 2011). As  increases in isokinetic strength have been found to be a better 
predictor of exercise capacity as compared to oxygen carrying capacity in 
haemodialysis patients (Diesel et al., 1990), it is no surprise that with increases in 
VO2max,  strength gains have been also been observed.  The mechanisms behind 
increases in physical function and the extent that exercise capacity influences physical 
function is yet to be established. A possible mechanism may be through the changes in 
lean body composition following exercise (Heiwe & Jacobson, 2011); indeed such 
changes have previously been associated with habitual physical activity (Johansen et al., 
2000).  
Further benefits of exercise in CKD patients, although less established, include 
cardiovascular adaptations (Cheema, 2008) including changes in blood pressure, 
resulting in reductions in antihypertensive medications (Miller et al., 2002; Macdonald 
et al., 2005), reductions in systemic inflammation (Cheema, 2008), improved weight 
control in obese patients (Segura-Orti & Johansen, 2010) and increased health related 
quality of life (Heiwe & Jacobson, 2011). 
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Despite these reports exercise has failed to be established as part of routine care in 
CKD. This is due in part to the fact that the generalisation of these findings is 
compromised as there appears to be a lack of randomised controlled trials (RCT) with 
few outcomes being examined in more than one RCT (Segura-Orti & Johansen 2010, 
Heiwe & Jacobson, 2011). Furthermore, most studies present small sample sizes due to 
recruitment difficulty in this cohort (Segura-Orti & Johansen, 2010). In addition, many 
studies have failed to address issues concerning the practicalities of implementing 
exercise interventions in this population. Finally, interventions have often failed to 
follow basic exercise and physiological principles to ensure effectives and efficiency of 
exercise programmes. 
This thesis aimed to add randomised controlled data to the growing evidence of 
the benefits of exercise as an adjunctive therapy in patients with Stages 4 & 5 CKD. 
Factors relating to survival were explored in detail. The first of these was renal 
transplantation, the treatment of choice for Stage 5 CKD patients. The second factor 
was dialysis access, an essential aspect of renal replacement therapy which is usually 
implemented in Stage 4 CKD in preparation for haemodialysis (Fluck & Kumwenda, 
2011). The third factor, dialysis adequacy, was a central aspect in patient management 
as patients move from Stage 4 to Stage 5 CKD and haemodialysis commences. The 
final factor was muscle wasting, an established problem in patients who are in Stage 5 
and have been receiving maintenance haemodialysis.  
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Renal Transplantation 
Kidney transplantation is a form of renal replacement therapy whereby an organ 
transplant from a deceased or living donor is received by a patient with 5 CKD. Patients 
who receive a transplant often present with a greater quality of live and experience 
increased longevity in comparison to those awaiting a transplant (Mannon, 2009; 
MacPhee et al., 2012). It is therefore unsurprising that renal transplantation is the 
preferred method of renal replacement therapy. Yet despite advances in surgical and 
immunosuppressive strategies (Casesa, 2007) survival and aspects of quality of life such 
as physical functioning still remain below age matched sedentary healthy population 
(MacPhee et al., 2012; Painter, 1997). Furthermore, a high percentage of transplant 
recipients present with co-morbidities such as cardiovascular disease, hypertension, 
new-onset diabetes after transplantation, obesity, haemotoligic complications, metabolic 
disorders and bone diseases (Mannon, 2009). Interventions aimed at further enhancing 
quality of life and survival as well as managing post transplantation outcomes and com-
morbidities are therefore warranted . 
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Vascular Access for Haemodialysis 
Vascular access, the point where blood leaves and is returned to the body during 
extracorporeal treatment, is a fundamental requirement for haemodialysis. Vascular 
access is the single most important cause of morbidity in the haemodialysis population 
and accounts for 20% of hospitalisations (Roy-Chaudhury et al., 2005). Types of 
vascular access include permanent or temporary tunneled catheters, arteriovenous grafts 
or arteriovenous fistulae (AVF). Current recommendations suggest an AVF as a the 
gold standard type of access (National Kidney Foundation, 1997) as they require fewer 
interventions (Perera et al., 2004), result in fewer infections (Nassar & Ayus, 2001) and 
have lower hospitalisation rates (Dhingra et al., 2001) compared to other forms of 
access. In the UK, chances of survival after 6 months of dialysis initiation are increased 
by 20% by dialysing via an AVF in comparison to a tunnelled catheter (Fluck, 2011).  
An AVF is a surgically formed anastamosis of an artery and a vein (Figure 1.1.), 
predominantly created in the arm. When the AVF is created, shear stress elicits vascular 
remodeling via nitric oxide mediated vasodilatation as a result of the chronic nine fold 
increase in blood flow immediately after surgery (Konner, Nonnast-Daniel & Ritz, 
2003; Wedgwood, Wiggins & Guillou, 1984). The resultant increases in vein diameters, 
allowing easier cannulation and higher blood flows through the AVF, have been 
associated with greater dialysis adequacies (Chan et al., 2008).  
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Figure 1.1. A longitudinal, B mode ultrasound view, of a radiocephalic arteriovenous fistula created by 
anastomosing the cephalic vein to the radial artery at the wrist in a side to end fashion (Konner, Nonnast-
Daniel & Ritz 2003). A; radial artery; V, cephalic vein. 
 
Despite recommendations in favour of AVF placement, only 40% of 
haemodialysis patients commence dialysis with an AVF and only 41% of patients are 
dialysing via this type of access three months after initiating dialysis (Fluck 2011). 
These figures fail to reach British Renal Association standards recommending 85% of 
prevalent haemodialysis patients dialyse via an AVF (Fluck, Kumwenda 2011). This is 
probably due to the fact that more than half of fistulae created fail to mature adequately 
for the use of haemodialysis (Wong et al., 2011). Several factors have been linked with 
fistulae failure including neointimal hyperplasia, accessory or „branching‟ veins 
(Beathard et al., 2003; Feldman et al., 2003), surgical technique (Feldman et al., 2003) 
and co-morbidities such as vascular disease and heart failure (Ravani et al., 2005). 
However, the main biological reason for fistula failure appears to be insufficient 
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increases in vascular dilation and blood flow (Asif, Roy-Chaudhury & Beathard, 2006). 
Interventions aimed at decreasing fistula failure, possibly through increasing post 
operative vascular dilation and blood flow are warranted. Furthermore, as dialysis 
access plays such a large role in morbidity and mortality, care should be taken to avoid 
secondary AVF failure.   
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Haemodialysis Adequacy and Solute Removal 
When the kidney fails, biochemically active waste products known as uremic 
toxins accumulate and contribute to uremic syndrome. One method of removing such 
toxins is the extracorporeal form of renal replacement therapy known as haemodialysis 
administered in Stage 5 CKD. The efficacy of removing uremic toxins by haemodialysis 
is known as „dialysis adequacy‟ and is based on the rate of solute diffusion from the 
blood across the dialyzer membrane.  
Dialysis adequacy is currently measured by the clearance of the „small‟ molecule 
urea (National Kidney Foundation, 2006). Urea clearance can be quantified by 
calculation of Kt/Vurea defined as the urea clearance over dialysis time proportional to 
total body water, or by urea reduction ratio (URR), defined as the fractional reduction in 
blood urea nitrogen during a single haemodialysis session expressed as a percentage. 
The clearance of urea has been chosen as a marker for adequate solute removal for 
several reasons.  Firstly, its blood concentration is increased in uremia and therefore its 
removal should hypothetically indicate decreased uremia. Secondly, it is of low 
molecular weight allowing easy transfer across the dialysis membrane as well as a rapid 
compartmental diffusion. When referring to urea kinetics, this allows the 
implementation of a single pool model representation of total body water for most 
applications. 
It stands well documented that urea clearance is a significant predictor of 
hospitalisation (Hakim et al., 1994; Maiorca et al., 1995) and mortality (Desai et al., 
2009). Patients who have a low urea clearance, dialysing at a Kt/Vurea <1.0 (Maiorca et 
al., 1995) or a URR <60% (Owen et al., 1993) have a significantly increased relative 
risk of death. The likelihood of survival increases with enhanced urea clearance with 
mortality risk decreasing by 7% with every 0.1 increment in Kt/Vurea  (Held et al., 1996) 
until an optimum Kt/Vurea of 1.3 is reached (Iseki, Tozawa & Takishita, 2003; Marshall 
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et al., 2006). There appears to be a “ceiling effect” with survival benefits reaching a 
plateau at a Kt/Vurea of 1.3 (Held et al., 1996; Charra et al., 1992) to 1.6 (Charra et al., 
1992). In fact patients dialysing at a particularly high Kt/Vurea or URR (above 71%) 
actually show an increased relative risk of mortality (Chertow et al., 1999; Salahudeen, 
Dykes & May, 2003). This could be due to “over dialysis” depleting electrolytes which 
could lead to the onset of potentially fatal arrhythmias or, more likely, the harmful 
effect of vigorous dialysis on malnourished patients (Chertow et al., 1999; Salahudeen, 
Dykes & May, 2003). The urea clearance and mortality relationship, therefore, appears 
to be one of a reverse J shaped nature (Chertow et al., 1999).  
It should be noted that the use of small molecule clearance as the only indicator of 
adequate dialysis remains controversial. It could be argued that urea, previously defined 
as a „mild‟ toxin (Bergstrom & Furst, 1986), does not represent the kinetic behaviour of 
more toxic water-based solutes such as phosphate and xanthine for example (Vanholder 
& Glorieux, 2003),  or that of other uremic toxins that are protein bound or have a 
higher molecular weight (Dhondt et al., 2000). Middle molecules and protein bound 
solutes have toxic effects which may relate to inflammation, cardiovascular disease and 
mortality (Vanholder et al., 2003) in CKD patients. It cannot be denied that these 
solutes play a role in uremic syndrome and investigation of urea and creatinine alone 
may represent an over-simplified view of dialysis adequacy (Vanholder, Van Laecke & 
Glorieux, 2008).  
 Beta2-Microglobulin (β2-M) is produced in the majority of cells as an expression 
of the human leukocyte antigen class 1, and has long been used as a marker of uremic 
toxin “middle molecules” and dialysis adequacy.  Normative serum values of this 
molecule lie between 1.5 and 3 mg/L. In CKD patients, however, levels usually range 
from 20 – 50 mg/L and have been reported up to 100 mg/L in extreme cases (Drueke & 
Massy, 2009). Efficient removal of β2-M is imperative as high serum concentrations of 
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this molecule have been associated with mortality. Okuno et al., (2009) revealed β2-M 
to be a significant, independent predictor of mortality with serum levels ≥ 32.2 mg/L 
resulting in a significantly higher death rate. In support of this, Cheung et al., (2006) 
reported an increased relative risk of mortality of 1.11 for every 10 mg/L increase in 
serum β2-M level with serum levels of 42.5 mg/L providing a 60% greater  risk of death 
compared to levels  ≤ 27.5 mg/L (Cheung et al., 2006). In particular, β2-M is associated 
with infectious, rather than cardiovascular deaths, with a 21% increase in the relative 
risk of an infectious death with every 10mg/L increase in serum concentrations (Cheung 
et al., 2006, Cheung et al., 2008).  Reasons for this decrease in survival may be that β2-
M is representative of other middle molecule toxins with similar kinetics. Furthermore, 
the accumulation of this molecule is a precursor to the development of β2-M 
amyloidosis, a disorder where amyloid fibrils invade synovial membranes and 
osteoarticular sites, causing destructive osteoarthropathies (Drueke & Massy, 2009).  
Middle molecule removal, such as β2-M clearance is enhanced with the use of 
high flux dialysis membranes. However, results of the „Hemodialysis (HEMO) study‟ 
reported that the use of such membranes had no significant impact on all cause 
mortality or hospitalisation compared to low flux membranes (Cheung et al., 2003). Yet 
reduced serum levels of  β2-M decrease the risk of all cause mortality and dialyser 
clearance has been shown to be a predictor of serum  β2-M (Cheung et al., 2006). 
Tentatively speaking, the use of high flux membranes alone may not result in large 
enough improvements in β2-M clearances to cause clinically significant changes in 
serum concentrations.   Therefore adjunctive strategies to enhance β2-M clearance are 
warranted.  
Phosphate has previously been realised as a marker of inorganic substances. 
Phosphate retention is an additional consequence of renal failure, contributing to 
secondary hyperparathyroidism which ultimately results in bone diseases and further 
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uremic complications. Serum phosphate levels in CKD are considerably elevated 
ranging from 6.2 – 6.3 mg/dL compared to normative values ranging from 2.6 – 4.5 
mg/dL (Pohlmeier & Vienken, 2001). High serum phosphate levels are noteworthy as 
they have been associated with a higher risk of mortality. Patients presenting with 
serum phosphate levels above 6.5 mg/dL have a 27% greater relative risk of mortality 
compared to those with serum levels between 2.4 – 6.5 mg/dL (Block et al., 1998). 
Although the underlying mechanisms through which hyperphosphatemia increases 
mortality remain indistinct, associations with cardiovascular risk factors such as 
haemodynamic disturbances and soft tissue cardiovascular calcification appear to relate 
increased serum phosphate levels with cardiovascular death (Qunibi, 2004). Despite 
concerted efforts of nephrologists to lower serum phosphate levels only 55% of 
haemodialysis patients in the UK obtain target values of this inorganic solute (Dawnay 
et al., 2010). Table 1.2. lists the current interventions implemented to reduce serum 
phosphate levels and their associated difficulties. Evidently there is a requirement for 
treatments to normalize serum phosphate levels in haemodialysis patients. 
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Table 1.2. Current interventions to prevent hyperphosphatemia in haemodialysis patients (Pohlmeier, 
Vienken 2001, Gutzwiller et al., 2003). 
Intervention Limitation 
Dietary restriction of phosphate intake  -Restricts adequate protein intake 
 
Phosphate binders to absorb phosphate in 
the gut 
-Side effects such as aluminium 
intoxication, hypocalcaemia, 
gastrointestinal problems 
 
Higher clearance through more changes 
in dialysis 
-Increased dialysis blood flow resulting in 
higher Kt/V fails to increase phosphate 
removal 
-Decreased removal following 1 hour due to 
limited transport from the intracellular 
space  
 
Increased treatment time 
Increased treatment frequency 
-Organisational problems 
-Cost implications 
-Patient unwillingness 
-Impractical 
 
Correcting acidosis through bicarbonate 
therapy  
-Discontinuity in data  
 
Previous efforts to enhance dialysis treatment have centred around factors such as 
increasing dialysis dose, through manipulation of dialysis time and dialyser flows, and 
enhancing larger molecule clearance by utilizing dialyzer membranes with higher 
porosity or flux. These interventions were addressed in the randomised controlled 
HEMO study (Eknoyan et al., 2002) whereby the effects of a standard or high dose of 
haemodialysis and the use of low or high flux membranes on all cause mortality were 
investigated. The surprising results of this study revealed that the risk of all cause 
mortality was not significantly influenced by dialysis dose or membrane flux.  More 
frequent dialysis sessions have also been suggested. However, this concept is 
confronted with the barriers of patient compliance and cost implications (Locatelli et al., 
2005).  A major challenge for dialysis therapy, therefore, is to improve the efficiency of 
dialysis with interventions aimed at enhancing more than just urea clearance alone being 
highly warranted. Strategies aimed at achieving clinical standards of dialysis adequacy 
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as well as reducing dialysis time and thus impacting on patient QoL and financial costs, 
are sought after.   
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Muscle Wasting in Maintenance Haemodialysis Patients 
Muscle wasting is known as a debilitating response to disuse and disease resulting 
from a disturbance in the normal balance between protein synthesis and breakdown. 
Muscle atrophy is frequently observed in maintenance haemodialysis (HD) patients 
(Workeneh & Mitch, 2010) and has been reported via several methods of body 
composition analysis.  Cross sectional histological studies elicit significant type IIa and 
IIx muscle fibre atrophy, portrayed by a reduced fibre cross sectional area, in CKD 
patients compared to healthy controls (Sakkas et al., 2003). In addition diminished lean 
body mass, measured by dual energy x-ray absoptiometry, has previously been reported 
in this patient population (Heimburger et al., 2000; Macdonald et al., 2004). 
Additionally, magnetic resonance imaging (MRI) scans reveal less contractile tissue in 
the lower leg in CKD patients compared to healthy sedentary controls (Johansen et al., 
2003) confirming muscle atrophy.  
The main causes of muscle wasting in CKD (Figure 1.2.) have been identified as 
anorexia, malnutrition and vitamin D deficiency  (Bossola et al., 2006; Mak et al., 
2011); co morbid conditions such as chronic heart failure, insulin resistance, excess 
angiotensin II and ageing (Workeneh & Mitch, 2010; Franssen, Wouters & Schols, 
2002); inflammation and hormone resistance (Iglesias et al., 2004); severe acidosis 
(Mak et al., 2011; Rajan & Mitch, 2008); increased resting energy expenditure (Utaka 
et al., 2005); the actual HD process itself (Lim, Yarasheski & Flanigan, 1998) and 
diminished physical function leading to disuse atrophy (Johansen et al., 2003). 
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Figure 1.2. Factors contributing to muscle wasting in CKD patients. Johansen et al., (2000) suggested 
that these factors may lead to inactivity which leads to further muscle wasting augmenting a vicious cycle 
of disuse atrophy.  
 
Figure 1.3. summarises the hormonal physiological mechanisms behind protein 
synthesis and breakdown. In CKD hormone irregularities prevent phosphoinositite 3-
kinase (pI3K) activity thereby lowering protein kinase B (AKT) activation. This results 
in a decrease in serine kinase protein activation ultimately leading to a decrease in 
protein synthesis via the mammalian target of rapamycin pathway (mTOR). 
Furthermore, reduced AKT activation results in insufficient energy to phosphorylate 
class O forkhead box proteins (FOXO), allowing them to enter the cell nucleus and up 
regulate ubiquitin lipase (E3) production thereby activating the ubiquituin protease 
system (UPS) which promotes protein degradation.  In cases of inflammation tumor 
necrosis factor –alpha (TNF-α) has also been found to unregulate E3 lipases activation 
the UPS system as well as activating the Capase 3 system. Suppression of AKT has also 
been linked to activation of the Capase 3 system (Rajan, Mitch 2008, Mak, Cheung & 
Roberts 2008, Mak et al., 2011).     
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Figure 1.3. Simplified schematic representation of hormonal mechanistic physiology of protein synthesis 
and breakdown.  Adapted from (Rajan, Mitch 2008). Red arrows highlight changes prevalent in CKD 
patients. AKT, protein kinase B; E3, ubiquitin lipase; FOXO, forkehead box class O; FOXO – P; 
phosphorylated  forkehead box class O; IGF -1, insulin growth factor; mTOR, mammalian target of 
rapamycin; TNF –α; tumor necrosis factor-alpha; UPS, ubiquitin protease system.  
 
Catabolism of muscle protein in the CKD population poses as a major problem for 
several reasons. Firstly, a positive correlation between muscle mass and mortality has 
previously been reported (Huang et al., 2010) with decreases in lean body mass actually 
showing to be an independent predictor of mortality (Desmeules et al., 2004). There 
could be several explanations for this relationship. The oxidation of essential amino 
acids in the muscle resulting in protein catabolism could result in a failure to produce 
immunoproteins that protect against injury and infection (Richards, 1980). Furthermore, 
it could be that factors causing protein energy wasting provide non traditional risk 
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factors to cardiovascular disease (CVD) thus further increasing the mortality risk of 
patients CKD (Bonanni et al., 2011). A further consequence of muscle wasting is an 
increased risk of hospitalisation as total muscle mass has been reported to be inversely 
correlated the number of hospitalisation days (Bajardi et al., 1991). Additionally, as 
previously mentioned, wasting is associated with factors such as insulin resistance, 
inflammation and oxidative stress which all pose as risk factors to co morbid conditions 
such as diabetes and CVD (Bonanni et al., 2011; Lee et al., 2007).   
Further consequences of muscle wasting in this cohort include a reduced reduced 
quality of Life (QoL) as well as reduced physical function. Muscle wasting could 
indirectly affect QoL through its relationship with physical function as physical 
functioning has been found to affect QoL above social and emotional functioning 
(Churchill et al., 1987). As mentioned previously haemodialysis patients report physical 
function levels below age norms (Painter et al., 2000). This may be a result of muscle 
wasting as medium to strong positive correlations have been revealed between muscle 
quantity, functional capacity and strength in HD patients (Macdonald et al., 
2004;Johansen et al., 2003). Atrophy has also been shown to be associated with reduced 
oxygen extraction at the muscle (Marrades et al., 1996). Further consequences are noted 
as reduced physical activity has a detrimental effect on muscle morphology, muscular 
strength and motor control (Clark, 2009; Clark, Fernhall & Ploutz-Snyder, 2006) thus 
creating an augmentative vicious cycle between physical function and muscle wasting 
(Figure 1.2.). 
Previous successful anabolic interventions have included the use of androgens, 
growth hormone (Storer, 2009), anabolic steroids (Johansen et al., 2007; Macdonald et 
al., 2007) and nutritional supplementation (Storer, 2009) . However, not only are longer 
term studies required for the safety and efficacy of these interventions (Storer, 2009) but 
in some cases an increase in muscle mass has not had the expected beneficial effect on 
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physical function (Johansen et al., 2007; Macdonald et al., 2007). Interventions to 
reverse muscle wasting and enhance physical function in CKD patients are therefore 
warranted.   
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Thesis Aims 
The aim of this thesis was to investigate the effect of exercise as an adjunctive 
therapy in Stage four and five CKD patients, providing a variety of developmental 
opportunities to the PhD candidate. The first report of the thesis aimed to explore the 
benefits of exercise in kidney transplant patients via a systematic review of existing 
literature. The empirical aspect of the thesis investigated the effect of exercise in 
enhancing outcomes pertaining to vascular access, haemodialysis adequacy and muscle 
wasting. It was hypothesised that randomized controlled trials employing gold standard 
outcome measures would reveal significant beneficial effects of exercise on outcomes 
that are strongly associated with quality of life, hospitalisation and survival in this 
patient population (Roy-Chaudhury et al., 2005; Desai et al., 2009; Desmeules et al., 
2004).  It should be highlighted, however, that hospitalisation and survival per se were 
not investigated in the reported trials.
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Thesis Layout 
The thesis is presented in a „paper style‟ format in that the information presented 
in each chapter is reported in the scientific style required for publication in peer 
reviewed journals.  
Chapter 2 reports a systematic review on the effects of physical activity on 
immediate outcomes in kidney transplant patients. The paper has been published in 
Advances in Chronic Kidney Disease 2009, Vol. 16, No. 6.  
Chapters 3 address issues pertaining to vascular access in Stage 4 and 5 CKD 
patients, exploring the effects of an eight week progressive resistance forearm exercise 
intervention on AVF maturation. A feasibility study for the implementation of a large 
multicentre trial is reported. This paper will be submitted for peer review to 
Nephrology, Dialysis, Transplantation.  
Chapter 4 addresses dialysis adequacy in Stage 5 maintenance haemodialysis 
patients and investigates the acute effects of exercise carried out during dialysis on 
dialysis adequacy and solute removal. This study will be submitted for peer review to 
The American Journal of Kidney Disease.   
Chapter 5 addresses muscle wasting in Stage 5 maintenance haemodialysis 
patients, exploring the implementation of a 12 week intradialytic progressive resistance 
training for anabolism in maintenance haemodialysis patients. This study has been 
submitted for peer review to Medicine and Science in Sports and Exercise. 
Funding sources are disclosed at the beginning of each chapter. The editorial 
contributions of Dr Jamie Macdonald are acknowledged.
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CHAPTER 2 
 
Kidney transplantation: A systematic review of interventional and observational 
studies of physical activity on intermediate outcomes. 
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Abstract 
 
Background. Kidney transplant patients have decreased quality and longevity of 
life.  Whether exercise can positively affect associated outcomes such as physical 
functioning, metabolic syndrome, kidney function, and immune function, has only been 
addressed in relatively small studies.  Thus the aim of this systematic review was to 
determine effects of physical activity level on these intermediate outcomes in kidney 
transplant patients.   
Methods. We electronically and hand searched to identify 21 studies (six 
retrospective assessments of habitual physical activity and 15 intervention studies 
including six controlled trials).  After study quality assessment, intermediate outcomes 
associated with quality and longevity of life were expressed as correlations or 
percentage changes, plus effect sizes. 
Results. Habitual physical activity level was positively associated with quality of 
life and aerobic fitness, and negatively associated with body fat (medium to large effect 
sizes).  Exercise interventions also showed medium to large positive effects on aerobic 
capacity (10 to 114% increase) and muscle strength (10 to 22% increase).  However, 
exercise programmes had minimal or contradictory effects on metabolic syndrome, and 
immune and kidney function. 
Conclusions. In kidney transplant patients, physical activity intervention is 
warranted to enhance physical functioning.  Whether exercise impacts on outcomes 
associated with longevity of life requires further study. 
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Introduction 
 
The number of patients with chronic kidney disease receiving a kidney transplant 
is increasing, with 18,000 transplants completed annually in the USA alone (USRDS, 
2008).  With better immunosupression regimes and antibiotics, acute cases of morbidity 
and mortality following transplantation have been substantially reduced.  Nevertheless, 
outcome (poor quality of life, morbidity and mortality) of kidney transplant patients 
(KTx) remains poor compared to the general population .   
As a consequence of improving longevity of life, quality of life is now of critical 
importance to the transplant patient.  Quality of life is made up of various domains 
including physical functioning (Kouidi, 2004).  Disappointingly, studies have shown 
that physical functioning after transplantation remains only marginally improved 
compared to when on haemodialysis (Nyberg et al., 1995)and fails to normalize to even 
that of the sedentary healthy population (Painter et al., 1997).  In KTx both decreased 
aerobic capacity and muscle strength, due to use of immunosuppressive medications 
and also a persistent sedentary lifestyle, are likely to contribute to the reduced physical 
functioning typically observed (Dew et al., 1997).  Cardiovascular fitness  is also a 
strong independent predictor of survival (Sietsema et al., 2004). 
Comorbid conditions are also of increasing importance to the transplant patient, 
affecting both quality and longevity of life.  Many comorbid conditions present in KTx 
have similar antecedents as in the general population.  For example, cardiovascular 
disease, the biggest cause of death in transplant patients, is similarly associated with 
components of the metabolic syndrome (USRDS, 2008).  Also of specific importance to 
the kidney recipient is graft survival.  Many modifiable risk factors of late graft failure 
exist.  Fat mass gain is typical post transplantation (van den Ham, Kooman & van 
Hooff, 2002), and obesity has been associated with poor graft outcome (Jindal & 
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Zawada, 2004). Additionally, as in all patients with chronic kidney disease, inadequate 
control of hypertension and hyperglycemia are likely to quicken loss of kidney function 
(Briggs, 2005). 
Consequently care of the kidney transplant patient must now aim to improve 
quality of life, reduce chronic medical complications and prevent graft failure.  The 
Surgeon General states that exercise can increase physical functioning and improve 
quality of life.  Additionally exercise is advocated for prevention and treatment of 
hypertension, hyperlipidemia, diabetes, and cardiovascular disease in both healthy 
persons and in chronic kidney disease patients receiving maintenance haemodialysis 
(Cheema & Singh, 2005).   
Potential efficacy of physical activity in KTx is suggested by the annual 
Transplant Games, where very motivated patients have been shown to achieve near 
normal levels of physical fitness (Painter et al., 1997).  Unfortunately confirmation is 
lacking of similar efficacy in the general kidney transplant population.  However a 
number of smaller observational and experimental studies investigating physical activity 
have been completed.  Although there may be insufficient data to determine direct 
effects of exercise on quality of life, morbidity, mortality and graft failure, combining 
results from smaller studies may provide useful information on efficacy of exercise for 
intermediate outcomes such as physical functioning, cardiovascular disease risk factors, 
diabetes, immune function, bone disease and kidney function.  Thus the aim of this 
systematic review is to determine effects of physical activity on these outcomes in KTx. 
 
 
 
 
 
     31 
Methods 
 
The following databases were searched: PubMed, Cochrane Central Register of 
Controlled Trials (CENTRAL), the Physiotherapy Evidence Database (PEDro) and 
Sports Discuss using key words relating to the disease condition (e.g. kidney) and to the 
intervention (e.g. physical activity).  Hand searching was also used but grey matter such 
as technical reports were ignored.  Included studies were case studies, retrospective or 
prospective designs, with participants aged > 18 yrs and a functioning graft.  Selected 
studies investigated physical activity as an independent variable and detailed outcomes 
of quality of life, physical functioning, cardiovascular disease risk factors, immune 
function, diabetes, bone disease or kidney function.  Studies on joint kidney pancreas 
transplants were excluded. 
Study quality was assessed subjectively.  For studies on habitual physical activity, 
quality of determination of exercise participation was assessed: A (accelerometer, 
metabolic cart or doubly labeled water), B (prospective diary or pedometer) and C 
(retrospective questionnaire).  For interventional studies, scores were instead based on 
quality of training protocols compromising: i) specificity to measured outcomes, ii) 
sufficient overload to have an effect and iii) progression to maintain overload.  Each 
factor was given a score of 1 (none/not known), 2 (inadequate) or 3 (adequate) and an 
overall study composite score from C (inadequate) to A (adequate) was calculated.  For 
all studies risk of bias was determined compromising: i) selection bias ii) performance 
bias iii) attrition bias and iv) detection bias.  Again, each factor was given a score of 1 
(high risk/not known), 2 (medium risk) or 3 (low risk) and an overall composite score 
from C (high risk) to A (low risk) was given. 
Relevant information (see column heads on Tables 2.2. – 2.4.) was displayed in 
summary tables.  Simple correlational data was summarized as Pearson‟s r values; 
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effect sizes were interpreted directly from r as small (0.1), medium (0.3) or large (0.5) 
(11).  Multiple regression data was summarized as R
2
 values; effect size was calculated 
as R
2
 / (1 – R2) and interpreted as small (0.02), medium (0.15) or large (0.35) (Cohen 
1992).  Between group comparisons were expressed as % differences and within group 
comparisons were expressed as % change from baseline; effect size was then calculated 
as (x1 – x2) / SD2, and interpreted as small (0.2), medium (0.5) or large (0.8) (Cohen 
1992).  For cohort intervention studies with non-comparable control groups (Table 
2.3.), data for the KTx exercise group only were treated as a within group comparison.  
For experimental studies with comparable control groups (Table 2.4.), within group 
comparisons were expressed as % change from baseline for both groups; interaction 
effect size was calculated as recommended by Bausell and Li (2002) (effect size 
difference1 – effect size difference2) / 2 and were interpreted as small (0.1), medium 
(0.3) or large (0.5). 
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Results 
 
Included study designs. Twenty-one studies (plus eleven case studies detailed in 
supplementary material) were identified that met inclusion criteria (Figure 2.1.).  Of the 
included studies, six were retrospective assessments of habitual physical activity level 
on outcome (including one longitudinal study) (Table 2.2.); nine were time series 
designs with outcomes obtained pre and post an exercise intervention and had either no 
control group (five studies) or a non comparable control group such as healthy persons 
or alternative diseases (four studies) (Table 2.3.); and six studies were comparably 
controlled trials (included four randomized controlled trials) (Table 2.4.).  Subgroups of 
KTx studied included glucose intolerant or not (Orazio et al., 2011; Sharif, Moore & 
Baboolal, 2008), metabolic syndrome or not (Armstrong et al., 2006), and physically 
active or not (Painter et al., 1997).  Control groups (Table 2.4.) were generally normal 
routine care, with no sham exercise or attention control groups, except for one study 
that compared exercise to a statin (Gonzalez-Molina et al., 1993).  One study also 
included the untrained contralateral leg as a control (Horber et al., 1987). 
Excluded studies. Two studies were excluded due to repetition of results from 
other studies  (Painter et al., 2001; Horber et al., 1985a; Horber et al., 1985b); two 
studies were excluded because of lack of any outcome data (Svoboda, 2001; Joy, 
Neyhart & Dooley, 2000); one study was excluded because of investigation of acute 
effects only (Cosio-Lima et al., 2006); and one study was excluded because it  could not 
be obtained (Leasure et al., 1999).   
Case studies. Ten relevant case studies were identified (Einollahi et al., 2008, 
Mourning, 2006; Howard-Jones, 2005; Browne et al., 2001; Grafstein, Fernandes & 
Boldt, 1997; Hestin et al., 1993; Roney & Wellington 1985; Bradlow et al., 1984; Fanti 
et al., 2002). Three studies were personal accounts of RTx patients advocating benefits 
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of exercise (Mourning, 2006; Howard-Jones, 2005; O'Moore, 1999).  One study was of 
an RTx patient who participated in boxing without identifiable acute damage to the 
kidney (Einollahi et al., 2008).  Two studies identified injuries to the kidney 
(subcapsular bleeding) following heavy lifting of boxes and impact by a squash ball 
(Browne et al., 2001; Roney & Wellington, 1985).  Some studies identified Achilles 
tendon rupture but these were not caused by participation in exercise programmes so are 
not reviewed in detail here.  One study noted exercise induced steal of kidney blood 
flow following transplant with the renal artery connected to the left external iliac artery, 
and later femorofemoral bypass (Fanti et al., 2002).  A number of non-peer reviewed 
case studies highlighted athletes competing at professional level in the sport (data not 
shown).   
Study quality. Study quality is provided in detail in supplementary material.  All 
cross sectional studies relied upon retrospective self report questionnaire assessments of 
physical activity level, and were thus all graded C (poor) (Table 2.1.). In seven of the 
15 intervention studies (Sharif, Moore & Baboolal 2008; You et al., 2008; Juskowa et 
al., 2006; Korabiewska et al., 2007; Triolo et al., 1989; Surgit et al., 2001; Gonazales-
Morino et al., 1993), physical activity interventions were of poor quality and did not 
adhere to (or did not report data on) the basic principles of exercise training.  In contrast 
three (Kempeneers et al., 1990; van den Ham et al., 2007; Miller et al., 1987) and five 
studies (Horber et al., 1987; Horber et al., 1985a; Violan et al., 2002; Painter et al., 
2003; Painter, Krasnoff 2002) obtained scores of B (medium) and A (excellent), 
respectively.   
However no studies obtained maximum scores for control of bias and thus results must 
be interpreted accordingly.   
Subject demographics. Five hundred and eighty five subjects (496 KTx, 52 other 
transplants, 16 haemodialysis patients, 21 healthy controls) were included in studies of 
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habitual physical activity (Table 2.2.), whilst 340 subjects (281 KTx, 4 other 
transplants, 25 haemodialysis patients, 30 healthy controls) were included in 
interventional studies with non comparable control groups (Table 2.3.) and 398 KTx 
subjects were included in interventional studies with comparable control groups (Table 
2.4.).  Reported age ranged from 27 ± 4 years to 56 ± 12 years.  Time with transplant 
ranged from two days to 109 ± 52 months (~nine years), while dialysis vintage pre-
transplant, when reported, ranged from 3 ± 2 to 54 ± 45 months.  Co-morbidity data was 
often not reported, but exclusion criteria in the majority of studies detailed 
contraindications to exercise testing including cardiovascular disease, and four studies 
excluded diabetics (Korabiewska et al., 2007; van den Ham et al., 2007; van den Ham 
et al., 2005; van den Ham et al., 2000). 
Exercise interventions. Exercise interventions were run as outpatient supervised 
programmes in four studies (Horber et al., 1987; Horber et al., 1985a; Juskowa et al., 
2006; van den Ham et al., 2007; Violan et al., 2002); as inpatient programmes where 
sessions were alternately supervised or unsupervised in one study (Juskowa et al., 
2006); were started as supervised programmes then progressed to at home unsupervised 
in two studies (Korabiewska et al., 2007; Miller et al., 1987); or were home based in 
three studies (Sharif, Moore & Baboolal, 2008; Painter et al., 2003; Painter et al., 2002) 
(Tables 2.3. & 2.4.).  Two studies did not mention the exercise setting (Kempeneers et 
al., 1990; Gonzalez-Molina et al.,1993).  Reported mode of exercise in intervention 
studies included aerobic (typically walking, jogging, cycling or swimming) in seven 
studies (Sharif, Moore & Baboolal, 2008; Surgit et al., 2001; Miller et al., 1987; Violan 
et al., 2002; Painter et al., 2003; Painter et al., 2002, Gonzalez-Molina et al., 1993), 
aerobic and strength training in one study(Kempeneers et al., 1990), isokinetic training 
in two studies (Horber et al., 1987; Horber et al., 1985a), alternative interventions such 
as calisthenics, ball games and a DanJeon breathing exercise programme in two 
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studies(You et al., 2008; Kempeneers et al., 1990), or a combination of strength training 
and alternative interventions (e.g. isometric activities) in two studies (Juskowa et al., 
2006; Korabiewska et al., 2007).  Duration of programmes ranged from one month  
(Juskowa et al., 2006) to ~ two years (Miller et al., 1987); frequency ranged from one 
(Sharif, Moore & Baboolal, 2008) to seven sessions per week (Juskowa et al., 2006, 
Korabiewska et al., 2007) (typically two to three per week).  Intensity of aerobic 
training, when reported, was typically 60 – 80% of heart rate or peak power max 
(Kempeneers et al., 1990; van den Ham et al., 2007; Violan et al., 2002; Painter et al., 
2003; Painter et al., 2002), except for one study completed at 40 – 60% max heart rate 
(Miller et al., 1987).  Progressive resistance training was of low to moderate intensity, 
progressing to 3 x 10 repetitions at 60% of one repetition maximum (strength) and 3 x 
30 repetitions at 35% of one repetition max (strength/endurance) (van den Ham et al., 
2007).  When used, isokinetic training was completed at maximal effort (Horber et al., 
1987; Horber et al., 1985a).  Eight studies failed to report sufficient detail regarding 
exercise prescription (Sharif, Moore & Baboolal, 2008; You et al., 2008; Juskowa et al., 
2006; Korabiewska et al., 2007; Surgit et al., 2001; Miller et al., 1987; Violan et al., 
2002; Gonzalez et al., 1993).   
Participant compliance. Ten of the fifteen exercise intervention studies did not 
report data on compliance.  Of the investigations that did report compliance, one study 
using a supervised outpatient programme suggested attendance at 75% of organized 
sessions over six months (Kempeneers et al., 1990), while others using home based 
exercise suggested 67%  (Painter  et al., 2002; Painter, 2008) to 88% (Sharif, Moore & 
Baboolal, 2008) of subjects were partaking in regular exercise at ~12 months.  Another 
home based study suggested 38% were fully compliant, 54% partially compliant, and 
2% non compliant to a six month intervention including both dietary restriction and 
exercise intervention (Triolo et al., 1989). 
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Quality of life. Self reported measures of quality of life were reported in one 
study of habitual physical activity level (Painter et al., 1997) (Table 2.2).  The cross 
sectional data reported significantly greater scores for physical functioning (large effect 
size) and role limitation due to physical health domains (small effect size) in active 
compared to inactive organ transplant patients (Painter et al., 1997).  Only one of two 
intervention studies (Table 2.4.)  revealed significant increases in quality of life in 
exercising patients as compared to controls (You et al., 2008); this study was of poor 
quality and effect size was unknown.  The other study (of better quality) showed only 
trends for improvement in physical functioning components (p = 0.06, small interaction 
effect sizes) (Painter et al., 2002).   
Physical functioning. Muscle strength was assessed in seven studies (Horber et 
al., 1987; Horber et al., 1985a; You et al., 2008; Korabiewska et al., 2007; Kempeneers 
et al., 1990; van den Ham et al., 2007; Painter et al., 2003).  Habitual physical activity 
level did not independently influence muscle strength (van den Ham et al., 2007) 
(Table 2.2.).  However, all exercise interventions significantly increased both upper and 
lower body strength, and effect sizes were generally medium to large, especially in 
studies with focused strengthening exercises (e.g. calisthenics (Kempeneers et al., 1990) 
or isokinetic training (Horber et al., 1987; Horber et al., 1985a) (Table 2.3.).  In 
comparably controlled studies interaction effect sizes were small but differences in 
strength gain between groups remained significant (Table 2.4.). 
Cross sectional data revealed that habitual physical activity accounts for 17 to 
34% of the variance in VO2peak (medium effect size, Table 2.2.), and more active 
individuals had ~40% increased aerobic capacity (large effect size).  Seven of seven 
interventional studies reported significant increases in exercise capacity following an 
exercise intervention (Table 2.3. & 2.4.).  Increase in VO2peak ranged from 10% to 29%, 
while increases in maximal metabolic equivalents (MET) ranged from 19% to 114%.  
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Effect sizes ranged from small to large in non-comparably controlled studies (Table 
2.3.) and were medium in comparably controlled studies (Table 2.4.). 
Components of Metabolic Syndrome. The number of people who were physically 
active was higher in those without compared to those with metabolic syndrome 
(Armstrong et al., 2006).  Specifically, blood pressure was measured in three 
interventional studies (Kempeneers et al., 1990; Miller et al., 1987; Painter et al., 2003) 
but exercise showed no significant effects on this outcome (Table 2.3. & 2.4.).  
Additionally one study measured hypertensive medication use (Painter et al., 2002) 
(also reported in Painter et al., 2003) but this outcome also failed to be responsive to 
exercise (Table 2.4.).  Although one cross sectional study (Orazio et al., 2011) 
suggested substantially higher exercise participation in patients who were glucose 
tolerant compared to those who were intolerant, interventional studies (Sharif, Moore & 
Baboolal, 2008; Juskowa et al., 2006) revealed disparate findings on blood glucose 
levels and the only comparably controlled study suggested a small effect size (Juskowa 
et al., 2006).  Six studies included blood lipid measures ; Gonzalez-Molina et al., 1993), 
and exercise intervention paradoxically caused both increases and decreases of these 
measures.  Medication use for diabetes and blood lipid control was either not reported 
or did not change in the above studies. 
Body Composition. Cross sectional studies revealed that habitual physical activity 
accounts for 10 to 21% of variance in body fat measures (Orazio et al., 2011; van den 
Ham et al., 2000), and that body fat was lower in more active individuals (Painter et al., 
1997) (medium effect size).  However intervention studies were less successful in 
reducing body fat (Painter et al., 2003; Painter et al., 2002) (very small to small effect 
sizes).  In contrast, habitual physical activity had no (van den Ham et al., 2005) or even 
negative (van den Ham et al., 2000) effects on lean body mass (Table 2.2.) but 
intervention studies showed significant positive effects of exercise programmes on 
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parameters related to muscle (Horber et al., 1987; Horber et al., 1985).  Still, not all 
studies concurred that intervention increased muscle (Painter & Krasnoff, 2002), and 
effect sizes were small.  Habitual physical activity level had only small effects on bone 
related parameters (Grotz et al., 1995)(Table 2.2.) but an interventional study using 
impact exercise showed a large positive effect on bone turnover markers (Kempeneers 
et al., 1990) (Table 2.3.). 
Immune function. Two studies investigated markers of immune function in RTx.  
The first (Surgit et al., 2001) showed positive effects of exercise on various immune 
parameters without inducing rejection of the graft (Table 3.3.).  The second (Juskowa et 
al., 2006) showed a non significant increase (medium effect size) of an immune 
associated pro-inflammatory cytokine (interleukin 18) (Table 4.4.). 
Kidney function. No studies measured effects on graft failure.  However five 
studies assessed estimated glomerular filtration rate or serum creatinine levels (Sharif, 
Moore & Baboolal, 2008; You et al., 2008; Juskowa et al., 2006; Korabiewska et al., 
2007; Miller et al., 1987; Painter et al., 2002) (Tables 2.3. & 2.4.).  One study of poor 
quality (You et al., 2008) showed significant positive effects of exercise on kidney 
function (effect size unknown, Table 2.4.).  Three studies showed non-significant and 
only very small or small effects of exercise (Sharif, Moore & Baboolal, 2008; 
Korabiewska et al., 2007; Painter & Krasnoff, 2002; Painter et al., 2002).  In one 
uncontrolled study (Miller et al., 1987) serum creatinine increased during the 
intervention period (statistically non-significant but medium effect size, Table 3.3.). 
Adverse events. Adverse events were generally poorly reported.  However, 
adverse events were specifically mentioned in Kempeeners et al. (1990) who carried out 
an alternative exercise intervention involving calisthenics, aerobic exercises and ball 
games. Injuries occurred in 3 out of 16 participants and were reported as medial tibial 
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stress syndrome, stress fracture and acute musculotendinous injury.  In contrast, Violan 
et al. (2002) reported “no noteworthy sports related injuries after training”.
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Discussion 
 
Observational studies. Identified studies assessing habitual physical activity level 
and outcomes all relied on self-report retrospective questionnaires, rather than more 
objective assessments of physical activity or energy expenditure.  Only one study 
utilized a longitudinal design (Grotz et al., 1995), with others relying on a cross 
sectional design.  Nevertheless, surprisingly strong relationships were identified in these 
studies between physical activity level and outcomes (Orazio et al., 2011; Sharif, Moore 
& Baboolal, 2008; Armstrong et al., 2006; Korabiewska et al., 2007; Painter et al., 
2002), with physical activity level explaining 10 – 34% of variance in exercise capacity 
and body composition.  Furthermore, substantially lower exercise participation was 
noted in those with glucose intolerance, metabolic syndrome and obesity compared to 
those without these conditions (Painter et al., 1997; Orazio et al., 2011; Sharif, Moore 
& Baboolal, 2008; Armstrong et al., 2006).  Conversely, in a study investigating 
activity level as the independent variable (i.e. highly active versus sedentary 
participants), aerobic capacity and quality of life was higher in the active group (Painter 
et al., 1997).  Of course whether physical activity is a cause or consequence of these 
conditions is not determined from these data.  Furthermore, some studies also showed 
minimal effects of physical activity on certain outcomes: habitual physical activity had, 
for example, minimal effects on bone (Grotz et al., 1995) and muscle related parameters 
(van den Ham et al., 2005; van den Ham et al., 2000).  These lack of effects may be due 
to crude measures of activity level, as more specific measures of habitual activity 
showed different findings dependent on whether occupational, sport or leisure activity 
was assessed (van den Ham et al., 2000). 
Interventional studies. The interventional studies located and reviewed herein 
provide further support for benefits of exercise on certain outcomes in KTx patients.  
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However, results must be interpreted cautiously.  To date, relatively few studies have 
been completed in this population, and only six controlled trials were identified, 
compared to 20 in the hemodialysis population (Cheema & Singh, 2005).  Furthermore, 
quality of the interventions was occasionally poor.  Intervention studies utilized exercise 
programmes that often did not meet general training principles, with half of the studies 
scoring the lowest grade of C.  In these studies, specificity, overload and progression 
were not ensured, even when accounting for application to a chronically diseased 
population.  For example, it is generally believed that low exercise capacity in KTx is 
primarily due to physiological alterations at the peripheral level (van den Ham et al., 
2005).  Of the studies with aerobic capacity as an outcome, only one study has included 
the most anabolic of exercise interventions, progressive resistance training (van den 
Ham et al., 2007),  while other studies utilized purely aerobic interventions (Sharif, 
Moore & Baboolal, 2008; Surgit et al., 2001; Miller et al., 1987; Painter & Krasnoff, 
2002; Gonzalez-Molina et al 1993) or nonspecific “strengthening” exercises (Sharif, 
Moore & Baboolal, 2008; You et al., 2008; Juskowa et al., 2006; Korabiewska et al., 
2007; Surgit et al., 2001).  Furthermore sufficient overload was not achieved (or not 
reported) in some studies (Korabiewska et al.,2007; Juskowa et al., 2006; Sharif, Moore 
& Baboolal, 2008;You et al., 2008; Surgit et al.,2001}} Gonzalez et al 1993), perhaps 
because of fear of injuring patients, or due to financial and practical constraints of 
implementing programmes of sufficient duration supervised by exercise professionals 
(Gordon et al., 2005).  It is therefore somewhat surprising that despite ignoring these 
training principles, the reviewed studies show some remarkable results on reported 
outcomes, as discussed below.  Presumably the low physical functioning of the 
population (Dew et al., 1997) means that even inefficient interventions can have 
beneficial effects.   
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Quality of life. This review suggests that quality of life intermediates such as the 
physical functioning components of strength (Horber et al., 1987; You et al., 2008; 
Juskowa et al., 2006; Korabiewska et al., 2007; Kempeneers et al., 1990; van den Ham 
et al., 2007) and aerobic capacity (Surgit et al., 2001; Kempeneers et al., 1990; Miller et 
al., 1987; Violan et al., 2002; Painter & Krasnoff,2002; Painter, 2008) seem 
undoubtedly improved in KTx with exercise intervention.  However, whilst quality of 
life was improved in those with higher habitual physical activity (Painter et al., 1997), 
increased physical functioning did not translate into significant improvements in self 
reported quality of life in all intervention studies (Painter & Krasnoff, 2002; Painter et 
al., 2002).  This small effect may be due to the unusually physically active control 
participants recruited in centers that implement exercise interventions.  Due to the 
perceived importance of quality of life to the now longer living kidney transplant 
patient, and the lack of return to normal values of  quality of life with transplantation 
(Dew et al., 1997), these findings require urgent confirmation.  
Longevity of life. No studies have investigated end points of morbidity, mortality, 
or graft failure, but intermediate outcomes of survival and specifically of 
cardiovascular, diabetic and bone disease have been investigated.  As stated, all exercise 
interventions improved aerobic capacity, which has been linked with survival in chronic 
kidney disease (Sietsema et al., 2004).  The improvements were substantial (10-114%) 
and as expected were greatest in studies of longer duration.  The optimal mode for 
increasing aerobic capacity is not discernible from these few studies due to differences 
in study duration, but it is notable that comparable improvements were obtainable in 
home based unsupervised studies et al., 2002; Painter et al., 2002) as in outpatient, 
supervised studies (Surgit et al., 2001; Kempeneers et al., 1990; van den Ham et al., 
2007;Violan et al., 2002) 
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In contrast, effects of exercise on the metabolic syndrome were minimal in the 
KTx studies reviewed.  Positive effects of exercise on total cholesterol were confined to 
poor quality studies (Sharif, Moore & Baboolal, 2008; You et al., 2008) and otherwise 
were minimal, with small effect sizes (Juskowa et al., 2006; Painter et al., 2003).  This 
is a response similar to that seen in non-diseased populations over similar durations (< 
one year) (Roberts & Barnard, 2005).  Generally, high density lipoprotein (HDL-C) is 
more responsive to exercise intervention (Roberts & Barnard, 2005).  While some 
studies reviewed herein suggest improved HDL-C with training, their results must be 
interpreted with caution as bias in these studies was likely (Triolo et al., 1989) 
Gonzalez-Molina et al., 1993).  In a better quality study, Painter showed small positive 
effects on HDL-C (Painter et al., 2003).  In explanation, although the utilized exercise 
programme was of sufficient duration and intensity to elicit more favorable lipid 
changes in non-CKD persons, it failed to show any reduction in body fat (Painter et al., 
2002), a primary factor associated with lipid profiles.  Blood lipid responses to exercise 
may also be attenuated in this population due to increased dietary intake following 
transplantation, and confounding effects of corticosteroids on body fat (van den Ham, 
Kooman & van Hooff, 2002).   
Similarly, exercise failed to elicit expected changes in blood pressure or 
hypertensive medications.  Diastolic and systolic blood pressure is typically lowered by 
7.4 and 5.8 mmHg, respectively, with exercise intervention in otherwise healthy 
persons, and responds regardless of exercise mode (Roberts & Barnard, 2005).  Thus 
the lack of response in the three studies herein (Kempeneers et al., 1990; Miller et al., 
1987; Painter et al., 2003) is surprising.  However, two studies were uncontrolled and 
may have been confounded by natural progression of hypertension customary to KTx 
(Briggs, 2005), and only one study measured medication dose (which did not reduce) 
(Painter et al., 2002). 
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Data on glycaemic control is similarly difficult to interpret.  One study completed 
specifically in patients selected as glucose intolerant suggested substantially lowered 
(large effect size) fasting blood glucose following combined exercise and dietary 
intervention (Sharif, Moore & Baboolal, 2008), whilst a second controlled study 
without concomitant dietary intervention showed minimal effect (Juskowa et al., 2006).  
Both studies were at high risk of bias and should be interpreted cautiously.   
The final component of metabolic syndrome is body fat.  Surprisingly only one 
group has specifically measured body fat as an outcome (Painter et al., 2003; Painter et 
al., 2002), and exercise had minimal effect (small effect size) over the period of one 
year.  Other parameters of body composition that are linked to outcome in the CKD 
population include muscle mass (Kato et al., 2003).  When this outcome was assessed 
as lean body mass or muscle cross sectional area, exercise effects were very small to 
small (Horber et al., 1987; Horber et al., 1985a; van den Ham et al., 2007; Painter et al., 
2002) with specific interventions aimed at targeting muscle size and function, such as 
isokinetic training, unsurprisingly showing more significant benefits.  In studies with 
very small effects, training was unspecific (e.g. aerobic (Painter et al., 2002)), or 
overload may not have been achieved (van den Ham et al., 2007).  Interestingly this 
later study (van den Ham et al., 2007) also showed increased lean body mass in a 
healthy control group prescribed the same exercise programme, suggestive of anabolic 
resistance in the RTx group (Kato et al., 2003).  An uncontrolled study also showed 
substantial benefits (large effect sizes) of exercise on bone turnover (Kempeneers et al., 
1990), suggestive of bone formation with potential benefits for reducing fracture risk 
and improving associated outcome.  Although data is scarce, effects on body 
composition seemed to occur even in patients on corticosteroids (Kempeneers et al., 
1990; van den Ham et al., 2007), although the response may be slightly attenuated 
(Horber et al., 1987).  
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Infection remains a significant cause of death in RTx patients (USRDS, 2008)and 
chronic moderate exercise may be beneficial to prevent infectious illnesses in normal 
persons (Mackinnon, 2000).  Still, the task of preserving immune function to prevent 
infection whilst avoiding graft rejection is delicate. The scant data reviewed herein 
suggests positive effects on various immune parameters.  However as no study has 
measured the actual incidence of infections and too few subjects have been studied to 
completely determine consequences for graft rejection, the significance of these 
findings remain unclear.  
Graft function. Components of metabolic syndrome have been implicated in 
progression of kidney failure.  As little effect of exercise was noted on metabolic 
syndrome, it is unsurprising that exercise also showed little benefit on kidney function 
(estimated glomerular filtration rate or serum creatinine) in the studies with this 
outcome measure (Sharif, Moore & Baboolal, 2008; Miller et al., 1987; Painter et al., 
2002; Gonzalez-Molina et al., 1993).  Although positive effects were noted in some 
studies (You et al., 2008; Korabiewska et al., 2007), high risks of bias including 
unmatched kidney function (Korabiewska et al., 2007) at baseline may have 
confounded these results. 
Safety. Adverse events were poorly reported in most studies.  When mentioned, 
all injuries were musculoskeletal, often associated with participation in non-
recommended competitive and high impact sports, and resolved successfully.  Exercise 
was not associated with any cardiac events.  Whilst data is scarce, and most studies 
excluded participants contraindicated for exercise testing (reducing generalisability), 
these exercise risks seem similar to that noted for the general CKD population (Cheema 
& Singh, 2005).  Furthermore specific issues highlighted as risks for exercising KTx 
(Griffin, 1998) were not realized (or not reported) in the studies reviewed. 
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Implications for practice. With the current evidence base it is impossible to state 
which modes of exercise are most efficient and to state the minimum dose required, but 
most studies completed to date have utilized aerobic exercise (60 – 80% of heart rate or 
peak power maximum) with consequent benefits for aerobic capacity.  However, as 
discussed above, theoretically weight training may be more specific to requirements of 
the transplant patient (van den Ham et al., 2005).  Other than non-specific 
“strengthening” programmes, weight training has only been used in one study at 
relatively low intensities (60% of 1 repetition max), and isokinetic training, whilst 
effective, requires expensive equipment.  Thus progressive resistance training 
interventions are encouraged, but must start at low intensities with adequate progression 
to ensure safety but sufficient overload.  Alternatively calisthenics and ball games may 
be particularly effective for strength and bone parameters.  But in general, exercise 
prescriptions could be based on guidelines as provided for specific conditions such as 
hypertension, hyperlipidemia, diabetes, and bone disease, as appropriate to the 
individual goals and comorbidities of the individual patient. 
Importantly none of the studies reviewed have specifically addressed different 
methods to encourage exercise participation.  A perceived facilitator to physical activity 
is “encouragement from healthcare providers” (Sanchez et al., 2007) and hopefully the 
evidence base reviewed herein may increase confidence of care teams to recommend 
exercise participation.  Note that unsupervised at home programmes seem effective, 
with associated reductions in cost of implementation as compared to supervised 
inpatient programmes.  However, the importance of regular follow up to aid 
compliance, following exercise training principles, and intervening for a minimum of 
six months, must be emphasized.  The included studies also relied on scientific 
measures (such as VO2peak) for exercise prescription and outcome assessment.  Yet 
healthcare teams could utilize simpler measures such as ratings of perceived exertion 
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(Borg, 1982)  to monitor exercise intensity and the Senior Fitness Test (Rikli & Jones, 
2001) to assess outcomes.   
Review limitations. This review is limited by a lack of grey literature searching.  
Publication bias may thus affect results.  Due to the small number of published studies, 
this review necessarily relied on cross sectional and uncontrolled intervention studies, 
and meta-analytical methods were not possible for the few and diverse outcomes 
currently reported.  Of particular concern is the general improvement in outcomes that 
occur spontaneously following transplantation, which may confound uncontrolled 
observational studies.  However, most of the included uncontrolled studies had mean 
transplant vintages of more than one year, partially reducing this effect.  Even when 
combining studies, many questions remain underpowered for their reported outcomes, 
and results should be interpreted accordingly.  Finally, biased study designs may 
confound findings of positive benefits of exercise.  Conversely, some of the studies 
utilised poor interventions that may explain lack of effects.   
Future research. Future studies must thus utilize designs and dissemination 
methods that meet Consort statement standards.  Particular attention must be paid to 
avoiding bias.  When selecting participants, age of participants may affect response in 
this population.  Researchers must decide whether to make results generalisable to the 
RTx population, for example by including diabetics, or whether to have strict inclusion 
criteria to simplify result interpretation.  If quality of life is an outcome measure, 
attention control arms are encouraged to reduce performance bias.  Care must be taken 
to avoid confounding by steroid dose, anemia improvement, and RTx vintage.  Attrition 
must be dealt with a priori, with compliance and adverse events recorded and detailed.  
Finally, blinding of assessors and use of intention to treat designs are needed to avoid 
detection bias.       
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Summary. In the general population physical activity has a myriad of potential benefits 
and positively affects outcome.  No studies have directly assessed effects of exercise on 
end points such as morbidity/mortality and graft failure in RTx patients.  However, 
positive effects were noted on intermediate outcomes such as aerobic fitness and muscle 
strength.  Presumably these adaptations contributed to the trends observed for 
improvement in quality of life.  However, in the few and relatively small studies 
reviewed, exercise had no consistent effect on metabolic syndrome or kidney function.  
Future studies must use better quality interventions and study designs to enable more 
detailed evaluation of these outcomes. 
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Figure 2.1. Flow diagram of selection of studies to review.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retrieved for detailed information 
(n = 136) 
 Potentially appropriate for review 
Scientific studies (n = )  
Case studies (n = ) 
 
Excluded 
 Irrelevant (n = 678) 
Potentially appropriate for review 
Scientific studies (n = 27)  
Case studies (n = 12) 
Included 
Scientific studies (n = 21)  
Case studies (see supplementary material) (n = 
11) 
Excluded 
Not English (n = 5) 
Background information (n = 92) 
Excluded 
Scientific studies: 
Repetition of results from other studies 
(n = 2) 
Lack of outcome data (n = 2) 
Not attainable (n = 2) 
Case study: 
No data involving increased physical 
activity level (n = 1)  
 
 
Database Search 
Pubmed  (n = 456) 
Cochrane Database of Systemic Reviews (n = 200) 
Cochrane General Register of Controlled Trials (n = 32) 
Sports Discuss (n = 122) 
PEDro (4) 
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Table 2.1. Quality assessment of reviewed studies.  
Studies of habitual physical activity Habitual physical activity assessment method Bias 
Author  Overall 
quality 
Selection bias Performance 
bias 
Attrition bias Detection 
bias 
Overall 
bias risk 
Orazio, (2009)   C 2 1.5 1 1 C 
Armstrong, (2006)   C 1 1.5 2 2 B/C 
van den Ham, (2005)   C 2 3 3 1 B 
van den Ham, (2000)   C 2 3 2 1 B 
Painter, (1997)   C 1 3 2 1 B 
Grotz, (1995)   C 2 1 1 1 C 
Exercise intervention studies (without 
a comparable control group) 
Exercise intervention  
training principles 
Bias 
 
Author Specificity Overload Progression Overall 
quality 
Selection bias Performance 
bias 
Attrition bias Detection 
bias 
Overall 
bias risk 
Sharif, (2008)  2 1 1 C 1 1 2 1 C 
van den Ham, (2007)  2.5 2 2 B 2 2 2 1 B 
Violan, (2002)  3 3 2 A 1 2 1 1 C 
Surgit, (2001)  2 1 1 C 1 2 1 1 C 
Kempeneers, (1990)  2 2 2 B 1.5 2 2 1 B/C 
Horber, (1987)  3 2 3 A 2 2 1 1 C 
Miller, (1987)  2 2 2 B 2 1 2 1 C 
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Horber, (1985)  3 2 3 A 1 2 1 1 C 
Triolo, (1989)  1 1 1 C 2 1 1 1 C 
Exercise intervention studies (with a 
comparable control group) 
Exercise intervention  
training principles 
Bias 
Author Specificity Overload Progression Overall 
quality 
Selection bias Performance 
bias 
Attrition bias Detection 
bias 
Overall 
bias risk 
Concealed 
allocation 
Random 
assignment / 
success 
You, (2008)  1 1 1 C 1 No 1 1 1 C 
Korabiewska, (2007)  2 1 1 C 1 No 2 1 1 C 
Juskowa, (2006)  1 1 1 C 1 Yes / 1 2 1 1 C 
Painter, (2003)  3 3 3 A 3 Yes / 3 2 1 1 B 
Painter, (2002)  2 3 3 A 3 Yes / 3 2 2.5 1 A/B 
Gonzalez, (1993)  1 1 1 C 1 Yes / 2 2 1 1 B/C 
Study Quality:  A, adequate; C, inadequate; 1, none/not known; 2, inadequate; 3, adequate. Study Bias: A, low risk; B, moderate risk; C, high risk; 1, high risk/not known; 2, medium 
risk; 3, low risk
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Table 2.2. Effects of habitual physical activity on outcomes in kidney transplant patients. 
Author Design Groups Transplant 
vintage 
(months) 
Questionnaire Outcome Differences 
between groups or 
correlation 
Effect 
size 
Orazio (2009)  
 
2 group 
cross 
sectional 
Glucose Intolerant 
 (n = 47) 
Glucose Tolerant 
 (n = 35) 
55 Physical Activity Statewide 
Questionnaire 
Diabetes: Habitual physical activity in glucose 
tolerant vs. glucose intolerant 
Habitual physical activity on glucose intolerance by 
multiple regression (multivariate odds ratio) 
127 % † 
 
0.940 † 
 
? 
 
?  
Body comp: Habitual physical activity on % body 
fat by multiple regression (R2) 
0.211 † 0.27 M 
Armstrong (2006)  2 group 
cross 
sectional 
Metabolic syndrome  
(n = 45) 
No metabolic syndrome 
(n = 26) 
81.6 -Physical Activity Statewide 
Questionnaire 
Exercise capacity: Habitual physical activity on 
VO2 max by multiple regression (R
2) 
0.17 † 0.20 M 
Metabolic syndrome: Number of physically active 
in without metabolic syndrome vs. with metabolic 
syndrome 
67 % † ? 
van den Ham  
(2005)  
 
 
3 group 
cross 
sectional 
KTx (n = 35) 
Haemodialysis (n = 16) 
Healthy control (n = 21)  
 
 
 
84 
 
Baecke Questionnaire 
 
Exercise capacity: Habitual physical activity on 
VO2 max by multiple regression (R
2) 
0.342 † 0.52 L 
Body composition: Habitual physical activity on 
lean body mass by multiple regression (R2) 
? ns ? 
Muscle strength: Habitual physical activity on 
quadriceps peak torque by multiple regression (R2) 
? ns ? 
van den Ham (2000)  
 
1 group 
cross 
sectional 
KTx (n = 77) 109 Baecke Questionnaire 
 
 
Body composition: Occupational activity index & 
lean body mass by correlation (r) 
Occupational activity index & fat mass, % fat, % 
-0.348  
 
? ns 
0.35 M 
 
? 
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lean body mass by correlation (r) 
Leisure activity index & body mass index by 
correlation (r) 
Leisure activity index & fat mass by correlation (r) 
Leisure activity index & lean body mass, % lean 
body mass, & % body fat by correlation (r) 
- 0.310 † 
 
-0.288 † 
 
? ns 
0.31 M 
 
0.29 M 
 
? 
Sport activity index & body mass index, fat mass, 
lean body mass & % body fat by correlation (r) 
? ns ? 
Painter (1997) 
 
 
2 group 
cross 
sectional 
Active (n = 98) 
Control (n = 30) 
(Of which KTx (n = 76) 
Other transplants (n = 52)) 
 
97 “Self report” Body composition: Body mass index: active vs. 
control 
- 10% † 0.59 M 
% body fat: active vs. control - 19% † 0.55 M 
Exercise capacity: VO2 peak: active vs. control 
[included other transplant types] 
+ 35% † 0.95 L 
VO2 peak: active vs. control [KTx only] + 47% 
? ? 
Quality of Life: physical functioning: active vs. 
control 
+ 15% † 0.81 L 
Role physical: active vs. control + 23% † 0.44 S 
Grotz (1995)  
 
1 group 
12 month 
observation 
KTx (n = 155) 55 
 
“Standard” questionnaire Bone: Energy expenditure during sports & bone 
gain by correlation (r) 
0.2 † 0.20 S 
Habitual physical activity & vitamin D therapy on 
bone gain by multiple regression (R2) 
? ns (p = 0.07) ? 
 
 
†, 
significant result whereby p ≤ 0.05; ?, information not provided in paper; S, small; M, medium; L, large.
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Table 2.3. Effect of exercise interventions on outcomes in kidney transplant patients (studies without a comparable control group).  
Author Design Groups Transplant 
vintage 
(months) 
Exercise prescription Outcome Differences vs. 
baseline in KTx 
exercise groupsignificance 
of within group main effect 
Effect 
size 
Sharif, 2008  
 
2 group 
intervention 
Glucose intolerant + 
exercise (n = 36) 
Glucose tolerant + no 
exercise (n = 79) 
6 (minimum) AUnsupervised 
BHome based 
CAerobic (walking, jogging & 
swimming) 
D?  
E120 min 
F1 x week 
G6-12 months 
Diabetes: 2 hr postprandial blood 
glucose  
- 15 % ‡ 0.76 L 
Kidney function: Estimated glomerular 
filtration rate 
- 2 % ns 0.07 vS 
Lipids: Total cholesterol - 7 % ns 0.27 S 
van den Ham, 
2007  
3 group 
intervention 
KTx (n = 35) 
Haemodialysis (n = 16) 
Healthy control (n = 21) 
86 ASupervised 
B? 
CAerobic (cycling, walking, 
swimming, gymnastics) & strength 
(progressive resistance training) 
D70% of peak watts 
3 x 10 reps @ 60% max 
3 x30 @ 35% max 
E120 min 
F2 x per week 
G3 months 
Exercise capacity: VO2 peak + 10 % ‡ 0.36 S 
Strength: Quadriceps peak torque + 10 % ‡ 0.29 S 
Body composition: Lean body mass 
(male) 
+ 0 % ns 0.02 vS 
Lean body mass (female) - 2 % ns 0.12 vS 
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Violan, 2002  
 
2 group 
intervention 
KTx  (n = 12) 
Haemodialysis (n = 9) 
74 ASupervised 
B? 
CAerobic (walking, jogging, ball 
games) 
D60% max HR (progresses) 
E50 min 
F3 x week 
G6 months 
Exercise capacity: VO2 peak 
 
+ 18 %  ‡ ? 
Surgit, 2001 
 
1 group  
intervention 
KTx = 12 
Liver transplant = 4 
12 - 24 ASupervised 
B? 
CAerobic (cycling) 
D? 
E45 min 
F3 x week 
G2 months 
 
Exercise capacity: VO2 peak + 11 %  
‡ ? 
Immune function: T helper cells  + ? % ‡ ? 
CD4+ to CD8+ ratio + ? % ‡ ? 
IgG & IgM levels + ? % ? ? 
Natural killer cells + ? % ‡ ? 
IgA ? ? ? ? 
T & B lymphocytes, activated T 
lymphocytes 
? ? ? ? 
Kempeneers, 
1990 
 
1 group 
intervention 
KTx (n=24)  
[detailed n=16] 
63 
 
ASupervised 
B? 
CCalisthenics, aerobic, ball games 
DMax 80% max HR 
E60 mins 
F3 x per week 
G6 months 
Blood pressure: Systolic blood pressure  - 2 % ns 0.12 vS 
Diastolic blood pressure  - 3 % ns 0.24 S 
Exercise capacity: VO2 peak + 29 % 
‡ 1.36 L 
Strength: Quadriceps peak torque + 22 % ‡ 1.19 L 
Bone: Serum calcium  + 1 % ns 0.26 S 
Serum alkaline phosphate activity  + 90 %‡ 1.09 L 
Serum inorganic phosphate  + 0 % ns 0.00 vS 
Urine hydroxyprolie excretion - 50 % ‡ 1.03 L 
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Author Design Groups Transplant 
vintage 
(months) 
Exercise prescription Outcome Differences vs. 
baseline in KTx 
exercise group 
Effect 
size 
Triolo 1989  
 
Controlled 
trial 
Low protein diet   
(n = 26) 
Control (n = 26) 
[Both groups exercise] 
? ASupervised  & unsupervised  
BOupatient & home based 
C? 
D?  
E? 
F ? 
G6 months 
Lipids: Total cholesterol [control group 
data] 
+ 21 % ‡ 0.71 M 
High density lipoprotein cholesterol 
[control group data] 
 
+ 49 % ‡ 1.39 L 
Horber, 1987  
 
2 groups 
intervention 
KTx (n = 9) 
Healthy control (n = 9) 
60 (median) ASupervised  
Boutpatient 
CIsokinetic 
D8-10 reps max flex % ext @ 60ºs-1 
4 x 180ºs-1 until exhaustion 
E20 min 
F3 x per week 
G1.75 months 
Body comp: Thigh muscle cross 
sectional area 
+ 7 % ‡ 0.30 S 
Strength: Quadriceps peak torque 
 
+ 15 % ‡ 0.49 M 
Miller, 1987 
 
1 group 
intervention 
KTx (n = 10) 17 ASupervised & unsupervised 
B? & home based 
CAerobic (walking & cycling) 
D40% - 60% max heart rate 
E25 – 40 min 
F3 x per  week 
G25 - 26 months 
Kidney function: Serum creatinine + 17 %ns  0.50 M 
Exercise capacity: Multiples of resting 
metabolic rate 
+ 114 % ‡ 3.05 L 
Blood Pressure: Systolic blood pressure + 5 % ns 0.33 S 
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Horber, 1985  1 group 
intervention 
KTx (n = 12) 
Control leg (n = 12) 
6 (minimum) ASupervised  
BOutpatient 
CIsokinetic 
D8-10 reps max flex % ext @ 60ºs-1 
4 x 180ºs-1 until exhaustion 
E20 min 
F3 x per week 
G1.8 months 
Body comp: Thigh muscle cross 
sectional area: exercised vs. non-
exercised leg 
+ 8 % ‡ 0.31 S 
Strength: Quadriceps strength (peak 
torque, 60 deg/s)  
+ 22 % ‡ 0.50 M 
 
When possible only data for the exercising kidney transplant patients are presented.  
‡
, significant vs. baseline value (p < 0.05); 
ns
, non significant; ?, insufficient information 
provided by author; KTx, kidney transplant patient; A, supervision; B, setting; C, mode; D, intensity; E, duration; F, frequency; G, length; vS, very small effect; S, small effect; M, 
medium effect; L, large effect.   See Methods for further explanation of statistics.
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Table 2.4. Effect of exercise interventions on outcomes in kidney transplant patients (with a comparable control group) 
Author Design Groups Transplant 
vintage 
(months) 
Prescription Outcome % change in exercise 
vs. controlsignificance of within 
group main effect/interaction 
Interaction 
effect size 
You,  
(2008) 
 
Controlled 
trial 
Exercise (n = 15) 
Control (n = 14) 
? Exercise:  ASupervised & unsupervised 
BOutpatient & home based 
CBreathing, strength & flexibility  
D60 min 
E? 
F4-6 x per week 
G2.25 months 
Control: Normal routine care 
Lipids: Serum cholesterol - ? ?/* ? 
Kidney function: Serum creatinine - ? ?/* ? 
Strength: Grip + ? ?/* ? 
Flexibility: Sit and reach + ? ?/* ? 
Quality of Life: ? + ? ?/* ? 
Korabiewska, 
(2007) 
 
Controlled 
trial 
Exercise (n = 35) 
Control (n = 32) 
1  
 
Exercise: First six months: ASupervised 
& unsupervised  
BInpatient & home based 
CMuscle strengthening, breathing, 
coordination, isometric & relaxation. 
D? 
E20-30min 
F2-3 x per  week 
G12 months 
After 6 months: C Walking 
Strength: Hand grip strength  + 16 vs. + 6 % ?/? 0.15 S 
Flexibility: Right radiocarpal joint 
extension  
+ 23 vs. + 10 % ?/? 0.26 M 
Lung function: Peak expiratory flow + 23 vs. + 10 % ?/? 0.30 M 
Kidney function: Serum creatinine  
 
- 27 vs. - 41 % ?/? 0.17 S 
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DSubmaximal intensity 
E10-20 min 
F1-3 weeks 
G6 months 
Control: Normal routine care 
Juskowa,  
(2006) 
 
Randomised 
controlled 
trial 
Exercise (n = 32) 
Control (n = 37) 
2 days 
 
Exercise: ASupervised & unsupervised 
BInpatient 
CMuscle strengthening, breathing, 
coordination, isometric & relaxation  
D? 
E30 min 
F7 x week 
G1-1.25 months 
Control: Normal routine care 
Atherosclerosis markers: Total 
homocysteine 
- 15 vs. + 23 % ‡/? 0.15 S 
 
Immune function: Interleukin 18 + 8 vs. - 12% ns/? 0.18 S 
Lipids: Total cholesterol + 25 vs. + 27% % ‡/? 0.03 vS 
High density lipoprotein cholesterol + 29 vs. + 6 % ‡/? 0.31 M 
Diabetes: Fasting glucose  - 19 vs. - 23 % ‡/? 0.10 S 
Painter,  
(2003) 
 
Randomised 
controlled 
trial 
Exercise (n = 51) 
Control (n = 45) 
 
 
 
 
 
 
1 
 
Exercise: AUnsupervised  
BHome based 
CAerobic (walking & cycling) 
D60-80% max heart rate 
E< 30 min 
F< 4 x per week 
G11 months 
Control: Normal routine care 
 
Blood pressure: Systolic  - 1 vs. - 4 % ns/ns 0.10 S 
Diastolic  + 3 vs. + 3 % ‡/ns 0.02 vS 
Lipids: Total cholesterol + 14 vs. + 14 %‡/ns 0.00 vS 
High density lipoprotein cholesterol + 19 vs. 8 %‡/ns (p=0.07) 0.16 S 
Exercise capacity: Multiples of 
resting metabolic rate 
+ 19 vs. 4 %‡/* 0.25 M 
Body composition: Body mass index + 12 vs. 8 % ‡/ns 0.10 S 
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Author Design Groups Transplant 
vintage 
(months) 
Prescription Outcome % change in exercise 
vs. controlsignificance of within 
group main effect/interaction 
Interaction 
effect size 
Painter,  
(2002) 
 
Randomised 
controlled 
trial 
Exercise (n = 54) 
Control (n = 43) 
“Within  2” Exercise: AUnsupervised  
BHome based 
CAerobic (walking & cycling) 
D60-80% max heart rate 
E< 30 min 
F< 4 x per week 
G11 months 
Control: Normal routine care 
Exercise capacity: VO2 peak + 25 vs. + 7 % ‡/* 0.30 M 
Physical activity on VO2 peak by 
correlation (r) 
0.24 ‡ 0.24 S 
Strength: Quadriceps: peak torque + 32 vs. + 19 % ‡/* 0.20 S 
Body composition: Fat mass + 24 vs. + 30 % ‡/ns 0.08 vS 
Lean body mass + 1 vs. + 3 % ‡/ns 0.05 vS 
Quality of Life: Short Form-36: 
physical functioning 
+ 25 vs. + 14 % ?/ns (p=0.06)  0.20 S 
Role physical  + 52 vs. + 12 % ‡/ns 0.19 S 
Physical component scale + 17 vs. + 10 % ‡/ns 0.17 S 
Kidney function: Serum creatinine - 12 vs. + 13 % ns/ns 0.16 S 
Blood pressure: Number of 
medications 
+ 15 vs. + 20 % ns/ns 0.08 S 
Gonzalez-Molina, 
(1993) 
 
 
 
 
 
3 month 
dietary 
intervention 
then 
randomised 
controlled 
trial 
Exercise (n = 20) 
Lovastatin (n = 20) 
? Exercise: A? 
B? 
CAerobic (walking) 
D?  
E? 
F? 
G3 months 
Lovastatin:  20mg/day 
Lipids: Total cholesterol + 5 vs. - 21 % ns/? 0.94 L 
High density lipoprotein cholesterol 
 
+ 4 vs. + 22 % ns/? 0.29 M 
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‡
, main effect of time or significant correlation (p < 0.05); *, significant interaction (p < 0.05); 
ns
, non significant main effect of time or interaction; ?, insufficient information 
provided by author; KTx, kidney transplant patient; A, supervision; B, setting; C, mode; D, intensity; E, duration; F, frequency; G, length; vS, very small effect; S, small effect; M, 
medium effect; L, large effect.  See Methods for further explanation of statistic.
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CHAPTER 3 
 
Progressive Resistance Forearm Exercise for Arteriovenous Fistula Maturation in 
Chronic Kidney Disease Patients: A Feasibility Study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source of funding: This study was supported by unrestricted grants from the North 
West Wales National Health Service Trust Endowment Fund and by North Wales 
National Health Service Trust Research and Development-Central Area. 
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Abstract 
 
Background.  Approximately half of arteriovenous fistuale fail to mature for 
haemodialysis use accentuating the need for interventions to enhance fistula success and 
maturation. This study aimed to investigate the feasibility and effect of a post operative 
forearm exercise protocol on fistula vessel diameters and blood flows, success and 
maturation. 
Methods. In this controlled feasibility trial, 31 participants were randomly 
allocated to either an EXERCISE (Mean (SD): 52 (14) years) or a CONTROL (60 (11) 
years) group following fistula surgery. EXERCISE involved a home based progressive 
resistance forearm exercise programme over 8 weeks. Exercise was prescribed four days 
/week for 30 minutes at an intensity perceived as „somewhat hard‟ to „hard‟. 
CONTROL received routine care. Primary outcomes included fistula artery and vein 
diameters and blood flows by duplex ultrasound, fistula success and maturation. 
Secondary outcomes were maximal isometric handgrip strength and forearm muscle 
circumference. Outcomes were measured one day, four and eight weeks post surgery. 
Feasibility was determined based on outcomes relating to the methodological process, 
resources, management and treatment effects. 
Results. EXERCISE had no effect on arterial diameter (95% CI, -0.24 [-1.12; 
0.51] mm; small effect size) or venous diameter (95% CI, 0.16 [-1.84; 1.24] mm; trivial 
effect size) with small and trivial effect sizes reported respectively. Due to difficulties 
obtaining reliable readings, changes in blood flow were not analysed. Nineteen percent 
and 33% of fistulae failed in EXERCISE and CONTROL respectively. EXERCISE did 
not affect maturation time (95% CI, 1 [-16; 28] days).  EXERCISE increased handgrip 
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strength (95% CI, 4.5 [0.5; 8.0] kg) but not forearm muscle circumference (95 % CI, 0.8 
[-1.9; 3.4] cm). The study was deemed feasible with modifications. 
Conclusions. This feasibility study infers post operative forearm exercise to have 
no effect on fistulae vasculature parameters, success or maturation. A similar protocol 
implemented before arteriovenous fistula creation, however, is hypothesized to enhance 
surgery success and maturation. Registered as a clinical trial NCT01061008. 
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Introduction 
 
The provision of good quality access remains a fundamental component of 
haemodialysis treatment. Current guidelines recommend an arteriovenous fistula (AVF) 
as the first choice of access (National Kidney Foundation,1997) with British Renal 
Association standards advocating for 65 - 85% of haemodialysis patients dialysing via 
this form of access (Fluck & Kumwenda, 2011). Arteriovenous fistulae are recognized 
as a superior form of access as they allow higher blood flows during dialysis, thus 
enhancing haemodialysis adequacy (Allon & Robbin, 2002). They also present with a 
lower risk of thromboses and lower intervention rates (Perera et al., 2004), lower 
infection rates (Nassar & Ayus, 2001) and lower hospitalisation, morbidity and 
mortality rates (Dhingra et al., 2001) in comparison to other forms of access such as 
arteriovenous grafts and permanent cuffed central venous catheters. Yet, despite these 
guidelines, in the United Kingdom only 40% of patients commence haemodialysis via 
an AVF (Fluck, 2011). This is in part due to high failure rates with up to 53% of AV 
fistulae failing to mature for the use of haemodialysis (Robbin et al., 2002; Wong et al., 
2011). Interventions to enhance the chances of AVF maturity are therefore sought after. 
Post operative forearm exercise could be such an intervention. Previous 
observations have verified that successful AVF maturation is more likely in fistulae 
with greater postoperative vascular diameters and blood flows (Robbin et al., 2002, Kim 
et al., 2001). These vasculature parameters could be increased through post operative 
forearm exercise with the rationale that firstly, the hyperaemic response to exercise 
elevates shear stress on the endothelial wall thus initiating vessel remodeling and 
arteriogenesis (Prior, Yang & Terjung, 2004). Secondly, if vessel diameter is enlarged 
then blood flow should also increase as the resistance to flow through a vessel is 
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inversely proportional to the fourth power of the radius (McDonald, 1974). Current 
guidelines recommend post operative forearm exercise for AVF maturation.However, 
this guideline is of opinion and there little evidence in its support (National Kidney 
Foundation, 1997). Previous research investigating hand grip exercise on forearm 
vasculature parameters in chronic kidney disease patients has shown disparate findings 
(Kumar et al., 2010; Leaf et al., 2003; Oder, Teodorescu & Uribarri, 2003; Rus et al., 
2005; Rodriguez Moran et al., 1984). Furthermore, these studies have implemented 
exercise interventions prior to AVF creation (Kumar et al., 2010; Leaf et al., 2003) or 
on fistulae that have already matured (Oder, Teodorescu & Uribarri, 2003; Rodriguez 
Moran et al., 1984). There are no known studies that have investigated the effect of 
postoperative forearm exercise on AVF vasculature parameters during the maturation 
phase.  
This feasibility study aimed to implement an eight week progressive resistance 
hand grip exercise programme immediately following AVF creation in CKD patients. 
As this type of study has not previously been carried out, the objective of this 
randomised controlled investigation was firstly, to assess the feasibility of the 
methodological processes and procedures for later use on a large scale multicentre trial. 
Secondly, to determine the effect sizes of the eight week exercise intervention on AVF 
vessel diameters and blood flows, success and maturation.
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Methods 
 
Study Design. This feasibility study was a two-centre, single blind, pre test post 
test, randomised controlled trial registered on clinicaltrials.gov as NCT01061008. 
Participants were randomly allocated to a progressive resistance handgrip exercise 
group or a control group using opaque envelopes in a 1:1 manner, stratified by gender, 
centre, AVF type (radial or brachio – cephalic) and surgeon.  
Participants. Stage four and five CKD patients were recruited from two renal 
units in North Wales, United Kingdom. Recruitment was co-ordinated through the 
vascular nurse at each centre. Eligible patients presented with Stage 4 of 5 CKD 
scheduled to have a native AVF fashioned in the arm. Patients were excluded if they 
were below 18 years of age; their clinician deemed them unable to withstand transiently 
raised systolic blood pressure by 35 mmHg, and diastolic by 25 mmHg; presented with 
contraindications to take part in forearm handgrip exercise or were unable to provide 
informed consent. Ethical approval was provided by Betsi Cadwaladr University Health 
Board Ethics Committee. All participants provided written informed consent. 
Interventions. Patients allocated to the exercise group carried out progressive 
handgrip exercises post operatively over an eight week period. On the same day 
immediately post operation patients were asked to flex and extend their fingers and start 
squeezing a rubber ball with the fistula arm as tolerated due to pain from the surgery. As 
soon as the patient was comfortable squeezing the rubber ball they commenced training 
utilizing a handgrip trainer (Ironman Pro, www.ironmanfitness.com, Figure 3.1.) with 
six intensity settings which allowed for progression in exercise intensity with gains in 
strength. The intensity quantification of each setting was determined using a tension 
load cell (Model 615 S, Tedea Huntleigh, Vishay, Basingstoke, UK) connected to the 
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spring loaded piston of the hand grip device (Figure 3.2). Participants were asked to 
exercise at least four days per week for 30 minutes, contracting the handgrip device at a 
rate of 30 repetitions per minute at an intensity relating to a rating of perceived exertion 
(RPE) of 14 on the 6-20 Borg scale (Borg 1982). When 30 minutes of exercise could be 
completed at an RPE below 14, exercise intensity was increased to the next setting of 
the hand grip device. Exercise was supervised by an exercise physiologist during the 
first week and was then carried out unsupervised at home, with patients completing 
daily exercise diaries over the eight week period. Weekly phone calls were made to 
monitor compliance and address any problems or queries.  
Patients allocated to the control group received routine care. However, they were 
restricted from using rubber squeeze balls for forearm exercise.  
Outcomes. Outcome measures were assessed one day, four weeks and eight 
weeks post operatively. To avoid harms, secondary outcome measures of handgrip 
strength and forearm circumference were assessed pre surgery rather than one day 
following surgery. 
Vascular Diameter and Volume Blood Flow. The primary outcome measure was 
AVF feeding artery and draining vein diameters. Volume flow through these vessels 
was also recorded as a secondary outcome measure. These measurements were taken by 
either a recently trained member in the research team (DK) or an experienced vascular 
sonographer (GR). Measurements were made using duplex ultrasonagraphy (iU22 
xMatrix Diagnostic Ultrasound System, Phillips, WA,USA) with a linear array 
transducer (L17-5) at a frequency of 7 MHz. Ultrasound examination was performed in 
a warm environment with the patient seated in an upright position, the arm comfortably 
supported at 45˚ from the body. Measurements were made at predetermined distances 5 
– 10 cm from the anastomosis (dependent on wound dressings and turbulent flow 
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around the anatomosis). The scanning position for each patient was traced using 
transparent sheets which allowed analogous measurement positions for all scans.  
Cross sectional vascular diameter measurements were made using conventional 
grey scale B Mode imaging. Diameters were measured from the inner edges of the 
vascular wall (Wiese & Nonnast-Daniel, 2004). An adequate test re – test reliability was 
reported for this measure with an ICC of 98% and a coefficient of variation (CV) of 4% 
determined from six different measurements from three individuals made on two 
separate occasions on the same day. The inter-rater reliability between the recently 
trained member of the research team and an experienced sonographer for this 
measurement was 90%, with a CV of 17%. 
 Volume flow in the longitudinal plane was acquired using pulse wave Doppler 
ensuring that sample volume covered the entire width of the vasculature and a complete 
angle of isonation  60 in order to detect a substantial Doppler shift frequency (Thrush, 
Hartshorne 2010). The inter-rater reliability between the recently trained member of the 
research team (DK) and an experienced sonographer (BHJ) for this measurement was 
only moderate (75%) with a high CV (20%). Due to the high variability of one off flow 
measurements (CV= 26%) measurements were carried out 3 times and averaged. 
Examples of vasculature images obtained by DK are displayed in Figure 3.3.. 
Maturation. A fistula was deemed mature according to either the KDOQI „rule of 
6‟ when the diameter of the draining vein was > 6 mm and presented with flows > 600 
ml/min (National Kidney Foundation, 1997) or when an experienced vascular nurse, 
who was blinded to group allocation, deemed maturation had occurred. Experienced 
vascular nurses have shown to have an 80% success rate in determining fistula 
maturation (Robbin et al., 2002). Arteriovenous fistula failure was declared if the 
patient was relisted for another surgery within the eight week study period.  
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Handgrip Strength. Maximal hand grip strength was determined using a handgrip 
dynamometer (5001A, Takei Co., Tokyo, Japan). Following a warm up at 50% and 75% 
of the estimated maximal voluntary contraction, three maximal contractions of 2-3 
seconds were performed and the peak value recorded.   
Forearm Circumference. Assuming a circular limb and muscle compartment, a 
symmetrically distributed fat rim and including bone correction, forearm circumference 
was determined by anthropometry (Heymsfield et al., 1982). 
Harms. Information on harms including joint, muscle or wound pain was recorded 
by the patient in their training diaries and also collected actively by the researcher 
during each weekly phone call to the patient. Other unexpected and serious (fatal, life 
threatening, or resulted in hospitalization) harms were collected passively as they 
occurred and during the trial period only.  
Feasibility. The main feasibility outcome was as either i) Stop – main study not 
feasible; ii) Continue but modify protocol – feasible with modifications; iii) Continue 
without modifications but monitor closely – feasible with close monitoring and iv) 
Continue without modifications – feasible as is (Thabane et al., 2010). This outcome 
was assessed at the end of the study and was based on the following:   
Process. Feasibility of processes that are key to the success of the main study 
included assessments on willingness of consultants to recruit patients, recruitment rates, 
consent rates, acceptability of group allocation and compliance with the specified 
interventions.  
Resources. Assessments on time and resource problems were based on the time to 
collect the data, the average time that patients were on surgical waiting lists before AVF 
surgery and the availability of ultrasound facilities at each centre.  
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Management. Assessment of human and data optimization problems included the 
ability of members of the research team to collect ultrasound data as compared to 
trained vascular sonographers and the amount of associated missing data.  
Scientific. The feasibility of treatment effects were based on the estimated effects 
of forearm exercise on the predefined outcome measures and the variance of such 
effects. Safety was based on the number of harms reported as a direct result of 
implemented interventions.    
Statistical Analyses. Data analyses were carried out separately for type of AVF 
(radiocephalic or brachiocephalic) due to a possible difference in effect sizes based on 
the differing vessel sizes of these two types of AVF. Outcome measures of maturation 
and success as well as harms were analysed on an intention to treat basis. All other 
outcomes were analysed on a per protocol basis.  
Data on feasibility and harms were presented descriptively only. As the purpose 
of this study was to observe possible estimated effects and the variance of the outcome 
measures, data was analysed for effect sizes and 95% confidence intervals rather than 
statistical significance. As recommended for feasibility studies of this size, median 
estimates and 95% confidence intervals representing upper and lower bound limits of 
the difference between the medians of change scores across groups were calculated 
using the Hodges and Lehman method. Effect sizes (r) were also calculated based on 
the assumption of non parametric data (Field, 2009), and were interpreted as trivial < 
0.3; small ≥ 0.3, medium ≥ 0.5 or large ≥ 0.8 (Cohen, 1988). Weekly training load data 
were analysed using a 2 x 8 (group x time) repeated measures ANOVA with p ≤ 0.05 
denoting statistical significance. Confidence interval data are presented as median 
values. All other data are presented as mean (standard deviation). A formal sample size 
estimation was not completed for this feasibility study. 
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Results 
 
Participants. Patients were recruited between May 2008 - October 2008 and 
September 2010 – January 2012. Participant flow throughout the study is shown in 
Figure 3.4. During this period a total of 75 surgeries for creation of a primary AVF 
occurred between both centres, with 63 of these patients assessed for eligibility.   
Of patients allocated to the exercise group 13 received radiocephalic fistulae and 3 
received brachiocephalic fistulae. Of the patients allocated to the control group, thirteen 
patients received radiocephalic fistulae and 2 received brachiocephalic fistulae.   
Of the 13 patients who received radiocephalic fistulae allocated to the control 
group, four patients were lost to follow up due to medical complications (n=1) and loss 
of interest (n=3). Of the 13 patients who received radiocephalic fistulae allocated to 
exercise group, two patients were lost to follow up due to death (n=1) and loss of 
interest (n=1).  Of the 5 patients who received brachicephalic fistulae, both patients 
allocated to the control group failed. Therefore, brachiocephalic fistulae were omitted 
from the analyses due to an unviable sample size. Thus, analyses of outcome measures 
were carried out in nine and 10 patients allocated to the control and exercise groups 
respectively. Participant characteristics are displayed in Table 3.1.  
Consultants at both centres were willing to recruit patients. With 9/9 (100%) 
eligible patients approached by consultants and 16/35 (46%) approached by a member 
of the research team consenting to participate in the study, recruitment was more 
successful when patients were informed about the study by their consultant rather than a 
member of the research team. 
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Training Load and Compliance. Training load, displayed in Figure 3.5., 
increased over the eight week training period as evidenced by a significant main effect 
over time (p = 0.004).  
Only one patient allocated to the exercise group did not accurately complete an 
exercise diary. Patients completed 94 (10) % of the required exercise sessions. The only 
reason for missing sessions was illness (9 sessions).  
Vascular Diameters 
Arterial Diameter. As depicted in Table 3.2. and Figure 3.6., the increase in 
arterial diameter from Week 0 to Week 8 was the same in both the exercise and control 
groups. The median difference and 95% confidence interval of absolute change values 
between the exercise and the control group was -0.24 [-1.12; 0.51] mm.  
In Week 0 to Week 4 increases in arterial diameter were the same in both the 
exercise and the control group with a small effect size observed (r = 0.3). The median 
difference and 95% confidence interval of absolute change values between the exercise 
and the control group was 0.30 [-0.30; 1.25] mm. 
In Week 4 to Week 8 the increase in arterial diameter was larger in the control group 
compared to the exercise group with a large effect size observed (r = -0.80). The median 
difference and 95% confidence interval of absolute change values between the exercise 
and the control group was -0.63 [-1.09; -0.13] mm. 
Venous Diameter. As depicted in Table 3.2. and Figure 3.7., the increase in 
venous diameter from Week 0 to Week 8 was the same in the exercise group compared 
to the control group with trivial effect sizes observed. The median difference and 95% 
confidence interval of absolute change values between the exercise and the control 
group was 0.16 [-1.84; 1.24] mm.   
In Week 0 to Week 4 increases in venous diameter were the same in both the 
exercise group and the control group with a small effect size observed (r = 0.3). The 
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median difference and 95% confidence interval of absolute change values between the 
exercise and the control group was -0.04 [-1.14; 0.77] mm. 
In Week 4 to Week 8 the increase in venous diameter was the same across both the 
exercise and groups with trivial effect size observed (r = -0.09). The median difference 
and 95% confidence interval of absolute change values between the exercise and the 
control group was -0.34 [-1.90; 0.86] mm. 
Feeding Artery and Draining Vein Blood Flows. Members of the research team 
sought difficulty in obtaining volume flow measurements. A total of 60 scans were 
completed throughout the trial, 46 of these by members of the research team and 14 of 
these by a trained sonographer. Adequate flow measurements were obtained in 14/14 
(100%) of scans carried out by the sonographer and only 28/46 (60%) scans carried out 
by members of the research team. This resulted in missing blood flow data in 7/11 
(64%) participants who were included in the per protocol analysis.  Due to this high 
proportion of missing data it was not possible to analyse the outcome measure of blood 
flow. 
Arteriovenous Fistula Success and Time to Maturation. Three of 16 (19%) and 
5/15 (33%) of fistulae failed in exercise and control groups, respectively.  Reasons for 
failing fistulae are described in Table 3.3.. Time to maturation was 41 (13) days in the 
exercise group and 38 (14) days in the control group with a trivial effect size observed 
(r = 0.2).  The median difference and 95% confidence interval of maturation days 
between the exercise and the control group was 1 [-16; 28] days. 
Hand Grip Strength. From Week 0 to Week 8 hand grip strength increased in the 
exercise group and decreased in the control group with medium effect sizes observed 
(Table 3.2.). The median difference and 95% confidence interval of absolute change 
values between the exercise and the control group was 4.5 [0.5; 8.0] kg.  
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In Week 0 to Week 4 hand grip strength increased in the exercise group and 
decreased in the control group with medium effect sizes observed (r = 0.55). The 
median difference and 95% confidence interval of absolute change values between the 
exercise and the control group was 6.0 [-0.5; 11.0] kg. 
In Week 4 to Week 8 handgrip strength increased in a similar manner across both 
groups with trivial effect sizes observed (r = -0.11). The median difference and 95% 
confidence interval of absolute change values between the exercise and the control 
group was -1.0 [-6.0; 4.0] kg. 
Forearm Muscle Circumference. From Week 0 to Week 8 forearm muscle 
circumference remained the same across both groups with trivial effect sizes observed 
(Table 3.2).  The median difference and 95% confidence interval of absolute change 
values between the exercise and the control group 0.8 [of -1.9; 3.4] cm.  
In Week 0 to Week 4 forearm muscle circumference was the same across both 
groups with trivial effect sizes observed (r = -0.27). The median difference and 95% 
confidence interval of absolute change values between the exercise and the control 
group was 0.5 [-2.2; 4.9] cm. 
In Week 4 to Week 8 forearm circumference was the same across both groups with 
trivial effect sizes observed (r = 0.13). The median difference and 95% confidence 
interval of absolute change values between the exercise and the control group was -0.7 
[-2.6; 2.2] cm. 
Harms. Harms reported during exercise sessions were tender thumb and fingers (3 
sessions) and a sharp pain in the AVF area (1 session). These harms were resolved 
without late effects or sequalae and did not prevent patients from continuing their 
allocated intervention. One patient in the exercise group was advised against starting the 
exercise intervention due to a complicated wound following surgery. Two patients from 
the exercise group were hospitalised during the eight week period following surgery due 
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to reasons unrelated to the exercise interventions. One of these patients died during the 
hospitalisation period. One patient from the control group dropped out five weeks 
following AVF surgery due to medical complications unrelated to the their allocated 
intervention. 
Feasibility. This study was deemed as feasible with modifications. Modifications 
and considerations that should be taken into account to run a large scale multicentre trial 
are discussed herein. 
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Discussion 
 
This study aimed to assess the feasibility of running a large scale multicentre trial 
on the effects of hand grip exercise on AVF vasculature parameters and maturation. The 
study was deemed feasible provided the following modifications and considerations are 
taken into account. 
1) Process 
1.1) In order to enhance recruitment and consent rates consultants should 
approach patients to inform them about the study rather than a member of the research 
team. One hundred percent of patients who were approached by their consultant 
consented to take part in this trial compared to 46% approached by a member of the 
research team. This supports previous findings that have shown that patients are more 
likely to take part in a trial if their regular clinician discusses research options with them 
(Harris Interactive, 2005). 
1.2) In this study 15% of patients who received an AVF were not assessed for 
eligibility. In order to prevent this loss of potential recruitment opportunities, 
correspondence regarding surgery dates and times should be carried out through the 
administrative staff of the surgeon as well as the vascular nurse. 
1.3) As current guidelines suggest distal placement of fistulae to preserve 
vasculature (National Kidney Foundation, 2006) the trial should focus on radiocephalic 
over brachiocephalic fistulae as higher numbers of these procedures would be expected. 
This is reflected in this study whereby 84% of consenting patients were scheduled to 
receive a radiocephalic fistula. 
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1.4) Failure rates (26% of consenting patients) and hospitalisation incidents (10% 
of consenting patients) across both groups should be considered when planning a 
sample size. 
1.5) Compliance to the exercise intervention was shown through objective 
significant increases in weekly training load as well as the medium effect sizes observed 
for increases in handgrip strength in the exercise group over the eight week intervention 
period. Furthermore, patients allocated to the exercise group completed 94% of 
scheduled sessions. This high compliance is possibly a result of the home based nature 
of the exercise programme with patients being able to exercise at personally convenient 
times at home or during dialysis sessions. Home based and intradialytic exercise 
programmes have previously reported higher compliance rates in comparison to 
supervised outpatient programmes (Konstantinidou et al., 2002).      
2) Resources 
2.1) Over a time period of 20 months, 11 complete data sets were available for per 
protocol analysis. However, 87 surgeries were scheduled during the period of this trial; 
therefore, if recruitment success is enhanced by taking on abovementioned 
recommendations (1.1 and 1.2) then it is possible that a larger sample could be collected 
in this time frame. 
2.2) Over the duration of this study the average time that patients were on the 
surgical waiting list for AVF creation was 82 ± 60 days. Due to high hospitalisation 
rates in CKD stages four and five with 45% - 69% of patients being hospitalised 
annually (USRDS, 2011; USRDS, 2012), it is possible that patients may be hospitalised 
whilst on the waiting list for AVF surgery. If patients are recruited onto the study as 
soon as they are listed for surgery their eligibility criteria should be reassessed prior to 
surgery in the event of a hospitalisation whilst on the waiting list. 
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2.3) Ultrasound resources were readily available at all centres with the same 
ultrasound equipment utilised by both centres. If a multicentre trial were to be 
implemented the compatibility of different scanning equipment between centres should 
be assessed.  
3) Management 
3.1) A large amount of missing data relating to arterial and venous blood flows 
resulted from the inability of members of the research team to collect this measure 
reliably. As experienced sonographers acquired this data accurately in 100% of their 
scans it is recommended that ultrasound measurements are carried out by an 
experienced vascular sonographer rather than a newly- trained research assistant. The 
Society of Vascular Technology in Britain and Ireland (http://www.svtgbi.org.uk) 
recommend at least one of the following qualifications to become fully competent in 
AVF surveillance: i) Full Society for Vascular Technology of Great Britain and Ireland 
accreditation; ii) Post graduate qualification in ultrasound imaging from a Consortium 
for Accreditation of Sonographic Education accredited course including arterial and 
venous module; iii) Level 3 radiologists with core training in vascular imaging; iv) 
Medical or surgical staff that have followed the Royal College of Radiologists 
recommendations for training in vascular scanning.  
4)  Scientific 
In general, the effects of exercise on AVF arterial and venous diameter were 
trivial to small. Previous reports of the inhibition of metalloproteinases responsible for 
arteriogenesis and the reduced generation of nitrogen oxide in uremic conditions have 
initiated discussions concerning a blunted flow mediated arterial enlargement in this 
disease state (Dammers et al., 2005a).  However, despite a diminished endothelial 
dysfunction, previous findings have reported increases in radial artery and vein diameter 
following forearm exercise in chronic kidney disease patients (Kumar et al., 2010; Leaf 
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et al., 2003; Oder, Teodorescu & Uribarri, 2003; Rus et al., 2005; Rodriguez Moran et 
al., 1984). An explanation for the contradictory observations may lie in the timing of the 
exercise implementation. Previous studies have investigated changes in vasculature 
parameters prior to AVF creation (Kumar et al., 2010), in fistulae that have been mature 
for more than three years (Rodriguez Moran et al., 1984) or in non fistula arms (Leaf et 
al., 2003; Oder, Teodorescu & Uribarri, 2003; Rus et al., 2005) whilst the current study 
implemented hand grip exercise of the fistula arm during the maturation phase. 
 Increases in shear stress on the endothelial wall leads to vascular remodeling and 
arteriogenesis (Prior, Yang & Terjung, 2004). Following AVF formation chronic 
increases in flow result in shear stress increases for at least one year (Dammers et al., 
2005a; Dammers et al., 2002; Ene-Iordache et al., 2003).  However, over time shear 
stress is normalised, supposedly due to structural adaptations of the arterial wall in 
response to increased shear stress (Girerd et al., 1996). Increases in shear stress initiated 
by exercise hyperaemia prior to AVF formation or when the fistula has been mature for 
several years (and shear stress has been normalized) may explain the increases in 
vasculature diameter previously reported. On the other hand, during the maturation 
stage it has been suggested that there is a continued increased shear stress despite 
corrective arterial remodeling, inferring that the challenge imposed by chronic increases 
in blood flow exceed the vascular adaptation capacity (Dammers et al., 2005a). With 
this rationale, further increases in blood flow from exercise induced hyperaemia during 
this stage would be futile.    
In addition, AVF failure was similar across both forearm and exercise groups. It 
should be taken into consideration that apart from vessel diameter and blood flow there 
are many other factors that have been shown to predict AVF failure. These include 
vascular disease, heart failure, untreated hypertension, stroke history, gender,  age, late 
referral, interopertaive heparin dose and surgical technique (Feldman et al., 2003; 
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Ravani et al., 2005), some of which may play a larger role than post operative 
vasculature diameter and blood flow in AVF success. Using optimum surgical 
technique, for example, has a predictive probability for maturation success as high as 
84% (Feldman et al., 2003). The number of variables affecting maturation may explain 
the large variability observed in the outcome measures.   
The observations of effects and confidence intervals on the main outcome 
measures of this study are not in favour of implementing postoperative forearm exercise 
for AVF maturation. However, more emphasis is being placed on preservation of sites 
for vascular access (Fluck & Kumwenda, 2011). Pre surgical diameter and blood flow 
have been shown to influence the success of AVF surgery (Wong et al., 2011). One 
randomized control trial has investigated the effects of chronic exercise on resting blood 
flows and forearm vessel diameters in CKD patients prior to AVF creation (Kumar et 
al., 2010). That study reported significant increases in resting arterial blood flow 
velocities as well as increases in artery and vein diameters of 0.2 [0.1;0.3] mm and 0.6 
[0.4;1.2]mm respectively. The exercise intervention implemented in that study lacked 
physiologically effective prescription parameters and therefore these reported benefits 
of exercise may even be underestimated. Furthermore, it is unknown whether these 
increases translated to enhanced AVF success and maturation. Based on such evidence 
and in combination with the observations of the current study, it is suggested that the 
exercise protocol proposed in the current study may be more beneficial if implemented 
before AVF surgery. As the average surgery waiting list time observed in the current 
study was 10 weeks, this provides an opportunistic window for an 8 week exercise 
prescription between surgery referral and AVF creation. It therefore appears to be more 
feasible to implement the methodological protocol carried out in the current study 
before AVF creation, observing the impact of any potential benefits on surgery 
outcome.  
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In conclusion, the findings of the current suggested that hand grip exercise 
immediately following AVF creation to have no effect on AVF vasculature parameters, 
success or maturation. A similar protocol, taking into account the suggested protocol 
modifications and implemented before AVF creation, however, is hypothesised to 
enhance surgery success and maturation.  
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Figure 3.1. Ironman adjustable handgrip device. 
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Figure 3.2. Quantification of setting intensity of the Ironman handgrip device. Adapted from Law (2008). 
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Figure 3.3. Vasculature of a mature AVF at 8 weeks post surgery. Images are taken 5 cm from the 
anastomosis. The cephalic vein diameter and flow are displayed in the top left and top right hand images, 
respectively. The radial artery and flow are displayed in the bottom left and right hand images 
,respectively.   
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Figure 3.4. Participant flow throughout the study.
 
Surgeries missed 
n = 12 
AVF Surgeries 
n = 75 
Assessed for Eligibilty  
n = 63 
Allocated to Exercise 
Group 
n = 16 
 
Badiocephalic fistula excluded due to small 
sample size n = 3 
Lost to follow up n = 2 
(Death n=1; Dropout n = 1) 
Unable to exercise following surgery n = 1 
  
 
Analysed 
n = 10 
Radiocephalic fistula  
failed  
n = 3 
 
Allocated to Control 
Group 
n = 15 
Badiocephalic fistula excluded 
due to small sample size n = 2 
Lost to follow up n = 4 
(Medical complication n=1; 
Dropout n = 3)  
 
Analysed 
n = 9 
Radiocephalic fistula failed  
n = 5 
 
Excluded 
n = 35 
Contraindication to exercise forearm n = 1 
Deceased whilst on waiting list n = 3 
Moved dialysis centre n = 1 
Refused consent n = 19 
Surgery cancellation n = 1 
Unable to consent n = 5 
Unstable medical condition n = 2 
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Figure 3.5. Weekly training load (repetitions x weight) of participants allocated to the forearm exercise 
group. *, significant main effect for time indicating an increase of training load over time (p = 0.004). 
Values are mean (SD). 
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Figure 3.6. Absolute change in arterial diameter across forearm exercise and control groups at Weeks 0 – 
4; 4 – 8 and 0 – 8 following arteriovenous fistula creation. Ninety-five percent confidence intervals 
represent lower and upper bound limits of the difference between the median of arterial diameter change 
scores across groups calculated using the Hodges and Lehman method (Kirkwood, Sterne & Kirkwood, 
2003).  
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Figure 3.7. Absolute change in venous diameter across forearm exercise and control groups at Weeks 0 – 
4; 4 – 8 and 0 – 8 following arteriovenous fistula creation. Ninety-five percent confidence intervals 
represent lower and upper bound limits of the difference between the median of arterial diameter change 
scores across groups calculated using the Hodges and Lehman method (Kirkwood, Sterne & Kirkwood, 
2003). 
 
     91 
 
Table 3.1. Participant characteristics across groups of intention to treat data. 
 Exercise Control 
 
Demographics 
 
  
Age (years) 52 (14) 60 (11)  
Gender (male/female) 11/5 11/4 
BMI (kg/m
2
) 27 (8) 26 (6) 
CKD Stage:   
Four 7 7 
Five 9 8 
Aetiology of CKD:   
Arteriopathic 1 0 
Congenital 2 1 
Glomerulonephritis 5 9 
Miscellaneous 8 5 
Type of Renal Replacement Therapy:   
Haemodialysis 6 5 
Peritoneal Dialysis 2 2 
Transplant 1 1 
Co-morbid Conditions:   
Diabetes 3 6 
Ischemic Heart Disease 1 0 
Hypertension 7 5 
Smokers  4 3 
Medication (tablets/day) 
 
  
Scheduled Arteriovenous Fistula Surgery Characteristics 
 
 
Arteriovenous Fistula Type:   
Brachiocephalic fistula 3 2 
Radiocephailc fistula 13 13 
Arteriovenous Fistula Attempt  
 
  
Haematology and Biochemistry 
 
  
Albumin (g/L) 41 (4) 37 (5) 
Creatinine (umol/L) 268 (141) 367 (197) 
Haemoglobin (g/dL) 10.7 (1.3) 11.4 (2.1)  
Urea (mmol/L) 
 
13.8 (7.7)  11.7 (6.5) 
 
BMI, Body Mass Index; CKD, Chronic Kidney Disease.
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Table 3.2. Data representing outcome measures collected for forearm exercise and control groups at 0, 4 and 8 weeks following arteriovenous fistula creation. 
 
Outcome Measure 
 
Exercise 
 
Control 
Effect 
Size 
(r) 
Median 
[95% CI] 
 
Week 0 
 
 
Week 4 
 
Week 8 
 
Week 0 
 
Week 4 
 
Week 8 
 
Week 0-8 
 
Week 0-8 
 
Arterial Diameter (mm) 
 
 
3.26 (0.68) 4.07(0.54) 4.14 (0.69) 3.17 (0.38) 3.57 (0.71) 4.32 (0.63) Small -0.24  
[-1.12; 0.51] 
Venous Diameter (mm) 
 
 
3.77 (0.70) 5.28 (0.61) 5.78 (0.51) 4.09 (0.46) 5.62 (0.80) 6.42 (0.89) Very 
Small 
-0.16  
[-1.84; 1.24] 
Hand Grip Strength (kg) 
 
 
32 (15) 34 (15) 35 (15) 37 (5) 34 (8) 35 (6) Medium 4.5  
[0.5; 8] 
Forearm Muscle 
Circumference (cm) 
11.05 (2.78)  11.27 (2.57) 11.28 (2.13) 9.48 (1.89) 8.7 (2.78) 8.88 (2.44) Small 0.82  
[-1.90; 3.40] 
 
 Values are Mean (SD). Effect Sizes were calculated and interpreted as Very Small < 0.3; Small > 0.3; Medium > 0.5 and Large > 0.8. Median estimates and 95% confidence 
intervals representing upper and lower bound limits of the difference between the medians of change scores across groups were calculated using the Hodges and Lehman method 
(Kirkwood, Sterne & Kirkwood, 2003). CI, confidence interval.
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Table 3.3. Number of arteriovenous fistula failures, demographics of patients with failed fistulae and 
reasons for failure across both exercise and control groups.  
 Exercise Control 
Number of Failed Arteriovenous fistulae 3 5 
Age (years) 47 (9) 70 (10) 
Gender (male/female) 2/1 2/3 
Smokers (n) 0 1 
Diabetics (n) 1 3 
Reasons for Failure:   
Unsuccessful Surgery 0 3 
Poor Vessel Development 3 2 
 
Values are mean (SD).
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CHAPTER 4
Dialysis Adequacy and Solute Removal: Effect of Intradialytic Exercise.  
A Randomised Controlled Trial. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source of Funding: This study was supported in part by an unrestricted grant from 
BBraun Avitum, Melsungen, Germany. 
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Abstract 
 
 
Background. Dialysis adequacy is a significant predictor of hospitalisation and 
mortality in maintenance haemodialysis (HD) patients. Whether intradialytic exercise 
training can enhance dialysis adequacy is unclear. 
Methods. In a single blind, controlled, randomised crossover study, 11 HD 
patients (mean (SD) age: 58 (13) years) completed three trial arms: normal routine care 
(CONT); increased HD time of 30 minutes (TIME); and intradialytic exercise (EXER), 
consisting of 60 minutes of cycling exercise at 95% of the lactate threshold in the last 
90 minutes of HD. The primary outcome was equilibrated Kt/Vurea. Secondary outcomes 
included reduction and rebound ratios of urea, creatinine, phosphate and beta2-
microglobulin.  
Results. Increased HD time, but not exercise, increased equilibrated 
Kt/Vurea compared to control trials (TIME vs. CONT: 95% CI, 0.15 [0.05; 0.26]; EXER 
vs. CONT: 95% CI, 0.03 [-0.05; 0.12]). Increased time also improved reduction ratios 
of urea and creatinine. In contrast, exercise, but not time, increased phosphate reduction 
ratio (EXER vs. CONT: 95% CI, 8.6 [0.5;16.7] %; TIME vs. CONT: 95% CI, 5.0 [-1.0; 
11.1] %). 
Conclusions. This is the first rigorously controlled study to compare intradialytic 
exercise and longer HD session time for dialysis adequacy. An extra 30 minutes of HD 
time significantly enhanced dialysis adequacy as determined by the primary outcome of 
equilibrated Kt/Vurea, but exercise only enhanced phosphate clearance. Thus 
intradialytic exercise cannot replace the traditional prescription of increased HD time, 
but may be a useful adjunctive therapy for serum phosphate control. Registered as a 
clinical trial NCT01481688.  
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Introduction 
 
 
Haemodialysis remains the most popular form of renal replacement therapy with 
65% of Stage 5 CKD patients receiving this treatment modality in the United States 
(USRDS, 2011). Haemodialysis adequacy as defined by urea clearance is a significant 
predictor of hospitalisation (Hakim et al., 1994; Maiorca et al., 1995) and mortality 
(Desai et al., 2009). Previous methods of enhancing dialysis adequacy such as 
increasing the dose or frequency of dialysis sessions have been confronted with barriers 
of patient compliance and cost implications (Locatelli et al., 2005). Improving dialysis 
adequacy remains a major challenge for nephrologists. Therapeutic strategies to 
enhance dialysis adequacy, including the removal of solutes other than urea are thus 
highly warranted (Vanholder & Glorieux, 2003; Dhondt et al., 2000; Vanholder et al., 
2003). 
One suggested strategy is to exercise during dialysis. Equation modelling to 
simulate intradialytic exercise predicts that the hyperaemia to low perfusion tissues such 
as muscle will increase urea clearance (Smye, Lindley & Will, 1998). Furthermore, it 
has been suggested that the increase in dialysis adequacy with 60 minutes of 
intradialytic exercise is equivalent to increasing dialysis time by 20 minutes (Kong et 
al., 1999). However, previous studies investigating the effect of intradialytic exercise on 
solute removal have shown conflicting results (Kong et al., 1999; Parsons, Toffelmire & 
King-VanVlack, 2004; Leung, 2004; Vaithilingam et al., 2004; Parsons, Toffelmire & 
King-VanVlack, 2006) (Table 4.1.). The disparity in these findings may lie in differing 
exercise prescriptions with the timing, intensity and duration of exercise perhaps 
influencing solute clearance. For example, kinetic models imply that the majority of 
urea clearance occurs during the first half of dialysis (Leypoldt, 2005). If exercise were 
carried out during the second half of dialysis when lower plasma levels of urea are 
evident then a greater concentration gradient would be established between low 
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perfusion tissue and plasma, resulting in a greater diffusive flux in urea from the tissue 
to the plasma. In support of this speculation, it has been mathematically predicted that 
by sustaining high blood flow to low perfusion tissues in the latter part of dialysis, post 
dialysis urea rebound will almost be entirely eliminated (Smye, Lindley & Will 1998). 
Referring to exercise duration, previous observations (Kong et al., 1999; Parsons, 
Toffelmire & King-VanVlack, 2004; Leung, 2004; Parsons, Toffelmire & King-
VanVlack, 2006; Adorati, 2000) as well as simulative equations (Smye, Lindley & Will, 
1998) imply that high blood flow to low perfusion tissues should be sustained for longer 
than 30 minutes to have any effect on solute clearance from the lean tissue. In summary, 
exercise should be carried out in the later part of dialysis at an intensity allowing the 
greatest amount of hyperaemia to be maintained over the longest possible duration. 
Exercise just below the anaerobic threshold, that carefully managed post exercise 
hypotension, would allow such an exercise prescription. 
The purpose of this study was first, to implement an intradialytic exercise 
programme comprised of prescription parameters deemed most effective at enhancing 
dialysis adequacy, investigating its effects on small molecule, middle molecule and 
inorganic substance clearance. Second, to compare effects of intradialytic exercise to 
the traditional prescription of increasing dialysis time on solute removal. It was 
hypothesised that intradialytic exercise completed in the second half of dialysis would 
significantly increase solute clearance to the same extent as an extra 30 minutes of 
dialysis time.  
 98 
 
 Methods 
 
 
Study Design. This controlled trial utilised a crossover design (clinicaltrials.gov: 
NCT01481688). Each participant carried out three trial arms: CONTROL, EXERCISE 
and TIME. Trial arm order was randomised (DK) using a computer-generated 
(www.randomizer.org) list of random numbers which were concealed in sealed opaque 
envelopes.   
Participants. Patients were recruited between 01.07.2011 and 31.08.2011 from 
Gwynedd Hospital, UK. Eligible participants presented with Stage 5 CKD receiving 
haemodialysis three times per week. Participants were excluded if they presented with: 
age below 18 years; receiving routine haemodialysis for less than 3 months; 
contraindications to exercise; chronic access problems or recirculation; haemoglobin 
levels below 11 g/dL; persistent hypotension with pre-dialysis systolic blood pressures 
below 100 mmHg; episodic treatment induced hypotension with frequent drops in 
systolic blood pressure below 30 mmHg; unstable medical condition; or unable to 
provide informed consent. Ethical approval was obtained from Betsi Cadwaladr 
University Health Board Ethics Committee and the study adhered to the Declaration of 
Helsinki 2008. Participants provided written informed consent.  
Interventions. Each patient participated in two haemodialysis sessions of each of 
the trial arms: CONTROL, EXERCISE and TIME. 
CONTROL trials consisted of routine prescribed haemodialysis treatment.  
EXERCISE trials involved cycling exercise using equipment (Rehab Trainer 881 
E, Monark, Sweden) adapted (Living Life, UK) to fit the end of a dialysis chair 
(Stephen H Anatomical New, Garhen Bilance, Italy) (Figure 4.1.).  
Before trials commenced, the lactate threshold was determined via the 
individualised anaerobic threshold technique (Stegmann, Kindermann & Schnabel, 
1981). This involved a cycling submaximal exercise test consisting of 15 Watt 
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increments every 3 minutes (Koufaki, Naish & Mercer, 2001). Blood lactate sampling 
from the earlobe occurred at the end of each 3 minute stage until values around 6 
mmol/L (Urhausen et al., 1993) were reached. Lactate sampling continued every three 
minutes during the recovery until lactate levels dropped to peak levels during exercise. 
The point where recovery lactate concentration equaled peak exercise concentration 
acted as the anchor for fitting the line tangent to the blood lactate curve during exercise. 
The point where the tangent line initially met the blood lactate curve during exercise 
was taken to represent the individualised anaerobic threshold.  
 EXERCISE trials were completed during the last 1.5 hours of haemodialysis 
treatment and included a warm up of five minutes at an intensity equivalent to 50% of 
the anaerobic threshold.  Participants then exercised for 60 minutes at an intensity 
relating to 90% of their anaerobic threshold. To avoid post exercise hypotension a 
gradual cool down was carried out until resting blood pressures were reached. A 
hypotension protocol was also designed and implemented in the case of a hypotensive 
episode.  
TIME trials consisted of an additional 30 minutes added to each patient‟s current 
routine haemodialysis time. Thirty minutes was chosen as previous estimations propose 
that 60 minutes of intradialytic exercise result in urea clearances equivalent to 20 
minutes extra dialysis time (Kong et al., 1999). This was expected to improve due to 
exercise being carried out in the latter half of dialysis. Furthermore, clinicians typically 
increase dialysis time in 30 minute increments.  
Following completion of a diet and medications diary during the three days 
preceding the first trial, participants were provided with copies of their diaries and asked 
to maintain a similar dietary and medication intake throughout the study. Trials were 
carried out during mid and end of week treatment sessions allowing an equal number of 
non-dialysis days between trials. Haemodialysis treatment parameters were strictly 
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controlled for including: access type, blood flow, dialysate flow, dialyzer membrane, 
dialysate concentrate, ultrafiltration rate, temperature, bicarbonate and heparin dosage. 
The consistency of treatment parameters across trials was checked via trend files 
downloaded from the haemodialysis machine.  
Outcomes. 
Solute Clearance. Small molecules urea and creatinine, middle molecule beta2-
microglobulin (β2M) and inorganic substance phosphate were chosen to represent 
uremic toxins. Blood samples for serum concentrations and pH were taken pre, post and 
30 minutes post dialysis according to European Best Practice Guidelines (2002). Pre 
dialysis samples were taken directly from the dialysis needle immediately before the 
dialysis hose system had been connected or sodium chloride was injected.  Post dialysis 
samples were taken from the arterial port once the ultrafiltration flow was ceased and 
blood flow reduced to 100 ml/hr for 15 seconds.  These molecules were analyzed at 
Betsi Cadwaldr University Health Board laboratories using automated analysers 
(AU2700, Olympus, USA) by individuals blinded to participant identification, trial arm 
and sample time. 
The primary outcome measure was equilibrated Kt/Vurea (eKt/Vurea) calculated 
according to European Best Practice Guidelines (2002). This measure was chosen due 
to its clinical acceptance as a marker of dialysis adequacy. Secondary outcome 
measures included single pool Kt/Vurea (spKt/Vurea), solute reduction ratios (National 
kidney Foundation, 2006) and post dialysis rebound of solutes (Kong et al., 1999) 
[Equations are provided in supplemental materials, pp. 119].  
Additionally, continuous sampling of spent dialysate (Argiles et al., 1997; Noiri et 
al., 2000) using a modified, reverse infusion pump (Perfusor Secura FT, BBraun, 
Germany) was employed to measure urea, creatinine, β2M and phosphate excretion in 
the spent dialysate. Total solute excretion was calculated by multiplying the sample 
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concentration by the total waste volume (total spent dialysate + ultrafiltration volume).   
This technique has previously been validated (Argiles et al., 1997; Noiri et al., 2000). In 
the present study internal validity of this technique was suggested by a significant 
correlation (r = 0.71; p = 0.007) with spKt/Vurea. However, the test - retest coefficient of 
variation was 37%, suggestive of considerable intraindividual variability of this 
secondary outcome measure.  
Harms. Information on harms was collected actively at the beginning and end of each 
haemodialysis treatment. Proformas (templates with information completed by a lead 
researcher following a set pattern) were completed following a participant interview and 
checking routine haemodialysis treatment records. Specifically, information on 
musculoskeletal injuries (cramp, muscle soreness, strain or joint pain), cardiovascular 
events (chest pain or shortness of breath confirmed by an irregular ECG or elevated 
cardiac markers), episodic hypotension (sudden drop in blood pressure below 90 mgHg 
or diastolic drop of 20 mmHg with accompanying clinical symptoms) and access 
complications (altered needle pressures requiring alterations to dialysis pump speed or 
access site pain) were recorded. Decisions about whether events were attributable to the 
intervention were made by unblinded clinicians (MMJ, NAJ). The decision whether to 
withdraw a patient from the trial following a harm was made by discussion between a 
clinician and the patient.  
Other unexpected and serious (fatal, life threatening, or resulted in hospitalisation) 
harms were collected passively as they occurred and during the trial period only.  
Regardless of attribution or withdrawal, all harms are reported.   
Statistical Analyses. Where possible the average results of the two haemodialysis 
sessions of each trial were used for the analyses. However, trials were excluded from 
analyses if treatment had to be altered or a harm prohibited trial completion. In such a 
case it was ensured that there was a complete data set from at least one session for each 
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trial per participant. Trial arms were repeated until one such complete data set was 
obtained. Thus, in this efficacy study data were analysed and presented on a per 
protocol rather than an intention to treat basis. 
Following assumption checks, differences in outcome measures between trials 
were analysed using repeated measures analysis of variance (ANOVA). If the omnibus 
ANOVA was statistically significant, post hoc Tukeys tests were carried out, without 
adjustment for multiple comparisons, to determine differences between trials.  Effect 
sizes (d) were calculated for these post hoc comparisons using Cohen‟s method, and 
interpreted as small, < 0.3; medium < 0.5; or large, > 0.8 (Cohen, 1988).  For the 
primary outcome measure of eKt/Vurea 95% confidence intervals for the difference 
between the means were also calculated. 
Data were analysed using the Statistical Package for the Social Sciences (version 
18; IBM, New York, USA). Statistical significance was set at p ≤ 0.05. Data is 
presented as mean (SD). Data on harms were presented descriptively only.
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Results 
 
 
Participants. Participant flow through the study is presented in Figure 4.2.. 
Participants‟ haematology and biochemistry data were within ranges recommended by 
the Renal Association Standard (Dawnay et al., 2010) (Table 4.2.). Exercise intensity at 
the lactate threshold was 45 (15) Watts.  
Treatment Parameters. Complete per protocol data sets from at least one and 
where possible the average of the two sessions across all trial arms were collected from 
11 participants. Eighty-four treatments were carried out in total (26 CONTROL, 33 
EXERCISE and 25 TIME). Of these, 58 treatment sessions contributed to the analysis 
consisting of 22 CONTROL, 19 EXERCISE and 17 TIME trials. Reasons for exclusion 
of individual trials were CONTROL: 4 access problems; EXERCISE: 3 harms, 8 access 
problems, 2 haemodialysis machine faults, 1 investigator error; TIME: 2 harms and 6 
access problems. Treatment parameters were not significantly different between trials 
(Table 4.3.).   
Blood pH increased significantly throughout dialysis, rising from 7.42 (0.01) pre 
dialysis to 7.47 (0.01) and 7.47 (0.10) at mid dialysis and the end of dialysis, 
respectively (p < 0.001). However, this increase was not different between trials, as 
evidenced by a non significant main effect for trial (p = 0.58) and a non significant time 
x trial interaction (p = 0.25). 
Total dialysis time was 237 (9) minutes for CONTROL and EXERCISE trials and 
267 (9) minutes for TIME trials. During EXERCISE trials participants cycled for 53 
(11) minutes (excluding warm ups, cool down and breaks) at an intensity of 40 (13) 
Watts.   
Equilibrated Kt/Vurea. As depicted in Figure 4.3. and Table 4.4., TIME 
significantly increased eKt/Vurea in comparison to CONTROL. EXERCISE had no 
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significant effect on eKt/Vurea.  The difference and 95% confidence interval between 
TIME and CONTROL was 0.15 [0.05; 0.26] and between EXERCISE and CONTROL 
was 0.05 [-0.05; 0.12]. 
Single Pool Kt/Vurea. TIME also significantly increased spKt/Vurea in comparison 
to both control and exercise trials (Table 4.4.). Exercise had no significant effect on 
spKt/Vurea.  
Urea. TIME significantly increased serum urea reduction ratio in comparison to 
both EXERCISE and CONTROL trials (Table 4.4.). EXERCISE had no significant 
effect on serum urea reduction ratio. Although total cleared urea in the spent dialysate 
showed a similar pattern to serum urea levels, with a higher clearance noted following 
TIME, values failed to reach statistical significance with small effect sizes observed. 
Neither TIME nor EXERCISE had any significant effect on the serum urea rebound 
ratio.  
Creatinine. TIME significantly increased the serum creatinine reduction ratio 
compared to CONTROL trials (Table 4.4.). EXERCISE had no significant effect on 
serum creatinine reduction ratio. Although total cleared creatinine in the spent dialysate 
showed a similar pattern to serum creatinine levels, with a higher clearance noted 
following TIME, values failed to reach statistical significance with small effect sizes 
observed. Neither TIME nor EXERCISE had any significant effect on the serum 
creatinine rebound ratio.  
Beta2-Microglobulin. There was a trend, with a medium to large effect size, 
towards an increase in serum β2M reduction ratio following TIME (Table 4.4.). 
EXERCISE had no significant effect on serum β2M reduction ratios. Although total 
cleared β2M in the spent dialysate showed a similar pattern to serum β2M levels, with a 
higher clearance noted following TIME, values failed to reach statistical significance 
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with small effect sizes observed. There were no significant changes in serum β2M 
rebound ratios following either TIME or EXERCISE. 
Phosphate. In contrast to other uremic toxins, EXERCISE significantly increased 
the serum phosphate reduction ratio in comparison to CONTROL sessions (Table 4.4.). 
TIME had no significant effect on the serum phosphate reduction ratio. The difference 
and 95% confidence interval between TIME and CONTROL was 5.0 [-1.0; 11.1] % and 
between EXERCISE and CONTROL was 8.6 [0.5; 16.7] %. Although total cleared 
phosphate in the spent dialysate showed a similar pattern to serum phosphate levels 
(with large effect sizes), with a higher clearance noted following EXERCISE, values 
failed to reach statistical significance. Neither TIME nor EXERCISE had any 
significant effect on the serum phosphate rebound ratio.  
Harms. Expected harms reported during EXERCISE and TIME sessions were 
cramp (8/33 [36%] of EXERCISE trials), hypotensive episodes (3/33 [9%] of 
EXERCISE and 1/25 [4%] of TIME trials) and access problems (4/26 [15%] of 
CONTROL; 11/33 [33%] of EXERCISE and 6/25 [24%] of TIME trials). One 
unexpected cardiac event was reported during a TIME trial. Following chest pains 
confirmed with an irregular ECG the patient was taken off dialysis before the extra 
dialysis time had commenced and admitted as an inpatient. All harms were resolved 
without late effects or sequalae.   
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Discussion 
 
 
This is the first known study to rigorously compare the effects of intradialytic 
exercise with that of longer haemodialysis sessions on dialysis adequacy. As expected, 
an additional 30 minutes of dialysis time was effective at increasing urea and creatinine 
clearance. There was also a trend towards enhanced β2M clearance following increased 
dialysis time. Contrary to what was hypothesised, 60 minutes of aerobic exercise during 
the last quarter of haemodialysis had no significant effect on dialysis adequacy 
measured by single pool and equilibrated Kt/Vurea. Furthermore, intradialytic exercise 
did not significantly enhance small or middle molecule clearance measured by 
creatinine and β2M clearance, respectively. Intradialytic exercise did, however, show 
effectiveness at enhancing inorganic phosphate clearance in comparison to routine 
haemodialysis and additional haemodialysis time. 
There appears to be a disparity in the findings of previous studies investigating the 
effects of intradialytic exercise on dialysis adequacy. The results of the current study 
contrast with five investigations reporting 15 – 25% increases in dialysis adequacy, as 
measured by urea clearance, following intradialytic exercise (Kong et al., 1999; 
Parsons, Toffelmire & King-VanVlack, 2004; Parsons, Toffelmire & King-VanVlack, 
2006; Zaluska et al., 2002; Sun et al., 2002). Conversely, the findings of the current 
study concur with three others demonstrating intradialytic exercise to have no 
significant effect and small effect sizes on urea clearance (Leung, 2004; Vaithilingam et 
al., 2004; Adorati, 2000). It was originally hypothesized that these conflicting findings 
were due to different exercise modes, intensities, durations and timings of exercise 
during dialysis. Thus the current study implemented an exercise intervention that was 
physiologically deemed the most effective at enhancing dialysis adequacy. 
Consequently, the discouraging findings in relation to small and middle molecule 
clearance, but the positive effect on phosphate removal following exercise warrants 
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further discussion into the effects of intradialytic exercise prescription parameters on 
solute clearance. 
Previously, simulated equations based on regional blood flow models of dialytic 
kinetics have suggested that intradialytic exercise would increase urea clearance (Smye, 
Lindley & Will, 1998). The findings of the current study, however, do not support these 
equation models as increased blood flow to the muscle tissue induced by exercise 
hyperemia had no effect on urea clearance.    
In addition, these simulated equations further predicted that intradialytic exercise 
would virtually eliminate urea post dialysis rebound (Smye, Lindley & Will, 1998). 
Again, the present findings do not reflect this model as exercise hyperemia had no effect 
on rebound ratios. The reason for the lack of support for the simulated equation model 
is not immediately clear. Assuming the lack of effect is not due to an issue relating to 
the study design, presumably the assumptions of the equations are incorrect. One 
possibility is that the equations are based on the parallel regional blood flow model of 
urea kinetics, which is a complex model with a large number of assumed parameters 
(Eloot, Schneditz & Vanholder, 2012). The lack of effect of exercise hyperaemia in the 
EXERCISE trials as well as the lack of greater rebound ratios despite increased urea 
clearance with extra dialysis time support this explanation as these effects would be 
expected according to the parallel regional blood flow model (Schneditz, Platzer & 
Daugirdas 2009; Schneditz et al., 1995; Schneditz & Daugirdas, 2001).  
With regards to β2M kinetics during dialysis, a classic serial two pool model has 
been suggested whereby the intercompartmental transfer coefficient appears to be the 
rate limiting factor of removal (Leypoldt, 2005; Schneditz & Daugirdas, 2001). The flux 
of this molecule between compartments is relatively slow and does not reach its 
maximum during a standard haemodialysis session, thus encouraging recommendations 
for increased dialysis duration rather than more efficient dialysis sessions for enhanced 
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middle molecule clearance (Leypoldt, 2005). This model is supported by the findings of 
the current study whereby a trend towards increased β2M clearance was observed 
following longer dialysis sessions. According to this model, exercise would not be 
expected to influence β2M clearance as increased blood flows induced by hyperemia 
would not increase the intercompartmental transfer rate. 
In contrast to longer dialysis sessions, intradialytic exercise significantly enhanced 
inorganic phosphate reduction ratios. A four pool model has been proposed for 
intradialytic phosphate kinetics whereby phosphate generation from a third and fourth 
pool, possibly erythrocytes and bone, occurs when low plasma levels are reached in the 
later stages of dialysis (Spalding, Chamney & Farrington, 2002). It may be 
speculatively suggested that during intradialytic exercise the muscle acts as a fifth pool, 
increasing serum phosphate levels as a result of energy metabolism (Maimoun et al., 
2006; Sorlie et al., 1982) with this excess phosphate being cleared by the dialyser. Once 
exercise is complete, serum phosphate is utilized to replenish muscle stores, explaining 
lower serum phosphate concentrations observed immediately post dialysis.  Clinical 
benefits include an increased phosphate removal as well as a prevention of additional 
phosphate release from erythrocytes and bone. The finding that phosphate reduction 
ratios were increased following exercise and not altered by increased dialysis duration, 
support suggestions that dialysis efficiency is more effective than increased dialysis 
duration with regards to phosphate removal (Leypoldt, 2005). 
In summary, exercise had no significant effect on dialysis adequacy measured by 
the primary outcome of urea clearance. Although urea clearance is the preferred clinical 
marker of dialysis adequacy (National Kidney Foundation, 2006) it has been suggested 
that the investigation of urea alone may represent an over-simplified view of dialysis 
adequacy and that dialysis therapy should also aim to increase removal of more toxic 
middle molecules and inorganic substances (Vanholder et al., 2003; van Wessel et al., 
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2010). Accordingly, intradialytic exercise did not increase middle molecule clearance 
but it did result in greater reductions of serum inorganic phosphate. Exercise could 
therefore be prescribed as an adjunctive therapy for phosphate control (providing 
cramps and hypotensive episodes are controlled). Furthermore, other studies suggest 
that exercise provides benefits relating to physical function and cardiovascular health 
(Cheema, 2008). As exercise did not negatively alter blood pH or increase uremic toxin 
production in the present study, these findings  provide further support that intradialytic 
exercise should be implemented as part of routine care of haemodialysis patients.   
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Figure 4.1. A patient participating in the supervised intradialytic cycling required in the EXERCISE arm 
of the study. 
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Figure 4.2. Participant flow throughout the study.  
*Did not complete exercise trials due to cramp. HD; haemodialysis 
Total population of 
Gwynedd Hospital HD 
PatientsAssessed for 
Eligibilty  
n = 76 
Included 
n = 15 
Drop Out Before Treatment 
Allocation 
n = 3 
Started Home HD n = 1 
Received Transplant n = 1 
Moved Dialysis Centre n = 1 
Excluded from Analysis 
n=1 
Incomplete data set n =1* 
Analyzed 
n = 11 
 
 
Excluded 
n = 54 
Access Problems  n =4 
Dialysis < 3 months n = 6 
Home  HD  n= 12 
Hemoglobin <11g/dL n =1 
Medical contraindication to exercise n = 9 
HD < 3 months  n = 2 
Required assistance for ambulation < 50 yards  n = 13 
Unable to consent  n = 3 
Unstable medical condition  n = 2 
Refused Consent 
n=7 
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Figure 4.3. Equilibrated Kt/Vurea (eKt/Vurea) in response to interventions aimed at enhancing dialysis 
adequacy. 
Values are calculated from serum urea concentrations pre, post and 30 minutes post haemodialysis. 
CONTROL, routine haemodialysis; EXERCISE, cycling exercise carried out during haemodialysis; 
TIME, haemodialysis time increased by 30 minutes. 
Repeated measures analysis of variance showed a significant difference between groups (p = 0.02). Post 
hoc Tukeys tests revealed that increasing haemodialysis time by 30 minutes significantly increased 
eKt/Vurea compared to CONTROL trials (*p  0.05) Exercise had no significant effect on eKt/Vurea  (p ≥ 
0.1)
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Table 4.1. Current literature investigating the effects of intradilaytic exercise on solute removal.  
Author Design Groups Intervention Outcome Measure 
 
Difference Effect Size 
Kong 
(1999) 
Nephrol Dial 
Transplant 
 
 
 
 
 
 
 
 
 
 
Randomised 
Crossover 
Exercise  
Control 
N=11 
A 
Aerobic (Cycle) 
B
1 Session 
C 
25% increase in HR 
D
 60 min (5-20 min bouts) 
E
 ? 
F 
N/A 
Urea   
Kt/V ↑ 15% * Large (2.21) 
% Rebound ↓ 12% *  
Reduction Ratio ↑ 7% *  
Clearance Time ↓ 21% *  
 
Creatinine 
  
% Rebound ↓ 18% *  
Reduction Ratio ↑ 11% *  
Clearance Time ↓29% *  
 
Potassium 
  
% Rebound ↓ 29% *  
Adorati  
(2000) 
Short 
Communication 
Nephrol Dial 
Transplant 
 
 
Randomised 
Crossover 
Exercise N=8 
Control N=? 
A 
Aerobic (Cycle) 
B
 ? 
C 
Low resistance 
D
 80 min (4 X 20 min) 
E
 Last 20 min x every hour 
F 
 N/A 
 
Urea   
Total Removal (CSSD) ↑ 2% Trivial (0.006) 
% Rebound ↓ 20% ?  
 
Creatinine 
  
Total Removal (CSSD) ↑ 8% * Trivial (0.001) 
 
Phosphate 
  
Total Removal (CSSD) ↑ 11% * Trivial (0.002) 
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Parsons  
(2003) 
Clin Nephrol 
 
 
 
 
 
 
 
 
 
 
 
2 Parallel 
Groups 
Randomised 
Controlled 
Trial 
Exercise N=6 
Control  N= 7 
A 
Aerobic (Cycle) 
B
 3 x week 
C 
40 –50% max work load 
D
 45 min (3 x 15 min) 
E
 15 min/hr x first 3 hrs 
F 
 8 weeks 
Urea   
Serum (mmol/l) ↓2% vs. ↑8%  Small/Med (-
0.42) 
spKt/V ↔0% vs. ↓4% Small (0.36) 
eKt/V ↑ 8% vs. ↓3% Small (0.24) 
Dialysate Clearance 
(PDS; mmol) 
↑ 15% vs. ↓1% * Large (1.12) 
 
Creatinine 
  
Serum (µmmol/l) ↑5% vs. ↑10% Trivial  (0.04) 
 
Potassium 
  
Serum (mEq/l) ↓0.3 vs. ↑0.1 Large (-1.14) 
Vaithilingam 
(2004) 
Am J Kidney 
Dis 
Randomised 
Crossover 
Exercise Pre Dx 
Exercise During 
Dx 
Control 
N=12 
A 
Aerobic (Cycle) 
B
 3 x week 
C 
? 
D
 30 – 60 min 
E
 ? 
F 
 1 week 
Urea   
Total Weekly Removal 
(PDS; g) 
↑6% Trivial (0.01) 
Kt/V ↔ 0% Nil 
% Reduction ↑2.8 Trivial (0.02) 
 
Phosphate 
  
Serum (mg/dL) ↓ 4% Trivial (-0.12) 
Total Weekly Removal 
(PDS; mg) 
↑ 9% Trivial (0.0005) 
Beginning of Week  
Removal (PDS; mg) 
 
↓ 11% Trivial (0.001) 
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Leung 
(2004) 
JESF 
 
 
 
Randomised 
Crossover  
Exercise 
Control 
N=15 
A 
Aerobic (Cycle) 
B
 1 Session (midweek) 
C 
RPE 3 (moderate) 
D
 30 min 
E
 120-150 x 240 min 
F 
 N/A 
 
Urea   
Removal (PDS; g) ↑ 6% Trivial (0.002) 
Rebound (%) ↓2.7% Trivial (-0.01) 
Parsons 
(2006) 
Arch Phys Med 
Rehabil 
1 Group 
Repeated 
Measures 
Exercise 
N=13 
A 
Aerobic (Cycle/ 
Ministepper) 
B
 3 x week 
C  ↑ HR x 20bpm 
D
 60 min (2x 30 min) 
E
 0 – 120 min 
F 
 20 weeks 
Urea   
Serum (mmol/l) ↔ 0% Nil 
spKt/V ↑ 15% * Large (3.52) 
 
Creatinine 
  
Serum (µmmol/l) ↓ 3% Trivial (-0.0007) 
 
Potassium 
  
Serum (mmol/l) 
 
↔ 0% Nil 
 
Percentage difference represents the difference between exercise and control sessions/groups. 
spKt/V, single pooled Kt/V; eKt/V, equilibrated Kt/V; dx, dialysis; CSSD, continuous sampling of spent dialysate; PDS, partial dialysate sampling; A, exercise modality; B, exercise 
frequency; C, exercise intensity; D, exercise duration; E, exercise time during dialysis; F, length of exercise intervention; *, statistical significance declared (p < 0.05); ?, information 
not provided in paper. 
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Table 4.2. Participant characteristics of analysed data sets. 
Demographics 
 
Age (years) 56 (13) 
Gender (male/female) 8/3 
BMI (kg/m
2
) 28 (7) 
Aetiology of CKD (n):  
Arteriopathic 1 
Congenital 1 
Glomerulonephritis 4 
Miscellaneous 5 
Co-morbid conditions (n):  
Diabetes 2 
Ischemic heart disease 1 
Hypertension 6 
Medication (tablets/day) 11 (7) 
Haemodialysis Characteristics 
 
Access type (n):  
Arteriovenous fistula 9 
Venous catheter 2 
Haemodialysis vintage (months) 21 (15) 
Haemodialysis duration (minutes) 237 (9) 
Blood flow rate (ml/min) 354 (33) 
Dialysate flow rate (ml/min) 727 (45) 
Dialyzer membrane flux (n):  
High 10 
Low 1 
Dialysate concentrate (n):  
284 (K 1; Ca 1) 4 
375 (K 1; Ca 1.25) 6 
380 (K 2; Ca 1.5)  1 
Haematology and Biochemistry 
 
Albumin (g/L) 40 (4) 
Pre dialysis β2M (mg/dL) 25.9 (12.2) 
Pre dialysis creatinine (umol/L) 253 (88) 
Haemoglobin (g/dL) 11 (0.8) 
Pre dialysis phosphate (mmol/L) 1.6 (0.6) 
Pre dialysis urea (mmol/L) 16.4 (4.3) 
 
BMI, body mass index; CKD, chronic kidney disease; K, potassium (mmol/L); Ca, calcium (mmol/L); 
β2M, beta-2 microglobulin.  Data are means (SD) unless stated.
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Table 4.3. Haemodialysis treatment parameters across control, intradialytic exercise and increased time 
trial arms. 
Treatment Parameters Trial 
 
p  
CONTROL EXERCISE TIME 
 
Blood flow rate (ml/min)  355 (35) 355 (35) 355 (35) 1.00 
Dialysate flow rate (ml/min) 722 (51) 725 (43) 727 (46) 0.39 
Arterial pressure (mm/Hg) -156 (18) -147 (11) -146 (19) 0.31 
Venous pressure (mm/Hg) 167 (14) 163 (16) 162 (16) 0.27 
Transmembrane pressure (mm/Hg) 21 (7) 23 (4) 19 (4) 0.06 
UF rate (ml/hr) 466 (254) 425 (231) 415 (221) 0.10 
UF volume (ml) 1892 (971) 2315 (2257) 1921 (1029) 0.56 
 
 
CONTROL, routine haemodialysis; EXERCISE, cycling exercise carried out during haemodialysis; 
TIME, haemodialysis time increased by 30 minutes.  UF, ultrafiltration.  Data are means (SD).  Statistical 
significance was determined by repeated measures analysis of variance. 
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Table 4.4. Uremic toxin solute clearance for interventions aimed at increasing dialysis adequacy.  
Measure Trial p Effect size (d) 
EXERCISE  
vs.  
CONTROL 
Effect size (d) 
TIME 
 vs.  
CONTROL 
CONTROL EXERCISE TIME 
Urea       
Equilibrated Kt/Vurea 1.33 (0.18) 1.36 (0.24) 1.48 (0.28)* 0.02 Small Large 
Single pool Kt/Vurea 1.51 (0.19) 1.54 (0.24) 1.73 (0.27)*
§
 <0.001 Small Large 
Urea reduction ratio (%) 73 (4) 74 (5) 77 (5)*
§
 <0.001 Small Large 
Dialysate urea content (mmol) 284 (126) 288 (131) 302 (165) 0.96 Small Small 
Urea rebound ratio (%) 6 (2) 5 (3) 6 (4) 0.52 Small Medium 
Creatinine       
Creatinine reduction ratio (%) 66 (5) 67 (6) 69 (6)* 0.02 Small Medium 
Dialysate creatinine content (umol) 4525 (4852) 4553 (4725) 4586 (3926) 1.00 Small Small 
Creatinine rebound ratio (%) 10 (4) 10 (4) 9 (3) 0.88 Small Small 
ß2M       
ß2M reduction ratio (%) 50 (10) 53 (7) 58 (11) 0.09 Small Large 
Dialysate ß2M content (mg/dL) 140 (82) 153 (83) 167 (100) 0.13 Small Small 
ß2M rebound ratio (%) 16  (10) 11 (6) 11 (4) 0.12 Medium Medium 
Phosphate       
Phosphate reduction ratio (%)  50 (17) 59 (10)* 55 (12) 0.03 Medium Small 
Dialysate phosphate content (mmol) 22 (6) 28 (18) 27 (16) 0.52 Large Medium 
Phosphate rebound ratio (%) 26 (19) 20 (12) 29 (28) 0.45 Medium Small 
 
CONTROL, routine haemodialysis; EXERCISE, cycling exercise carried out during haemodialysis; TIME, haemodialysis time increased by 30 minutes; ANOVA, analysis of 
variance; *, significantly different to control trial (p < 0.05); 
§
, significantly different to exercise trial (p < 0.05). Effect sizes were calculated and interpreted as small, < 0.3; 
medium,< 0.5 or large, > 0.8. ß2M, beta2-microglobulin.  Statistical significance was determined by repeated measures analysis of variance. 
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Supplemental Material 
 
Equilibrated Kt/Vurea (eKt/Vurea): 
eKt/Vurea = -Ln(Ct30/C0 – 0.0083 x T) + (4 – 3.5 x Ct30/C0) x dBW/BW 
Whereby C0, pre dialysis blood urea nitrogen; Ct30, 30 minute post dialysis blood urea 
nitrogen; T, dialysis time; dBW, body weight loss during dialysis (kg); BW, post 
dialysis weight (kg) (European Best Practice Guidelines 2002). 
Single pool Kt/Vurea  (spKt/Vurea): 
spKt/Vurea = -Ln(Ct/C0 – 0.0083 x T) + (4 – 3.5 x Ct/C0) x dBW/BW 
Whereby C0, pre dialysis blood urea nitrogen; Ct, post dialysis blood urea nitrogen; T, 
dialysis time; dBW, body weight loss during dialysis (kg); BW, post dialysis weight 
(kg) (European Best Practice Guidelines 2002). 
Reduction Ratios (%): 
RR = 100 x ((X0- Xt)/ X0) 
Whereby X0, pre dialysis concentration; Xt, post dialysis concentration. (European Best 
Practice Guidelines 2002). 
Rebound Ratios (%): 
Rebound = 100 x ((Xt30/X0)/ (X0/Xt)) 
Whereby X0, pre dialysis concentration; Xt, post dialysis concentration (Kong et al., 
1999)
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CHAPTER 5 
Anabolic Exercise in Haemodialysis Patients: A Randomised Controlled Trial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source of funding: This study was supported by unrestricted grants from the North 
West Wales National Health Service Trust Endowment Fund and by North Wales 
National Health Service Trust Research and Development-Central Area.
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Abstract 
 
Background. The anabolic response to progressive resistance exercise training (PRET) 
in haemodialysis patients remains unclear.  This efficacy study aimed to determine 
whether a novel intradialytic PRET technique could safely reverse atrophy and 
consequently improve muscle strength and physical function in haemodialysis patients. 
A second aim was to compare any anabolic response to that of healthy participants 
completing the same programme. 
Methods. In a single blind controlled study, 23 haemodialysis patients and 9 healthy 
individuals were recruited and randomly allocated to PRET or an attention control 
(SHAM) group. PRET completed high intensity exercise: leg extensions using novel 
equipment. SHAM completed low intensity exercise: lower body stretching activities 
using ultra light latex bands. Exercises were completed thrice weekly, during dialysis in 
the haemodialysis patients, over 12 weeks. Outcomes included knee extensor muscle 
volume by magnetic resonance imaging, knee extensor strength by isometric 
dynamometer, lower body tests of functional capacity, and harms. Data were analyzed 
by a per protocol method using analysis of variance (ANOVA).   
Results: PRET elicited an anabolic response in both haemodialysis patients (PRET: +84 
(123) cm
3
; SHAM: -109 (118) cm
3
) and healthy participants (PRET: +136 (163) cm
3
; 
SHAM: -32 (54) cm
3
) (omnibus ANOVA: p=0.01). PRET also increased knee extensor 
strength in both haemodialysis patients and healthy participants. In contrast, PRET only 
enhanced lower body functional capacity in the healthy participants.  Harms possibly 
related to PRET included one case of muscle soreness, and five cases of intradialytic 
hypotension. 
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Conclusions: Intradialytic PRET elicited a normal anabolic and strength response in 
haemodialysis patients. The lack of a change in functional capacity was surprising and 
warrants further investigation.  Registered as a clinical trial: NCT0100783.
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Introduction 
 
Disease and disuse can disturb the normal balance between protein synthesis and 
breakdown, leading to muscle wasting. Muscle atrophy is frequently observed in 
maintenance haemodialysis (HD) patients (Workeneh & Mitch, 2010), with 18 – 80% 
of patients showing evidence of wasting (Mak et al., 2011) via various methods of body 
composition analysis (Johansen et al., 2003; Macdonald et al., 2004; Sakkas et al., 
2003a).  
Muscle wasting in this population is an important problem because it is an 
independent predictor of morbidity and mortality (Huang et al., 2010). Medium to 
strong positive correlations have also been revealed between muscle quantity and 
strength, oxygen extraction at the muscle and functional capacity in HD patients 
(Johansen et al., 2003; Macdonald et al., 2004; Cheema et al., 2010; Marrades et al., 
1996), suggesting muscle wasting also reduces physical functioning and habitual daily 
activity. Thus muscle wasting indirectly affects quality of life (QoL). 
Although many causes of muscle wasting have been identified in HD patients, 
disuse atrophy remains a consistently cited mechanism (Mak et al., 2011) that is rarely 
addressed by standard routine care.  Progressive resistance exercise training may be a 
safe, cost effective, anabolic intervention, having already been implemented in other 
diseases characterized by muscle wasting (Lemmey et al., 2009; Singh et al., 1999).  
However, in HD patients, despite having a positive effect on markers of anabolism 
(Balakrishnan et al., 2010), the effect of progressive resistance exercise training on 
muscle quantity, as assessed using recommended endpoints in studies on nutritional 
status in this population (Senior & Maroni, 1999), remains equivocal (Table 5.1.). 
For example, supervised outpatient progressive resistance exercise training 
programmes have failed to reverse muscle atrophy in HD patients (Kopple et al., 2007). 
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In any case, intradialytic programmes are more acceptable to patients, reducing drop out 
(Konstantinidou et al., 2002).  Of previous studies that have implemented intradialytic 
progressive resistance exercise training, muscle cross sectional area was assessed using 
gold standard imaging techniques in three studies (Cheema et al., 2007a; Cheema et al., 
2007b; Johansen et al., 2006), but only one significantly decreased muscle wasting 
(Johansen et al., 2006).  Two studies have also utilized the dual energy x-ray 
absorptiometry technique (Johansen et al., 2006; Chen et al., 2010), but only one 
significantly reversed atrophy.   
Thus the anabolic efficiency of progressive resistance exercise training in HD 
patients has been described as discouraging (Mak et al., 2011).  The cause of this lack 
of anabolic effect is unclear. Suggested reasons include that HD patients present with 
hypogonadism (Albaaj et al., 2006), insulin resistance (Mak, Cheung & Roberts, 2008) 
and a perturbed insulin like growth factor/ growth hormone axis (Mak, 2008), all of 
which are implicated in activating signaling pathways responsible for protein synthesis. 
Alternatively, previous interventions may simply have lacked the attributes considered 
necessary to elicit an anabolic response (Kraemer et al., 2002).  For example, 
interventions may have been of insufficient training load and lacked sufficient 
progression to elicit hypertrophy. 
Therefore the aim of this efficacy study was to determine whether a novel 
intradialytic PRET technique, that allows overload and progression, could safely reverse 
atrophy and consequently improve muscle strength and physical function in 
haemodialysis patients. A second aim was to compare any anabolic response to that of 
healthy participants completing the same programme. It was hypothesized that PRET 
would result in significant increases in muscle volume, strength and physical function in 
HD patients as compared to an attention control group, and that this response would be 
similar to that observed in healthy participants. 
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Methods 
 
Study Design. This study was a two-centre, single blind, pre test post test, 
randomised controlled trial registered on clinicaltrials.gov as NCT01007838. 
Participants were randomly allocated to receive a progressive resistance exercise 
training intervention (PRET) or a sham exercise attention control intervention (SHAM) 
using opaque envelopes in a 1:1 manner, stratified by disease state (HD patients or 
healthy participants), sex and centre. 
Participants. All participants provided written informed consent. Ethical approval 
was provided by Betsi Cadwaladr University Health Board Ethics Committee and 
Bangor University.  HD patients were recruited from two main centre renal units in 
North Wales, United Kingdom. Eligible patients presented with Stage 5 CKD receiving 
maintenance HD three times per week. Patients were excluded if they were below 18 
years of age; received HD for less than three months; required support for ambulation of 
less than 50 metres; presented with haemoglobin levels below 11 g/dL; presented with 
any neuromuscular or catabolic conditions; had received any anabolic treatment in the 
preceding three months; presented with acute infection; had any uncontrolled medical 
condition (e.g. poor diabetic control, poor dialysis adequacy); poor dietary control 
requiring dietician referral (e.g. insufficient protein intake); presented with 
contraindications to take part in exercise or were unable to provide consent. 
Currently sedentary but otherwise healthy participants were recruited via 
opportunistic sampling from the local North Wales community using posters placed in 
community centres. Participants were excluded if their general practitioner deemed the 
participant to have a contraindication to exercise, had suffered from a catabolic 
condition or received an anabolic or exercise intervention in the preceding three months.  
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Intervention.  The PRET groups completed a 12 week progressive resistance 
training programme three times per week, during routine HD sessions for the patients 
and during regular University visits for the healthy participants. Participants were 
encouraged to eat a light meal two hours before each exercise session.  
 Each session involved a leg press exercise using specially designed equipment 
(Fitness Systems, Bolton, UK) designed to fit to the end of a dialysis chair (Stephen H 
Anatomical New, Gardhen Bilance, Pomigliano d‟Arco, Italy) (Figure 5.1.). Large 
training loads were required to allow adequate training progression but obtaining these 
loads with traditional plate loading machines was deemed as unsafe and impractical in 
the renal unit. Therefore, the leg press equipment was designed to utilize a series of 
resistance bands providing a maximum resistance equivalent to 200 kg. In a pilot study 
the equipment was validated by using a tension load cell (Model 615 S, Tedea 
Huntleigh, Vishay, Basingstoke, UK), resolved and converted to force in kg by a data 
acquisition and analysis system (PowerLab 16SP; AD Instruments PTY, Colorado 
Springs, CO) to determine the resistance of various combinations of the resistance 
bands throughout the range of movement of the machine.  These calculated resistances 
were used to set and record training intensity.   
At the beginning of the programme, the one repetition maximal strength of the 
participants was predicted from an assessment of their five repetition maximum lift.  
This method has been validated previously (Brzycki, 1993) and was used to reduce the 
theoretical risk of injury associated with one repetition maximal strength testing in this 
population (Painter & Krasnoff, 2002). In training sessions, participants completed a 
five minute warm up, and then carried out three sets of eight to ten repetitions at 80% of 
their predicted one repetition maximum with one to two minutes rest period between 
each set (Figure 5.2). Based on resistance exercise biology, this training protocol was 
deemed to be the most effective at eliciting a hypertrophic response (Kraemer et al., 
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2002). When 10 - 12 repetitions could be completed at a rating of perceived exertion 
(RPE) below 15 (hard), predicted one repetition maximum was re-determined and the 
resistance increased. Weekly training volume was calculated as kg per lift × lifts per 
session × sessions per week.   
The SHAM attention control group carried out a series of unprogressive stretches 
using an ultra light Thera-Band (Hygenic Corporation, Akron, Ohio; Figure 5.2.). 
One stretch was carried out per week; stretches were selected from dorsiflexion, 
plantarfexion, knee flexion, knee extension, hip flexion and leg extension exercises.    
Outcomes. Outcome measures were assessed two days before and two days after 
the first and last intervention session, respectively, using assessors blinded to group 
allocation. HD patients were assessed following a routine dialysis session and only if 
clinically determined dry weight targets were achieved. 
Thigh Muscle Volume. The primary outcome measure was thigh muscle volume 
(quadriceps femoris, hamstrings, adductors) determined by magnetic resonance 
imaging. A three Tesla Philips Achieva magnetic resonance imaging system (Philips 
Healthcare, Best, The Netherlands) was used to obtain T1 and T2 images in the axial 
plane from the femoral tibial joint line to the top of the femoral head. The image 
parameters were as follows: T1 - acquisition matrix of 236 x 236, FOV 475 x 475 x 
198, voxel size 2 × 2 mm
2
, TE 2.3 ms, TR 4 ms, slice thickness 5 mm, acquisition time 
3 minutes. An example of the images obtained is displayed in Figure 5.3. The muscle 
cross sectional area of 12 evenly spaced axial slices (Tracy et al., 2003) was determined 
by manual tracing using image processing software (Version 4.x, Osirix, Pixmeo, 
Geneva) run on a laptop (MacBook Pro, OS X 10.6, 2.9 GHz Intel dual core processor 
with 6 GB ram, Apple, Holyhill, Ireland). The truncated cone formula was applied to 
calculate muscle volume. The test re-test reliability of this protocol, obtained in five 
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participants over a period of two days, expressed as a coefficient of variation (CV) was 
1.5% with an interclass correlation (ICC3,k) of 0.997.   
Muscle Strength. Isometric bilateral knee extensor strength was measured using a 
custom made isometric chair (Bodycare Products, Southam, UK) equipped with a load 
cell (615 S, Tedea Huntleigh, Vishay, Basingstoke, UK), resolved and converted to 
force in newtons by a data acquisition and analysis system (PowerLab 16SP; AD 
Instruments PTY, Colorado Springs, CO). Following a sub-maximal warm up and 
familiarization trial, three maximal voluntary contractions were performed with a 
minute rest between each. The highest value was used in the analysis. The ICC3,k of this 
test has previously been reported as 0.960 (Macdonald et al., 2005). 
Physical Function. Physical function was determined using a selection of tests 
from the Senior Fitness Test (Rikkli & Jones 2001). Physical function tests included the 
30 second sit to stand test, a measure of lower body strength (ICC3,k = 0.89); the eight 
foot get up and go test, a measure of speed and agility (ICC3,k = 0.95) and the six minute 
walk test, a measure of aerobic capacity (ICC3,k = 0.94) (Rikkli & Jones 2001). 
Harms. Information on harms was collected actively at the beginning and end of 
each exercise session. Proformas (templates with information completed by a researcher 
following a set pattern) were completed following a participant interview and, in HD 
patients, by checking routine dialysis treatment records. Specifically, information on 
musculoskeletal injuries (cramp, muscle soreness, strain or joint pain), cardiovascular 
events (chest pain or shortness of breath confirmed by electrocardiograph or elevated 
cardiac markers), acute hypotension (fainting and concomitant low blood pressure), 
acute hypertension (headache, altered vision, nosebleed or shortness of breath and 
concomitant high blood pressure) and access complications (altered needle pressures 
requiring alterations to dialysis pump speed or access site pain) were recorded.  
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Other unexpected and serious (fatal, life threatening, or resulted in hospitalization) 
harms were collected passively as they occurred and during the trial period only. 
Decisions about whether events were attributable to the intervention were made by un-
blinded clinicians at each site (MMJ, NAJ and MJK). The decisions whether to 
withdraw a patient from the trial following a harm was made by discussion between a 
clinician and the patient. Regardless of attribution or withdrawal, all harms are reported 
here.   
Quality of Life. Although this study was not designed or powered to assess quality 
of life as a primary outcome, preliminary data on self reported quality of life were 
obtained using the Short Form-36 version 2 (SF-36v2) health survey questionnaire 
(Ware et al., 2007). The SF-36v2 consists of 36 items which encompass eight domains 
of quality of life including physical function, role limitations due to physical health, role 
limitations due to emotional problems, bodily pain, vitality, general health, emotional 
well being and social functioning.  
Statistical Analysis. Data on harms and compliance were presented descriptively 
only. Other data were analysed using the Statistical Package for the Social Sciences 
(version 18; IBM, New York, USA) and presented as mean (SD). Statistical 
significance was set at p ≤ 0.05. Absolute data and absolute change data are reported as 
mean (standard deviation). In this efficacy study data were presented and analysed on a 
per protocol basis. 
Training loads in the PRET groups over the twelve week period were compared 
using a repeated measures analysis of variance with a between group factor of disease 
state (HD vs. healthy) and a within group factor of time (weeks one to twelve). 
At first, a between groups analysis of covariance (ANCOVA) was conducted to 
assess the effectiveness of progressive resistance training in CKD and healthy groups on 
muscle volume, knee extensor strength, physical function and quality of life. Covariates 
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were pre test scores for all main outcome measures, taken prior to the administration of 
any intervention. Dependant variables were post test scores for all main outcome 
measures.  However, the ANCOVA assumption of homogeneity of regression slopes 
was violated. Therefore, absolute change scores were analyzed via a single factor 
ANOVA omnibus test with four groups: HD PRET, HD SHAM, healthy PRET and 
healthy SHAM. If this omnibus ANOVA was significant, comparisons of the response 
between groups were made by post hoc independent t tests on change scores without 
adjustment for multiple comparisons. Thus the response could be compared i) between 
PRET and SHAM within the HD patients; ii) between PRET and SHAM within the 
healthy participants; and iii) between HD patients and healthy participants within the 
PRET group. The mean difference of change scores between groups and 95% 
confidence intervals were reported for muscle volume, strength and physical function 
measures. Effect sizes (d) were also calculated for these post hoc comparisons using 
Cohen‟s method, and can be interpreted as small (0.3), medium (0.5) or large (0.8) 
(Cohen, 1988). 
Analyses were completed following assumption checks for parametric, 
independent, nominal and normally distributed data, as well as homogeneity of variance 
and sphericity.  
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Results 
 
Participants, compliance and training volume.  The participants‟ flow through 
the study is presented in Figure 5.4.. Demographic and anthropometric data are 
presented in Table 5.2.. Although there were no statistical differences between the 
disease groups for age, height, body mass, or body mass index, the patients were 
slightly (albeit not statistically) older than the healthy participants (54.1 (16.8) vs. 45.0 
(16.1) years, p = 0.2). All HD patient baseline biochemistry and dialysis data were 
within Renal Association recommended ranges (Table 5.2.) and did not significantly 
change in either group throughout the study (data not shown). Furthermore no patient‟s 
haemoglobin concentration dropped below 11 g·dL
-1
 during the study.  
In the PRET groups, training volumes significantly increased over the 12 week 
intervention period as evidenced by a significant analysis of variance main effect of 
time (p = 0.03, Figure 5.5.). An increase in training volume of a similar extent was 
observed in the healthy participants, shown by a non-significant group x time 
interaction (p = 0.3), and a non-significant main effect of group (p = 0.2).  Compliance 
to PRET was similar in both HD patients and healthy participants with 94 (3) % and 93 
(3) % of training sessions completed, respectively. Despite the high exercise intensity, 
all participants were able to complete all 3 sets of 8-10 repetitions throughout the 
programme. Reasons for missing sessions in the HD PRET group were illness (14 
sessions), scheduling issues (2 sessions) and dialysis equipment problems (2 sessions). 
Reasons for missing sessions in the healthy PRET group were holidays (8 sessions) and 
unexplained nonattendance (4 sessions).  
Thigh Muscle Volume.  PRET elicited a significant anabolic response in 
haemodialysis patients (Figure 5.6.; Table 5.3.) with a significant increase in muscle 
volume observed in HD PRET compared to HD SHAM (p = 0.007; d = 0.4; 95% CI, 
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193 [63; 324] cm
3
). A trend and strong effect size for a greater change in muscle 
volume was shown in healthy PRET compared to healthy SHAM (p = 0.1; d = 0.2; 95% 
CI, 169 [-41; 379] cm
3
) in response to PRET. There was no significant difference in 
muscle volume change between HD PRET patients and healthy PRET participants (p = 
0.5; d = 0.1) suggesting a similar anabolic response to resistance exercise.   
Knee Extensor Strength.  PRET elicited a significant strength response in 
haemodialysis patients (Figure 5.7.; Table 5.3.) as evidenced by a significantly greater 
change in HD PRET compared to HD SHAM (p = 0.01; d = 0.6; 95% CI, 56 [15; 98] 
N). A trend and strong effect size for a greater change in healthy PRET compared to 
healthy SHAM (p = 0.06; d = 1.0; 95% CI, 118 [-9; 245] N) was shown (Figure 5.7.; 
Table 5.3.). There was no difference in knee extensor strength between HD PRET 
patients and healthy PRET participants (p = 0.6; d = 0.2) suggesting a similar strength 
response to resistance exercise between HD and healthy participants. 
Physical Function.  PRET only elicited an improvement in physical functioning 
in healthy participants.  For sit to stand scores, a significant omnibus ANOVA (p = 
0.003; Table 5.3.) was followed up and revealed a significantly greater change in 
healthy PRET compared to healthy SHAM (p = 0.005; d = 0.2; 95% CI, 5 [3; 8] units). 
In contrast, in the HD patients the response to PRET was not different to SHAM (p = 
0.3; d = 0.3; 95% CI, 1 [-1; 4] units).  Furthermore, the response to PRET was greater in 
the healthy participants than in the HD patients (p = 0.004; d = 0.8). 
Similarly, for six minute walk distance, a significant omnibus ANOVA (p = 0.03; 
Table 5.3.) was followed up and revealed a significantly greater change in healthy 
PRET compared to healthy SHAM (p=0.01; d = 3.03; 95% CI, 31[36; 188] yards). In 
contrast, in the HD patients the response to PRET was not different to SHAM (p = 0.4; 
d = -0.17; 95% CI, 15 [-25; 54] yards). Combined with the finding that the response to 
PRET was similar in the healthy participants and the HD patients (p = 0.7, d = 0.32) the 
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data suggest that PRET enhances six minute walk distance, but in HD patients this 
enhancement is no greater than SHAM exercise.   
For eight foot get up and go scores the omnibus ANOVA was not significant (p = 
0.3; Table 5.3.) and therefore was not followed up.  Thus the data reveal that regardless 
of disease state PRET is no more effective than SHAM exercise at improving eight foot 
get up and go scores.  
Harms. In HD patients expected harms reported in the PRET and SHAM groups, 
respectively, were musculoskeletal (cramp: 5 vs. 5; delayed onset of muscle soreness: 1 
vs. 0; joint pains: 0 vs. 5) and hypotension (5 vs. 0). An unexpected reported harm was 
laceration wounds on the back (PRET: 1; SHAM: 0). In the healthy participants, only 
one musculoskeletal harm was reported (delayed onset of muscle soreness), and this 
was in the PRET group.  
Quality of Life. In the domains of bodily pain and social functioning, PRET 
generally had a positive effect in the healthy participants but this was not the case in the 
HD patients. Specifically, PRET elicited a large and significant improvement in bodily 
pain in healthy participants (omnibus ANOVA: p = 0.003; PRET: +34 (5) %; SHAM: -
3 (16) %; p = 0.005; d = 2.4) but not in HD patients (PRET: 0 (15) %; SHAM: +2 (15) 
%; p = 0.1; d = 0.1). PRET also elicited a large and significant improvement in social 
functioning in the healthy participants (omnibus ANOVA:  p =0.04; PRET: +23 (20) %; 
SHAM: -9 (19) %; p = 0.05; d = 1.4) but not in HD patients (PRET: +7 (18) %; SHAM: 
-1.5 (8) %; p = 0.2; d = 0.3).  Progressive resistance training had no significant effects 
on change scores for physical function (omnibus ANOVA: p = 0.1), role limitation due 
to physical problems (omnibus ANOVA: p = 0.5), general health (omnibus ANOVA: p 
= 0.3), vitality (omnibus ANOVA: p = 0.4) and role limitation due to emotional 
problems (omnibus ANOVA: p = 0.4) in either the healthy participants or HD patients.   
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Discussion 
 
In an attempt to determine if muscle wasting could be reversed in HD patients, the 
aim of this single blind randomized controlled trial was to implement an intradialytic 
exercise programme that met basic progressive resistance exercise training principles. 
As hypothesized, using novel equipment that allowed adequate overload and 
progression, twelve weeks of high intensity PRET elicited an anabolic response in HD 
patients and healthy participants.  PRET also increased muscle strength.  However, an 
unexpected finding was that in HD patients PRET was no more effective than SHAM 
exercise at improving functional capacity.  
When the temporal nature of muscle wasting observed herein in the HD SHAM 
group (and previously by other authors (Johansen et al., 2003; Johansen et al., 2006)) is 
taken into account, the anabolic response to PRET in HD patients appears to be normal. 
In the present study there is exactly a 6% difference in response of muscle volume 
between PRET and SHAM interventions, in both the HD patients and the healthy 
participants.  These data are somewhat in contrast to the majority of previous studies 
(Kopple et al., 2007; Cheema et al., 2007a; Cheema et al., 2007b; Castaneda et al., 
2001) and a recent meta-analysis (Heiwe & Jacobson, 2011) that have failed to show a 
significant hypertrophic response to exercise in HD populations.  The simplest 
explanation is that previous studies have not provided significant overload and 
progression; resistance training guidelines state that adaptation processes will only 
occur if a greater force is continually exerted to meet higher physiological demands 
(Kraemer et al., 2002). It is doubtful that this simple principle has been adhered to in 
previous studies that have prescribed intradialytic exercise utilising ankle weights that 
can only provide a maximum weight of 15 kg.  
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It should also be remembered that the anabolic response observed herein is 
supported by two previous studies (Johansen et al., 2006; Chen et al., 2010).  In fact, in 
those studies‟ the anabolic response was slightly larger (8-10%) than observed herein, 
perhaps because the present study utilized only one lower body exercise, where as 
previous studies have utilized multiple lower and whole body exercises that might be 
expected to induce a larger and systemic hypertrophic effect (Dong & Ikizler, 2009).  
Furthermore, in the present study the use of an attention control group rather than just 
routine care, and an outcome of whole thigh muscle volume rather than muscle cross 
sectional area, may reduce the size of the reported anabolic response. 
Encouragingly, these findings suggest that if anabolic resistance is present in HD 
patients (Mak et al., 2011), this resistance can be overcome providing exercise 
programmes are of sufficient training volume. Thus despite perturbed sex hormone, 
insulin and insulin like growth factor/growth hormone  pathways (Mak et al., 2011, 
Albaaj et al., 2006), an anabolic response to PRET is possible in HD patients. This 
finding is consistent with studies that have administered sex hormones (Johansen et al., 
2006) and insulin-like growth factor/growth hormone (Storer 2009), successfully 
increasing muscle volume.   
Interestingly, the response of functional capacity to PRET differed between HD 
and healthy participants. Although increases in strength in the HD patients following 
PRET appeared promising, they did not translate into improved sit to stand, get up and 
go or six minute walk test scores. In fact this disappointing finding is consistently 
reported in studies investigating intradialytic progressive resistance training in HD 
patients (Cheema et al., 2007a; Cheema et al., 2007b; Johansen et al., 2006; Chen et al., 
2010). This lack of an effect is particularly surprising, considering similar interventions 
carried out in other catabolic conditions (such as rheumatoid arthritis) have shown 
significant increases in the same measures of functional capacity as utilized in the 
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present study (Lemmey et al., 2009). It is noteworthy that for six minute walk test data, 
PRET and SHAM exercise similarly increased functional capacity; it is possible that 
despite familiarization with outcome measures, patients could have felt apprehensive 
and been over cautious in the baseline tests, resulting in a learning effect in both groups 
at post test. Variability in this learning effect may have masked any potential 
interactions (Hopkins, 2000). However, it is also interesting to note that intradialytic 
aerobic exercise has generally proven successful at enhancing functional capacity in HD 
patients (Macdonald et al., 2005; Cheema et al., 2006). Speculatively, intradialytic 
PRET may be compromised due to the difficulty of completing exercising on a dialysis 
chair, restricting movement throughout the range of motion required to improve 
functional capacity.  Medication use or comorbidities in this population may also blunt 
the expected functional response to PRET. Future research in this area could provide an 
interesting insight into the mechanisms behind enhanced functional capacity in this 
population.  
Progressive resistance exercise training also had no effect on QoL in HD patients. 
Assuming this was not due to being underpowered to detect changes in QoL, a possible 
explanation could be that patients who volunteer to take part in exercise trials are 
generally healthier patients with a better quality of life. In fact, the patients who took 
part in this study presented with QoL scores similar to age matched Welsh normative 
values of healthy individuals (Burholt & Nash, 2011).  In addition, exclusion criteria 
meant that patients with uncontrolled medical complications, and therefore an expected 
poorer QoL, were excluded from this study. It is possible that had these patients been 
included they may have experienced greater QoL changes as a result of an exercise 
intervention. 
A limitation to this study was the absence of whole body protein synthesis and 
diet measurements to indicate whether nutritional intake confounded body composition 
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responses. Previous literature has shown large increases in body fat percentage 
following PRET (Johansen et al., 2006; Headley et al., 2008), perhaps due to an 
increased appetite following exercise (Hopkins et al., 2011). In addition protein intake 
may moderate anabolism in response to muscle contraction (Burd, Wall & van Loon, 
2012). A further limitation lies in the small, conveniently sampled healthy control 
group. As a result, it is stressed that statistical comparisons between diseased and non-
diseased participants‟ response to PRET should be interpreted cautiously. However, the 
strength of including this comparison group is that it allows, for the first time, such 
comparisons to be made.  
In conclusion, using novel intradialytic equipment to allow adequate overload, 
PRET was safe, and increased muscle volume and strength in hemodialysis patients. A 
similar anabolic response to PRET was observed in HD patients and healthy 
participants, precluding assumptions of anabolic resistance to exercise in this patient 
population. However, the clinical significance of an increase in muscle volume by 6% 
(as observed herein) remains to be determined. While reversing muscle wasting is 
theoretically beneficial for reducing morbidity and mortality, the lack of an effect on 
functional capacity and quality of life was surprising and warrants further investigation.   
 138 
 
 
 
Figure 5.1. Novel resistance exercise equipment (Fitness Systems, Bolton, UK) designed equipment  
designed to fit to the end of a dialysis chair (Stephen H Anatomical New, Gardhen Bilance, Pomigliano 
d‟Arco, Italy). The leg press equipment utilised a series of resistance bands providing a maximum 
resistance equivalent to 200 kg. 
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Figure 5.2. Haemodialysis patients, allocated to the SHAM attention control group (left) and the PRET group (right), participating in their respective interventions during a routine 
haemodialysis session. 
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Figure 5.3. Example of a cross sectional T1 weighted magnetic resonance imaging scan of the thigh 
muscles. Slices are taken from 30% (top), 50% (middle), and 80% (bottom) of the length of the thigh as 
measured from the top of the femoral head to the femoral tibial joint line. 
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Figure 5.4. Participant flow throughout the study.  
PRET, progressive resistance exercise training; SHAM, attention control. 
*, completed additional exercise. 
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Figure 5.5. Training volume in progressive resistance exercise training groups over the 12 week intervention period. 
Training volume increased from week one to twelve similarly in both haemodialysis patients and healthy controls,  as evidenced by a significant main effect of time by analysis of 
variance (p = 0.03), a non-significant group x time interaction (p = 0.3) and a non-significant main effect of group (p = 0.2). 
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Figure 5.6. Changes in absolute thigh muscle volume by magnetic resonance imaging over the 12 week 
intervention period 
HD, haemodialysis patients; PRET, progressive resistance exercise training; SHAM, attention control.  
PRET elicited anabolic responses in haemodialysis patients and healthy participants, as evidenced by a 
significant omnibus analysis of variance (p = 0.01), and post hoc independent t-tests between PRET and 
SHAM groups (*, p < 0.05; , p < 0.10).  
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Figure 5.7. Isometric knee extensor strength absolute change over the 12 week intervention period. 
HD, hemodialysis patients; PRET, progressive resistance exercise training. 
PRET elicited a strength response in hemodialysis patients and healthy participants, as evidenced by a 
significant omnibus analysis of variance (p = 0.002), and post hoc independent t-tests between PRET and 
SHAM groups (*, p < 0.05; , p < 0.10). 
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Table 5.1. Current literature investigating the effects of resistance training on body composition measures of recommended nutritional endpoints in CKD patients. 
First Author Design Groups Intervention Outcome Measure Results Effect Size 
Intradialytic Studies 
Chen  
(2010) 
Nephrol Dial 
Tranplant 
RCT  Resistance 
Exercise 
 Control 
 
A
 Lower body PRT using 
ankle weights  
B
 2 x Week 
C
 60% 1RM (6-10 RPE) 
D
 2 sets x 8 reps 
E
 12 Weeks 
 
DXA 
Whole Body Lean Mass 
(kg) 
 
Exercise:  5%* 
Control:    3% 
 
Small/ Medium 
(0.4) 
Leg Lean Mass (kg) Exercise:  4%* 
Control:    4%  
Small 
(0.33) 
  Whole Body Fat Mass 
(kg) 
Exercise:  5%* 
Control:    7% 
Small 
(0.36) 
Cheema 
(2007) 
Am J Kidney 
Dis 
RCT 
 
 12 Week 
Resistance 
Exercise 
 24 Week 
Resistance 
Exercise 
 
A
 Whole body PRT using 
free and ankle weights 
B
 3 x Week 
C
 RPE 15 - 17 
D
 2 sets x 8 reps 
E
 12 Weeks 
CT 
Thigh Muscle CSA 
(cm
2
) 
 
Exercise:  2 % 
 
 
Medium  
(0.59) 
Intramuscular Fat  Exercise:0.2   % Very Small 
(0.07) 
Cheema 
(2007) 
JASN 
RCT  Resistance 
Exercise 
 Control 
 
A
 Whole body PRT using 
free and ankle weights 
B
 3 x Week 
C
 RPE 15 - 17 
D
 2 sets x 8 reps 
E
 12 Weeks 
 
 
CT 
Thigh Muscle CSA (cm 
 
Thigh Muscle 
Attenuation 
(Hounsfield Units)  
 
Total Mid Thigh Fat 
(cm
2
)  
 
Exercise:  1 % 
Control: 0.9 % 
Exercise:  1  
Control: 0.9 % 
 
Exercise:0.1  % 
Control: 0.5 % 
 
Small  
(0.3) 
Medium 
(0.52) 
 
Very Small 
(0.02) 
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Johansen 
(2006) 
JASN 
RCT  Resistance 
Exercise 
 Control 
 (Nandrolone 
Decanoate) 
 (Nandrolone 
Decanoate + 
Exercise) 
A
 Lower body PRT using 
ankle weights 
B
 3 x Week 
C
 60% 3RM 
D
 3 sets x 8 reps 
E
 12 Weeks 
DXA 
Lean Body Mass (kg) 
 
Exercise: 2 % 
Control:    0 % 
 
Very Small 
(0.18) 
Fat Mass (kg) Exercise: 9 %* 
Control: 0.4  % 
Very Small 
(0.16) 
MRI 
Quadriceps CSA 
 
Exercise: 3 %* 
Control:  7 % 
 
Medium 
(0.4) 
 
Supervised Outpatient Studies 
Kopple 
(2007) 
JASN 
RCT  Resistance 
Exercise 
 Control 
 (Aerobic 
Exercise) 
 (Resistance + 
Aerobic 
Exercise) 
A
 Lower body PRT using 
weight machines 
B
 3 x Week 
C
 70-80% 5RM 
D
 3 sets x 8 reps 
E
 18 Weeks 
Anthropometry 
Mid Thigh Muscle Area 
(cm
2
) 
DXA 
Fat free Mass (kg) 
 
 
Leg Fat Free Mass (kg) 
 
Exercise: 3 % 
Control:   1 % 
 
Exercise: 1 % 
Control:   2 % 
 
Exercise: 2 % 
Control:   1 % 
 
Medium  
(0.4) 
 
Very weak 
(0.1) 
 
Very Weak 
(0.06)    
   
Headley 
(2002) 
Am J Kidney 
Disease 
Within 
Subject 
 Control 
 Resistance 
Exercise 
A
 Whole body PRT using 
weight machines 
B
 2 x Week 
C
 10 -15 RM (RPE 15) 
D
 3 sets x 8 reps 
E
 12 Weeks 
 
 
 
Anthropometry 
(Skinfolds) 
Fat (%) 
 
 
Exercise:   4% 
Control:  2% 
 
 
Small 
(0.4) 
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Casteneda 
(2001) 
Ann Intern 
Med 
RCT  Control 
 Resistance 
Exercise 
A
 Whole body PRT using 
weight machines 
B
 3 x Week 
C
 80% 1RM 
D
 3 sets x 8 reps 
E
 12 Weeks 
CT 
Thigh Muscle CSA 
(cm
2
) 
 
Exercise: 2 % 
Control:   2 % 
 
Small 
(0.2) 
 
RCT, Randomised Controlled Trial; DXA, Dual X-Ray Absoptiometry; CT, Computerised Tomography; MRI, Magnetic Resonance Imaging; CSA, Cross Sectional Area; *, 
statistical significance declared (p<0.05); A, mode of exercise; B, frequency of exercise; C, intensity of exercise; D, training volume per session of exercise; E, length of intervention.   
. 
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Table 5.2. Baseline characteristics of all groups 
Characteristic Haemodialysis patients Healthy participants 
PRET SHAM PRET SHAM 
Age (years) 48 (18) 58 (15) 50 (15) 40 (17) 
Sex (male/female) 7/2 6/4 2/2 0/4 
Body mass index (kg/m
2
) 25 (3) 26 (5) 30 (7) 25 (5) 
Comorbid conditions 
Hypertension 
Diabetes 
Myocardial infarction 
    
5 4 1 1 
0 2 0 0 
0 3 1 0 
Number on medications 
Beta blockers 
Ace inhibitors 
Angiotensin  
receptor blockers 
Calcium channel blockers 
Alpha blockers 
Benzodiazepines 
Erythropoiesis Stimulating Agents 
    
5 2 1 0 
3 4 0 0 
0 0 0 0 
2 5 0 0 
1 2 0 0 
0 4 0 1 
6 7 0 0 
Etiology of HD 
Glomerulonephritis 
Infective/Obstructive 
Hereditary 
Uncertain 
  
N/A N/A 
4 5 
1 1 
1 0 
3 4 
Dialysis Vintage (months) 46 (54) 66 (47) 
N/A N/A 
Kt/Vurea 1.34 (0.13) 1.50 (0.24) 
Hemoglobin (g·dL-1) 11.7 (1.8) 12.1 (2.1) 
Albumin 41 (3) 42 (3) 
Serum bicarbonate (mmol·L-1) 22.4 (3.2) 22.5 (2.7) 
Serum potassium (mmol·L-1) 4.8 (1.0) 5.0 (0.6) 
 
PRET, progressive resistance exercise training; SHAM, attention control. 
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Table 5.3. Muscle volume, strength and physical functioning absolute data before and after the 12 week intervention period. 
 
Outcome measure Hemodialysis patients Healthy participants Analysis 
of 
change 
scores
a
 
HD 
PRET 
vs. 
healthy 
PRET
b
 
HD 
PRET 
vs.  
HD 
SHAM
b
 
Healthy 
PRET 
vs. 
healthy 
SHAM
b
 
PRET SHAM PRET SHAM Statistical significance (p value) 
Muscle volume (cm
3
)         
Pre 2822 (438) 2490 (601) 2877 (710) 2183 (527) 0.01 0.531 0.007 0.096 
Post 2906 (489) 2380 (643) 3013 (863) 2151 (527)     
Knee extensor strength (N)          
Pre 179 (109) 151 (79) 382 (103) 239 (80) 0.002 0.636 0.012 0.064 
Post 287 (86) 201 (77) 471 (191) 210 (31)     
Sit to stand (reps)         
Pre 11 (2) 10 (4) 21 (6) 23 (6) 0.003 0.005 0.270 0.004 
Post 13 (3) 11 (5) 28 (8) 25 (7)     
8 foot get up & go (s)         
Pre 5.8 (1.2) 6.7 (1.8) 4.4 (0.2) 4.3 (0.7) 0.260 N/A N/A N/A 
Post 5.0 (0.8) 6.2 (1.8) 3.8 (0.4) 4.5 (0.2)     
6 minute walk distance (m)         
Pre 532 (95) 460 (162) 536 (47) 559 (26) 0.026 0.701 0.446 0.012 
Post 571 (101) 520 (160) 600 (54) 511 (38)     
 
PRET, progressive resistance exercise training; SHAM, attention control.  
a
, omnibus single factor analysis of variance; 
b
, post hoc independent t-test; N/A, not applicable (analysis 
of variance omnibus did not reach significance negating need for follow up test.
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CHAPTER 6 
General Discussion
 151 
 
Summary of Findings 
 
The aim of this thesis was to investigate the effect of exercise on outcomes related 
to QoL and survival in CKD Stages four and five. In general, randomised controlled 
data suggested that exercise had some beneficial effect on outcomes relating to 
hospitalisation, morbidity and mortality in this patient population. The observed 
benefits of exercising outweighed its risks, thus supporting the initiative for adjunctive 
exercise prescription in the management of this disease state. 
In the renal transplant population existing literature reveals that exercise has a 
beneficial effect on intermediate outcomes such as aerobic capacity and muscle 
strength, which possibly contribute to the improved QoL observed in this cohort. 
Exercise is recommended in this patient group with prescriptions based on guidelines 
provided for the specific co-morbidies of each individual patient. Home based 
interventions should be supported and encouraged by healthcare providers. In order to 
enable more detailed evaluation of exercise intervention on outcome measures in this 
cohort future studies require better quality interventions with strong research designs. 
The effects of exercise on endpoint outcome measures such as morbidity, 
hospitalisation and mortality still warrant investigation. 
Despite current guidelines to implement post operative hand grip exercise for 
AVF maturation, a feasibility study revealed post operative forearm exercise to have 
little to no effect on AVF vasculature diameters, operative success or maturation. 
However, a similar exercise prescription implemented prior to AVF creation could 
potentially enhance surgery success.  
Implementing intradialytic exercise proved effective at enhancing dialysis 
adequacy in terms of phosphate clearance and could potentially be prescribed for 
phosphate control. However, intradialytic exercise did not enhance dialysis adequacy 
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defined by small and middle molecule toxin clearance. Nevertheless exercise did not 
result in increased production of these uremic solutes. Therefore, haemodialysis patients 
that partake in exercise are not at risk of an increase in uremic toxin and harmful 
metabolite production as a result of exercising intradialytically.  
High intensity progressive resistance exercise training during dialysis prevented 
muscle wasting, significantly increasing muscle volume and strength following three 
months of training. Preliminary evidence was provided to suggest that the anabolic 
response in the haemodialysis population was similar to that observed in healthy 
sedentary individuals, dispelling previous conceptions suggesting anabolic resistance in 
this cohort. Interestingly, despite changes in muscle volume and strength, these 
increases did not render the expected benefits in physical function.   
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Methodological Advancements 
 
The strength of the studies reported in this thesis lies in their attempts to reduce 
risks of bias. The review of exercise in the transplant population was completed 
systematically and extensively evaluated the risk of bias.  The objective and explicit 
methods employed in a systematic review limit bias and improve the reliability and 
accuracy of conclusions in comparison to a standard review. This review extensively 
assessed the risk of bias associated with each study and also addressed the „FITT‟ 
(Frequency, Intensity, Type, Time) principle (Segura-Orti & Johansen, 2010) as a part 
of the quality assessment of intervention studies. These factors allow the appropriate 
interpretation of the available evidence. In addition, they encourage superior 
methodological designs in future studies. A further strength of the systematic review is 
that it reveals the exaggerated effect observed with weaker methodologies.  For 
example, with regards to glucose tolerance, observational and cross sectional studies 
suggest higher habitual physical activity levels and exercise participation in glucose 
tolerant patients whereas interventional studies reveal disparate findings with small 
effect sizes on blood glucose concentrations.    
Intervention studies in this thesis were of a randomized controlled nature, utilising 
gold standard outcome measures and implementing of superior exercise prescriptions 
that adhered to the „FITT‟ principle. Based on exercise physiology these interventions 
could plausibly be effective at enhancing the respective outcome measures.  
Albeit being a feasibility study, the investigation into forearm exercise for AVF 
maturation is the only known randomised controlled trial to investigate the effects of 
this type of exercise immediately post AVF surgery, despite clinical recommendations 
made in its favour (National Kidney Foundation, 1997). Furthermore, in comparison to 
previous research in the field (Kumar et al., 2010; Oder, Teodorescu & Uribarri, 2003; 
 154 
 
Rus et al., 2005; Rodriguez Moran et al., 1984), it encompassed a rigorous exercise 
prescription providing adequate progression and a sufficient exercise frequency and 
duration to theoretically have a physiological effect on the relevant outcome measures.  
This feasibility study employed the use of duplex ultrasound as a non invasive 
technique to assess AVF vasculature parameters as outcome measures. The use of 
duplex ultrasound to assess anatomical and flow parameters of an AVF has been shown 
to have a high diagnostic value (Tordoir et al., 1989) and is recommended by current 
clinical guidelines supported with a high evidence level (National Kidney Foundation, 
1997). However, it should be noted that this technique is prone to suffer from operator 
dependency (Tordoir et al., 1989) as was observed when assessing flow volume in this 
feasibility study. Future research should therefore ensure a single experienced vascular 
sonographer at each centre. Furthermore, new outcome measures to predict AVF 
maturation have recently come to light including venous compliance (King et al., 2012) 
and pulse pressure measurements (Mengnjo et al., 2012). These could possibly be 
considered as additional outcome measures in future trials.  
With regards to intradialytic exercise prescription for dialysis adequacy, five other 
randomised controls have previously been reported in this area (Kong et al., 1999; 
Parsons, Toffelmire & King-Van Vlack, 2004; Leung, 2004; Vaithilingam et al., 2004; 
Adorati, 2000). The current study considered the prescription parameters of these 
previous studies in an attempt to implement a more effective exercise prescription. For 
example, in terms of exercise duration, Kong et al., (1999) who showed a significant 
increase in Kt/Vurea as a result of exercise, implemented exercise for 60 minutes during 
dialysis with ten minute rest periods between exercise bouts. Alternatively, studies that 
revealed no increases in Kt/Vurea exercised for shorter durations (less than 30 minutes) 
and with longer rest periods (up to 60 minutes)  (Parsons, Toffelmire & King-
VanVlack, 2004; Leung, 2004; Parsons, Toffelmire & King-VanVlack, 2006; Adorati 
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2000). This observation inferred that if high blood flow to low perfusion tissues was not 
sustained for longer than 30 minutes it would not allow sufficient time to enhance small 
molecule clearance from these lean tissue areas. In this regard, using simulative 
equations Smye, Lindley & Will (1998) estimated that blood flow to low perfusion 
areas gradually increases during exercise over 20 - 30 minutes before reaching a 
plateau. In addition, in the current study exercise was prescribed at the end of dialysis 
which differs from previously reported studies that implement exercise during the first 
two hours of dialysis (Parsons, Toffelmire & King-VanVlack, 2004; Leung, 2004; 
Parsons, Toffelmire & King-VanVlack, 2006; Adorati 2000). As previously mentioned, 
the rationale for this was based on  mathematical predictions stating that sustaining high 
blood flow to normally low flow tissue areas in the last 30 minutes of a 150 min dialysis 
session will almost completely eliminate post dialysis urea rebound (Smye, Lindley & 
Will 1998). 
Further methodological strengths of this study lie in the closely controlled 
treatment parameters throughout the study. Trend files downloaded from the dialysis 
machines recorded treatment parameters at 2 s epochs throughout each dialysis session 
allowing extensive analysis and control over these confounding variables. 
Measurements of toxins in the serum as well as the gold standard measurement of 
toxins cleared in the waste dialysate by continuous sampling of spent dialysis (CSSD) 
provided a double pool insight into the kinetics of the measured solutes. However, a 
limitation lies within the high intraindividual variation of the CSSD measure reported in 
this study. Future research should take this into consideration and potentially adapt the 
CSSD equipment in attempt to enhance the reliability of this measure.       
The investigation into progressive resistance training reported in this thesis adds 
to the randomised controlled data previously reported in four studies observing the 
effects of intradialytic resistance exercise on whole body composition measures 
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(Cheema et al., 2007a; Cheema et al., 2007b; Johansen et al., 2006; Chen et al., 2010). 
The current study adds methodological advancements to those previously reported 
(Cheema et al., 2007a; Cheema et al., 2007b; Johansen et al., 2006) in that the novel 
equipment utilised allowed the prescription of a very high intensity of exercise as well 
as an adequate progression with gains in strength, both of which are deemed necessary 
to elicit an anabolic response (Kraemer et al., 2002).  
The current study also incorporated the gold standard body composition of 
magnetic resonance imaging providing a more accurate measure of muscle mass 
compared to other anthropometric and nutritional measures which tend to underestimate 
protein wasting (Mathur et al., 2008). Furthermore, the measurement of muscle volume 
by magnetic resonance imaging provides a recommended endpoint of nutritional status 
in this patient population (Senior & Maroni,1999) in comparison to previous methods 
employed such as total body potassium or muscle fibre cross sectional area (Castaneda 
et al., 2001). In fact, the use of differing body composition methods across trials in this 
area may provide a partial explanation in the disparity in the findings. For example, 
Casteneda et al., (2001) reported a significant increase in total body potassium and 
muscle fibre cross sectional area following an outpatient resistance exercise programme 
yet no significant change in thigh muscle cross sectional area measured by 
computerized tomography was observed. In addition, Johansen et al. (2006) observed a 
significant increase in quadriceps cross sectional area as measured by magnetic 
resonance imaging, yet no significant change in lean body mass as measured by dual x-
ray absorptiometry following an intradialytic resistance exercise programme.  
A potential measure for future research could be to investigate changes in muscle 
quality by analyzing contractile tissue and intramuscular fat. This could be 
accomplished firstly by refining the scanning protocol implemented herein to obtain 
clearer images. These images can then be assessed for contractile tissue and 
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intramuscular fat by plotting signal intensity threshold histograms as shown in Figure 
6.1 (Holmback et al., 2002).
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Theoretical Physiology 
 
The body‟s response to the stress of exercise can often provide interesting insights 
into physiological mechanisms in both healthy and diseased populations. It is beyond 
the scope of the studies reported in this thesis to directly explore the intricate molecular 
or genetic mechanisms underlying exercise responses in the CKD population. However, 
the results of the studies can inform physiological hypotheses regarding the mechanistic 
responses to exercise and also potential physiological abnormalities within this disease 
state. 
Shear Stress and Arterial Remodelling. Sustained increases in blood flow lead to 
structural arterial remodelling. In response to acute increases in shear stress (the 
tangential force exerted by blood flow on the vessel wall) nitric oxide is released from 
the endothelial cells inducing a rise in intracellular smooth muscle cell cGMP resulting 
in vessel wall dilation (Dammers et al., 2005b). When this haemodynamic milieu is 
chronic, structural remodelling such as an increase in vessel wall thickness is observed 
(Dammers et al., 2005b). In this thesis, forearm exercise which induced acute 
hyperaemia, unexpectedly had no effect on proximal AVF vasculature cross sectional 
area. At first possible explanations for this discouraging finding were thought to be that 
either i) the forearm exercise prescribed did not allow sufficient and sustained increases 
in blood flow to allow structural remodelling or ii) the impaired endothelium dependent 
vasodilation observed in uremia (Morris et al., 2000) due to a reduced stimulation of 
nitrogen oxide (Passauer et al., 2005) could pose as resistance to the beneficial vascular 
effects of exercise.  
However, despite this suspected endothelial dysfunction, normal vascular 
responses in the brachial artery have previously been observed in response to shear 
stress increases in CKD patients (Dammers et al., 2005b). Additionally, increases in 
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forearm vasculature diameter have previously been reported in CKD patients 
participating in hand grip exercises on the non fistula arm or prior to AVF creation (Rus 
et al., 2005) .  
A similar ~5 fold increase in shear stress is observed in the radial artery acutely in 
response to the hyperaemia of hand grip exercise and chronically that of AVF creation 
(Girerd et al., 1996; Gonzales et al., 2009). It therefore appears surprising that 
additional vascular remodeling is not observed when theoretically speaking sheer stress 
should be acutely doubled by combining exercise with AVF formation. However, a 
possible explanation could lie in a finding reported by Dammers et al. (2005b) who 
inferred that the large increase in blood blow associated with AVF formation exceeds 
the adaptation capacity of the radial arteries. Therefore, it could be hypothesised that 
further increasing shear stress through exercise would be futile as the challenge imposed 
to the arterial system by the AVF formation already exceeds the vascular adaptation 
capacity.  
Kinetic Modeling of Uremic Toxins. Although exercise successfully increased 
phosphate clearance, the discouraging findings in relation to small and middle molecule 
clearance following exercise encouraged an exploration into the dialytic kinetics of the 
measured toxins. The aim of this discussion was not to prove the accuracy of one 
kinetic model over another but to explain these findings. Kinetic models are largely 
derived from simulations and, as biological and epidemiological data in their support is 
lacking (Eloot, Schneditz & Vanholder, 2012), it should be noted that these models are 
debatable. 
With regards to the small molecule urea, the hypothesis that intradialytic exercise 
would increase urea clearance was based on a parallel regional blood flow kinetic 
model. This model separates organ systems to a high or low flow systems according to 
their specific blood perfusion (Schneditz, Platzer & Daugirdas, 2009) (Figure 6.2.). The 
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model assumes that delayed urea removal is related to low perfusion of the muscle 
tissue compartment and that increased blood flow to low perfusion tissue will result in a 
greater urea clearance (Schneditz et al., 1995; Schneditz & Daugirdas, 2001). Simulated 
mathematical equations based on this model have suggested that increasing blood flow 
to low perfusion tissue by exercise hyperemia towards the end of dialysis would 
significantly increase urea clearance and almost completely eliminate urea rebound 
(Smye, Lindley & Will, 1998). However, the biological findings reported in this thesis 
do not support this model as hyperemia to the low perfusion muscle tissue did not have 
an effect on neither urea clearance nor urea rebound. Alternatively, these finding could 
be explained by the classic serial diffusion model which consists of simple connections 
between intra and extracellular compartments (Eloot, Schneditz & Vanholder, 2012) 
(Figure 6.3). This model incorporates a total body distribution of urea (Eloot, Schneditz 
& Vanholder, 2012) whereby the rapid transfer of urea from the intracellular to the 
extracellular compartment results in a precipitous equilibration of whole body urea 
(Metry et al., 1993). Within this model, intracorporeal changes in blood flow would not 
affect urea kinetics and therefore this classic model could provide support for the 
finding that increased dialysis time enhanced urea clearance whilst intradialytic exercise 
did not.  
The biological finding that beta2-microglobulin clearance tended to be increased 
with a longer dialysis duration over intradialytic exercise is consistent with classical 
serial modeling which is based on intercompartmental transfer. In the case of  beta2-
microglobulin,  its high transfer coefficient resulting in slow intercompartmental 
transfers appears to be the rate limiting factor of its removal (Leypoldt, 2005). Thus 
increasing intracorporeal blood flow would have no effect on the membrane transfer 
coefficient of this molecule whilst longer dialysis would allow more time for the 
transfer of this molecule across relevant membranes. Again, the notion that our findings 
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are consistent with serial kinetic modeling as opposed to the parallel model are 
supported by a recent beta2-microglobulin modeling investigation carried out by 
Maheshwari et al. (2011). The authors of this study established a regional blood flow 
model for beta2-microglobulin based on the assumption that hyperemia would result in 
an increased capillary surface area as well as an increased membrane pore size 
ultimately leading to enhanced toxin removal and thus reduced rebound. However, 
when the effect of exercise was simulated using this model there was no effect on the 
toxin rebound ratio. The authors state that both cardiac output and blood flow to 
differing perfusion regions are less important model parameters whilst toxin distribution 
volume and inter-compartmental clearance coefficients are more important parameters.  
Phosphate differs greatly from the previously mentioned uremic toxins as it 
presents with a four pool kinetic model during dialysis. A biphasic regulation of 
phosphate occurs whereby phosphate in released from a third and fourth pool when 
phosphate levels reach low and critically low levels respectively during the later stages 
of dialysis (Spalding, Chamney & Farrington, 2002). The physiologic mechanisms 
behind the increased phosphate removal during intradialytic exercise are unknown. 
However, it could be hypothesised that when exercising during the latter half of dialysis 
the phosphate produced from the muscle as a result of energy metabolism (Sorlie et al., 
1982) acts as a potential fifth pool prohibiting the need for phosphate release from the 
third and fourth pools. When exercise is complete, the excess serum phosphate released 
from the muscle is utilized for energy replenishment leading to reduced serum 
phosphate levels (Figure 6.4).   
Anabolic Resistance. Previous discouraging findings in response to intradialytic 
resistance exercise for skeletal muscle anabolism (Cheema et al., 2007a; Cheema et al., 
2007b; Johansen et al., 2006) have led to an underlying theory that CKD patients may 
in fact be resistant to the anabolic effects of exercise due to an irregularity in the insulin- 
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like growth factor 1 (IGF-1)/growth hormone (GH) axis (Mak, Cheung & Roberts, 
2008; Burd, Wall & van Loon, 2012). In healthy individuals resistance exercise 
stimulates skeletal muscle hypertrophy via mechanical and hormonal responses which 
activate signaling pathways promoting protein synthesis and reducing protein 
degradation. With regards to the hormonal response, resistance exercise results in an 
increase in GH which, when fitted into membrane receptors initialises several 
downstream signals leading to protein synthesis. In addition GH leads to increased IGF- 
1, a hormone which stimulates proliferation and differentiation of stem cells. However, 
in CKD there appears to be an IGF-1 insensitivity in that IGF-1 binding proteins, 
usually cleared through the kidney, are increased thereby decreasing the bioavailability 
of IGF-1 (Mak, 2008). Furthermore, a diminished IGF-1 gene expression in response to 
supramaximal increases in GH have been reported in CKD rat models (Mak, 2008). 
However, this theory had has not yet been fully tested in this patient population. Thus 
research warranted an exercise intervention deemed most appropriate for increases in 
skeletal muscle mass as was implemented in this thesis. The current findings revealed 
that skeletal muscle mass increased in CKD patients following high intensity 
progressive resistance exercise. Furthermore, although interpreted with caution due to a 
smaller sample size, this anabolic response appeared to be similar to that observed in 
healthy individuals thus questioning the previous conceptions regarding anabolic 
resistance. Therefore despite the hormonal irregularities reported in the disease state 
(Mak et al., 2011) they do not deter from the mechanisms behind skeletal muscle 
anabolism.      
 Mechanisms of Increased Physical Function. Of great interest was the lack of a 
physical function response to the reported progressive resistance training in CKD 
patients despite significant increases in muscle volume and strength. As small increases 
in physical function were observed in the control group a possible explanation could be 
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that there was a potential learning effect for the functional tests; variability in this 
learning effect may have masked any potential increases in these measures (Hopkins, 
2000). However, this does not explain neither the significant increase in physical 
function observed in the healthy group participating in the exact same intervention nor 
the consistently repeated finding showing no increase in objective functional measures 
following intradialytic resistance training in this population (Cheema et al., 2007b; 
Johansen et al., 2006; Chen et al., 2010).  
A further possible explanation may be that exercising in the dialysis environment 
could imply restrictions to the range of motion of exercises therefore limiting their 
functional benefit. However, this does not explain the increases in strength observed 
with intradialytic training (Cheema et al., 2007b; Johansen et al., 2006; Chen et al., 
2010) and furthermore, the increases in physical function observed in the healthy 
participants carrying out exercises with the same range of motions as the haemodialysis 
patients. 
The fact that increases in physical function have been observed following similar 
interventions in other disease states (Lemmey et al., 2009) implies that the explanation 
lies within factors corresponding to chronic kidney disease. However, this explanation 
is eliminated when increases in physical function are consistently reported following 
aerobic exercise intervention in this patient cohort (Heiwe & Jacobson, 2011).  
This finding could give us an insight into the mechanisms behind increased 
physical function in dialysis patients. Usually, in healthy individuals, changes in 
physical function with increased muscle mass are partly due to an increased number of 
motor neurons (McArdle, Katch & Katch, 2001). However 60 – 100% of dialysis 
patients present with peripheral neuropathies characterised by segmental demyelination 
and axonal degradation and furthermore motor neurons have been shown to be 
depolarised before dialysis due to hyperkalemia (Krishnan, Pussell & Kiernan, 2009). 
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As well as this, myopathies in the form of muscle fibre splitting and degradation, 
nuclear knots and fatty infiltration are also common in this patient population (Diesel et 
al., 1993). These factors could potentially inhibit changes in physical function through 
motor unit changes. It could be speculated that the physiological stimuli of aerobic 
exercise that are responsible for changes in physical function, such as mitochondrial 
biogenisis (Lanza, Sreekumaran & Nair, 2010) for example, are the more dominant 
mechanisms behind changes in physical function following exercise in this population. 
However, this hypotheses is only speculative and the observed increase in strength 
leaves it very much up to debate. Irrespectively, the mechanisms behind physical 
function in haemodialysis patients make for an interesting area for future research.  
 165 
 
Limitations  
 
Although specific limitations are highlighted in each chapter, the major limitation 
to this thesis lies in the generalisation of extrapolating the results across the CKD 
population. Anecdotally speaking, in most exercise studies in haemodialysis patients 
those who volunteer to participate in the exercise interventions are usually the patients 
who present with a better self reported quality of life and superior physical health, 
fitness and function. Additionally, the strict exclusion criteria implemented for ethical 
purposes in these studies prohibit patients of a poorer health status from participating in 
exercise, when in fact these patients would possibly show greater beneficial responses 
to increased physical activity. As a result, the findings of the studies reported herein 
may possibly be underestimated due to the selection bias of the samples. 
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Conclusions and Future Directions 
 
The systematic review of already existing findings in the kidney transplant 
population reported exercise to enhance outcomes such as aerobic capacity, strength and 
quality of life. This thesis reported evidence that exercise has a beneficial effect on 
dialytic solute clearance, skeletal muscle anabolism and strength as well as a potential 
for enhanced AVF success and maturation. The findings add to the myriad of health 
benefits of exercise reported in the CKD population including increased physical fitness 
and function (Heiwe & Jacobson, 2011), cardiovascular adaptations (Cheema 2008), 
quality of life (Heiwe & Jacobson, 2011) and longevity of life (O'Hare et al., 2003).  All 
harms reported in the studies were resolved without late effects or sequalae inferring 
that exercise in this cohort is safe and its benefits outweigh any potential risks.  
Yet, despite the wealth of literature documenting the health benefits of exercise as 
well as clinical guidelines recommending exercise participation in dialysis patients 
(K/DOQI Workgroup 2005) and even furthermore, the fact that the majority of patients 
strongly agree that a sedentary lifestyle poses a health risk (Delgado & Johansen, 2012), 
exercise is still not prescribed as part of routine care in the CKD population. For 
example, in comparison to cardiovascular disease whereby ~400 cardiac rehabilitation 
programmes are run in the UK (Lewin et al., 2010), only 10% of the 72 nephrology 
centres in the UK offer some form of exercise intervention as adjunctive therapy to 
CKD patients (British Renal Society Renal Rehabilitation Network, 2012). Reported 
barriers to exercise appear to be factors such as fatigue, lack of motivation and shortness 
of breath (Delgado & Johansen, 2012). Of more importance appears to be the barrier of 
deficient counseling of physical activity amongst healthcare providers with staff 
reporting a lack of confidence in their ability to administer information regarding 
exercise (Delgado & Johansen, 2010). In addition, there appears to be a disparity in 
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physician and patient opinions whereby a large proportion of physicians assume dialysis 
patients to be uninterested in physical activity when in fact patient surveys suggest that 
this is the case in only ~4% of patients (Delgado & Johansen, 2012). This problem 
needs to be addressed as patients trust the advice of their health care providers (Schutzer 
& Graves, 2004) and therefore staff can play a pivotal role in the initiation and 
maintenance of exercise behaviour.  
As addressed in all chapters of this thesis,  exercise prescriptions should  follow 
the FITT principle which should be based on the basic exercise physiology of the 
desired outcome in order to enhance efficacy and efficiency of the intervention.  
Although the positive findings relating to exercise participation reported in this 
thesis provide noteworthy and interesting information, the requisite for more large scale, 
multicentred, randomised controlled trials investigating hard outcome measures such as 
quality of life and mortality in CKD patients is still outstanding. Furthermore, the 
essential establishment of clear guidelines regarding the most effective exercise 
prescriptions are warranted in order to implement exercise as an adjunctive therapy in 
CKD on a large scale.     
 
           
            
 
 
 
 
 168 
 
 
Figure 6.1. An illustration taken from (Holmback et al., 2002) of the method used to determine 
contractile and non contractile components of muscle from a cross sectional magnetic resonance image 
slice of the ankle dorsiflexor muscles.  Signal intensity thresholds are determined for five clear different 
regions of interest (ROI). A: a mixture of contractile and non contractile tissue; B: background image; C 
& D: two smaples of what appears to be contractile tissue; E: subcutaneous fat only. From the signal 
intensity plots it can be seen that contractile tissue lies between 100 and 300 and intramuscular fat lies 
between 780 and 990. The ROI (e.g. a certain muscle group) is then selected and the percentage of pixels 
that lie between 100 and 300 will represent the percentage of contractile tissue and likewise for 
intramuscular fat. This method of analysis has been shown to be highly reliable (Holmback et al., 2002) .  
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Figure 6.2. The parallel regional blood flow kinetic model (Schneditz, Platzer & Daugirdas 2009). He, 
extracellular high-flow system; Hi, intracellular high-flow system; Le, extracellular low-flow system; Li, 
intracellular low-flow system; QL, low flow; QH, high flow; Qc, cardiac output; Qf, fistula flow; Qx, 
extracorporeal blood flow. 
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Figure 6.3. The classic two compartmental serial model (Eloot, Schneditz & Vanholder 2147). V1, plasma 
volume; V2, non-plasmatic volume; V, total distribution volume; C1, plasma concentration; C2, non-
plasmatic concentration; G1 and G2, generation rate in V1 and V2; E1 and E2, metabolic elimination in V1 
and V2; KR, renal clearance; KER, extra renal clearance; KD, dialyser clearance; K12, intercompartment 
clearance. 
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Figure 6.4. A schematic representation of the four-compartment model adapted from Spalding, Chamney 
& Farrington (2002) describing the kinetics of phosphate during both short and long haemodialysis 
treatments as well as intradialytic exercise during the end of dialysis . This model is a conventional two-
compartment model describing diffusive (Fd) and convective (Fc) fluxes across the dialysis membrane 
comprising a dialyzer phosphate clearance (Kd). Also indicated here is intercompartment phosphate flux 
(F1) governed by the intercompartmental mass transfer coefficient (Kie). The unique aspect of this model 
is the addition of a third pool or compartment that releases phosphate into the extracellular compartment 
(F3) based on the difference between the calculated intracellular and intrinsic intracellular target 
intracellular phosphate concentration and a fourth pool or compartment that releases phosphate 
intracellularly to protect the intracellular environment from dangerously low phosphate concentrations 
(F4) (Leypoldt, 2005). During intradialytic exercise it is hypothesised that the muscle acts as a fifth pool 
releasing phosphate (F5) and preventing the regulatory requirement of phosphate release from the third
 
and fourth pools. Following exercise serum phosphate is utilized to replenish energy stores (F6). The 
intracellular and extracellular compartments are indicated by subscripts i and e, respectively. 
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